fluorodeoxyglucose f18 has been researched along with Cancer of Head in 1086 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (0.18) | 18.7374 |
| 1990's | 70 (6.45) | 18.2507 |
| 2000's | 336 (30.94) | 29.6817 |
| 2010's | 502 (46.22) | 24.3611 |
| 2020's | 176 (16.21) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, S; Baker, A; Conboy, P; Haider, A; Haris, PA; Mair, M; Raj, L; Thiagarajan, S; Vaidhyanath, R; Walter, H; Wright, S | 1 |
| Deraniyagala, R; Grzywacz, VP; Hanna, A; Krauss, DJ; Wilson, GD; Wilson, TG; Yan, A; Yan, D | 1 |
| Ahmed, MM; Baker, A; Fagiry, R; Ibrahim, N; Mahmood, S; Mair, M; Menon, I; Vaidhyanath, R | 1 |
| Aryal, M; Bhambhani, C; Bhangale, A; Brenner, JC; Brummel, C; Cao, Y; Casper, K; Chinn, S; Gu, W; Haring, CT; Heft Neal, M; Lee, C; Malloy, K; McHugh, JB; Mierzwa, M; Mills, RE; Prince, ME; Schonewolf, C; Shah, J; Shuman, A; Spector, ME; Sun, Y; Swiecicki, PL; Tewari, M; Worden, FP | 1 |
| Cheng, NM; Fan, KH; Fang, KH; Fang, TJ; Hsieh, CH; Hsin, LJ; Hsueh, C; Huang, SF; Kang, CJ; Lee, LA; Lee, LY; Liao, CT; Lin, CH; Lin, CY; Lin, WN; Ng, SH; Tsai, CY; Tsao, CK; Wang, HM; Wang, YC; Yeh, CH; Yen, TC | 1 |
| Guzmán Pérez-Carrillo, GJ; Ivanidze, J | 1 |
| Al-Mamgani, A; Baris Karakullukcu, M; Bing Tan, I; Blank, CU; Broeks, A; de Boer, JP; Dirven, R; Elbers, JBW; Haanen, JBAG; Hooijberg, E; Jasperse, B; Karssemakers, L; Keijser, A; Klop, WMC; Krijgsman, O; Lohuis, PJFM; Lubeck, Y; Onderwater, S; Peeper, DS; Qiao, X; Schreuder, WH; Schumacher, TN; Seignette, IM; Smeele, LE; Smit, LA; Traets, JJH; van den Brekel, MWM; van der Leun, AM; van der Noort, V; van der Velden, LA; Vogel, WV; Vos, JL; Willems, SM; Zuur, CL | 1 |
| Chen, X; Dewhirst, MW; Forshaw, TE; Furdui, CM; King, SB; Li, Z; Madonna, M; Pathirannahel, BL; Poole, LB; Ramanujam, N; Shukla, K; Solingapuram Sai, KK; Tsang, AW; Vance, SA; Wu, H; Zhu, C | 1 |
| Andrearczyk, V; Boughdad, S; Castelli, J; Chen, H; Depeursinge, A; Elhalawani, H; Feng, X; Fuller, CD; Ghimire, K; Hatt, M; Iantsen, A; Jreige, M; Ma, J; Naser, MA; Oreiller, V; Pai, S; Peng, Y; Prior, JO; Rahmim, A; Rao, C; Vallières, M; Wang, L; Xie, J; Yang, X; Yousefirizi, F; Yuan, Y; Zhu, S | 1 |
| Chen, YH; Cheng, SC; Guenette, J; Gunasti, L; Haddad, R; Jacene, HA; Jo, VY; Lako, A; Rodig, S; Schoenfeld, JD; Shah, H; Uppaluri, R; Wang, Y | 1 |
| Evans, J; Hardman, J; McLaren, O; Williams, R; Zhu, Y | 1 |
| Hirosue, A; Kawahara, K; Kitajima, M; Minamitake, A; Murakami, R; Nakayama, H; Sakamoto, F; Sakata, J; Shiraishi, S; Yamana, K; Yoshida, R | 1 |
| Ludlow, D; Muller, RG; Weidenbecher, M | 1 |
| Balermpas, P; Bichsel, D; Giacomelli-Hiestand, B; Hüllner, M; Schwaninger, DR; Stadlinger, B; Stutzmann, NS; Valdec, S | 1 |
| Subramaniam, RM; You, H | 1 |
| Abdalla, AS; Khan, SA; Sheybani, ND | 1 |
| Eraj, S; Sher, DJ | 1 |
| Marcus, C; Subramaniam, RM | 2 |
| Subramaniam, RM | 1 |
| Gu, H; Li, M; Wang, Y; Wu, J; Xuan, G | 1 |
| Ju, C; Kong, T; Mukherji, SK; Pham, N | 1 |
| Abe, T; Endo, T; Kaswasaki, Y; Kouga, T; Suzuki, S; Toyoma, S; Yamada, T | 1 |
| Beaty, BM; Benefield, T; Chera, B; Jewells, VL; Muhleman, MA; Oldan, JD | 1 |
| Chan, C; Cheng Lau, Y; Dempsey, MF; Dyab, H; Grose, D; Hendry, F; James, A; Lamb, C; Maxfield, C; Paterson, C; Rulach, R; Schipani, S; Wilson, C; Zhou, S | 1 |
| Chen, W; Nie, X; Niu, J; Sun, J; Zeng, J; Zhou, J | 1 |
| Hadzhiyska, V; Ilcheva, M; Mladenov, K; Nikolova, P | 1 |
| García Vicente, P; García-Berrocal, JR; Mucientes, J; Rijo-Cedeño, J; Royuela, A; Villarreal, IM | 1 |
| Amer, A; Ginat, DT; Johnson, JM; Yeh, R | 1 |
| Beck, M; Brunner, T; Döscher, J; Eckstein, M; Fietkau, R; Gaipl, US; Gostian, AO; Hartmann, A; Hartwich, J; Hautmann, MG; Hecht, M; Illmer, T; Iro, H; Klautke, G; Kuwert, T; Müller, S; Rutzner, S; Schmidt, D; Semrau, S; Tamaskovics, B; von der Grün, J | 1 |
| Bedmutha, A; Kaushal, A | 1 |
| Alavi, A; Asadollahi, S; Kaghazchi, F; Korostoff, J; Mehdizadeh Seraj, S; Raynor, WY; Revheim, ME; Seierstad, T; Swisher-McClure, S; Werner, TJ; Zirakchian Zadeh, M | 1 |
| Hyayashi, T; Nikkuni, Y; Nishiyama, H | 1 |
| Burian, E; Callahan, N; Froelich, MF; Gassert, FG; Makowski, MR; Palla, B; Pyka, T; Rübenthaler, J; Schmid, A; von Schacky, CE; Wolff, C | 1 |
| Albert, NL; Avanzo, M; Belka, C; Corradini, S; Fanetti, G; Franchin, G; Holzgreve, A; Kurz, C; Landry, G; Lang, J; Lombardo, E; Marschner, S; Niyazi, M; Riboldi, M; Stancanello, J; Walter, F; Wang, Y; Weingärtner, J; Zschaek, S | 1 |
| Dias Domingues, DR; Leech, MM | 1 |
| Chen, MYC; Hsu, JT; Lin, NC; Tsai, KY | 1 |
| Akhtar, F; Beadle, BM; Colevas, AD; Divi, V; Gensheimer, MF; Harandi, N; Holsinger, FC; Le, QT; Liang, R; Liu, Y; Miller, JA; Moradi, F; Nguyen, NK; Pollom, EL; Ren, Y; Sundaram, V; Weng, Y; Zhang, C | 1 |
| Azevedo, EC; Baik, FM; Castillo, J; Chin, FT; Colevas, AD; Duan, H; Ferri, V; Freeman, L; Hom, M; Iagaru, A; Kaplan, MJ; Koran, ME; Lee, YJ; Martin, BA; Raymundo, RC; Rosenthal, EL; Shen, B; Valencia, A; van den Berg, NS; Zhou, Q | 1 |
| Danstrup, CS; Fisker, R; Kovacsne, A; Lyhne, NM; Zacho, HD | 1 |
| Aebersold, DM; Alberts, I; Bojaxhiu, B; Elicin, O; Rominger, A; Shelan, M; Sinovcic, D; Templeton, AJ; Wartenberg, J; Zaugg, K | 1 |
| Bunch, PM; Evans, JK; Farris, JC; Hughes, RT; Johnson, AG; Patel, Z; Schroeder, JA; Steber, CR | 1 |
| Dalianis, T; Hammarstedt-Nordenvall, L; Jara, SJ; Landin, D; Marklund, L; Munck-Wikland, E; Näsman, A | 1 |
| Bolt, H; Cheriyan, S; Cook, L; Hopkins, J; Mair, M; Noor, A; Ooi, EH; Woods, CM | 1 |
| Baugnon, KL; Fischbein, NJ; Mukherjee, S; Policeni, BA; Raghavan, P | 1 |
| Cui, Y; Jin, A; Lin, X; Ma, L; Yin, X | 1 |
| Chiu, NT; Lu, HH; Tsai, MH | 1 |
| Heinrich, MC; Kim, MS; Sandow, L; Thawani, R | 1 |
| Cardin, A; Dhillon, K; Dixon, B; Flatman, S; Fua, T; J R Magarey, M; Kleid, S; Manji, J; Prasad, J; Rischin, D; Tapia, M | 1 |
| Ala Eddine, C; Beddok, A; Buvat, I; Calugaru, V; Champion, L; Créhange, G; Nioche, C; Orlhac, F | 1 |
| Dollinger, M; Habicher, W; Schicho, A; Schleder, S; Schreyer, AG; Stroszczynski, C; Strotzer, Q; Wendl, C | 1 |
| d'Abadie, P; Gheysens, O; Opalinski, L; Schmitz, S; Van Eeckhout, P | 1 |
| Aren, E; Berry, M; Deshpande, S; Estall, V; Fowler, A; Jameson, MG; Johnston, M; Lee, M; Trada, Y | 1 |
| Chaushu, H; Even-Sapir, E; Gutfeld, O; Holan, A; Horowitz, G; Kampel, L; Muhanna, N; Nachalon, Y; Nard-Carmel, N; Oestraicher, Y; Ospovat, I; Oz, YN; Shapira, U; Ungar, O; Warshavsky, A | 1 |
| Erdogan, ST; Flygare, L; Söderkvist, K | 1 |
| Born, D; Broglie, MA; Hüllner, MW; Kovacs, Z; Maurer, A; Morand, GB; Nemes, CM; Nemmour, A; Pazahr, S; Rupp, NJ; Serrallach, B; Stadler, TM; Stoeckli, SJ | 1 |
| Cho, H; Jo, KH; Kang, WJ; Kim, J; Lee, SK; Park, K; Sohn, B; Woo, C | 1 |
| Abgral, R; Conan-Charlet, V; Dzuko Kamga, J; Leclere, JC; Tissot, V | 1 |
| de Vette, SPM; Langendijk, JA; Li, Y; Noordzij, W; Sijtsema, NM; Steenbakkers, RJHM; Van den Bosch, L; van Dijk, LV; Zhang, F | 1 |
| Doai, M; Matoba, M; Nagata, H; Nishino, Y; Ota, K; Tsuchiya, H; Tuji, H | 1 |
| Jantarato, A; Lerdsirisuk, P; Nantasuk, M; Pawano, P; Phonlakrai, M; Singhnoi, S; Siripongsatian, D; Wongsa, P | 1 |
| Agarwal, JP; Budrukkar, A; Ghosh-Laskar, S; Gupta, T; Joshi, A; Joshi, K; Kumar, A; Nair, S; Paul, S; Prabhash, K; Purandare, N; Rangarajan, V; Sinha, S; Swain, M | 1 |
| Allen, SG; Aryal, M; Brenner, JC; Cao, Y; Casper, KA; Chinn, SB; Elliott, DA; Malloy, KM; Mierzwa, ML; Prince, ME; Rosen, BS; Rosko, AJ; Schipper, MJ; Schonewolf, CA; Shah, JL; Shuman, AG; Spector, ME; Stucken, CL; Swiecicki, PL; Wong, KK; Worden, FP | 1 |
| Dendo, Y; Kaneta, T; Kodama, H; Kojima, I; Odagiri, H; Saitou, S; Takanami, K; Takase, K; Tanaka, Y; Usui, A | 1 |
| Feng, J; Gao, X; He, Y; Hu, Y; Ma, Y; Pan, Y; Peng, L; Xu, F; Zhu, X | 1 |
| Röhrich, M | 1 |
| Abd El-Gaid, S; Ashraf, A; Elahmadawy, MA; Kotb, M; Moustafa, H | 1 |
| Aro, K; Atula, T; Ilmarinen, T; Markkola, A; Schildt, J; Sistonen, HJ | 1 |
| Albert, NL; Belka, C; Cegla, P; Cholewinski, W; Ferentinos, K; Furth, C; Hajiyianni, M; Hofheinz, F; Holzgreve, A; Kaźmierska, J; Kotzerke, J; Landry, G; Lombardo, E; Marschner, SN; Maus, J; Nikulin, P; Rogasch, JMM; Strouthos, I; van den Hoff, J; Zschaeck, S | 1 |
| Kirita, T; Nakayama, Y; Tamaki, S; Ueda, N; Yagyuu, T; Yamakawa, N | 1 |
| Boyle, JO; Chen, L; Cohen, MA; Cracchiolo, JR; Dunn, L; Ganly, I; Gelblum, DY; Kang, JJ; Lee, NY; McBride, SM; Michel, LS; Patel, SG; Pfister, DG; Riaz, N; Schöder, H; Sherman, EJ; Singh, B; Tsai, CJ; Wong, RJ; Yu, Y; Zakeri, K | 1 |
| Fowler, A; Holloway, L; Lee, M; Lin, P; Min, M | 1 |
| Bartolomei, M; Bianchini, C; Bonsembiante, A; Caracciolo, M; Carandina, I; Ciorba, A; Cittanti, C; Corazzi, V; Migliorelli, A; Ortolan, N; Panareo, S; Pelucchi, S; Uccelli, L; Urso, L | 1 |
| Calais, J; Czernin, J; Hotta, M; Howard, T; Maliha, PG; Mendelsohn, AH | 1 |
| Atay, LO; Aydos, U; Cebeci, S; Duzlu, M; Pula, D; Yeniceri, A; Yilmaz, M | 1 |
| Hartel, G; Khoo, D; Liu, ZY; Punyadeera, C; Vasani, S | 1 |
| Chlap, P; Fowler, A; Jameson, MG; Keall, P; Lee, MT; Lin, P; Moses, D; Trada, Y | 1 |
| Beppu, S; Hanai, N; Kodaira, T; Nishikawa, D; Nishio, M; Sasaki, E; Sawabe, M; Suzuki, H; Tamaki, T; Terada, H | 1 |
| McKiddie, F; Nath, M; Philip, MM; Welch, A | 1 |
| Hellström, H; Kemppainen, J; Klén, R; Liedes, J; Malaspina, S; Rainio, O | 1 |
| Chlap, P; Forstner, D; Fowler, A; Holloway, L; Jameson, M; Keall, P; Lee, MT; Lin, P; Min, M; Moses, D; Trada, Y | 1 |
| Bernsdorf, M; Friborg, J; Gothelf, A; Håkansson, K; Kristensen, CA; Lindegaard, AM; Specht, L; Vogelius, I | 1 |
| Daisaki, H; Enomoto, A; Ishii, K; Ito, K; Kaida, H; Kimura, T; Kitajima, K; Otsuki, N; Sato, MP; Sekine, T | 1 |
| Agarwal, M; Rath, TJ; Wangaryattawanich, P | 1 |
| Abgral, R; Clément, C; Gujral, DM; Le Gal, G; Le Pennec, R; Leclère, JC; Maheo, C; Marianowski, R; Salaun, PY; Schick, U | 1 |
| Addison, D; Alvi, RM; Armstrong, KA; Awadalla, M; B Bakar, R; Banerji, D; Chan, AW; Hammad, B; Hassan, MZO; Jones-O'Connor, M; Mulligan, CP; Neilan, TG; Osborne, MT; Pitman, RK; Rokicki, A; Tawakol, A; Wang, Y; Warner, ET; Wirth, LJ; Zarif, A; Zhang, L | 1 |
| Beer, AJ; Beer, M; Böhm, F; Deininger, K; Hoffmann, TK; Lingl, JP; Schuler, PJ; Thaiss, W | 2 |
| Chan, C; Dempsey, MF; Dyab, H; Grose, D; Hendry, F; James, A; Lamb, C; Lau, YC; Maxfield, C; Paterson, C; Rulach, R; Schipani, S; Wilson, C; Zhou, S | 1 |
| Duvernay, J; Majoufre, C; Schlund, M | 1 |
| Beichel, RR; Buatti, JM; Graham, MM; Graves, SA; Smith, BJ; Xiong, X | 1 |
| Asel, C; Bauer, B; Gabriel, M; Poier-Fabian, N; Rubicz, N; Zwittag, P | 1 |
| Kasibhatla, MS; Koontz, BF | 1 |
| Dijkema, T; Doornaert, PAH; Hoeben, BAW; Kaanders, JHAM; Kasperts, N; Smid, EJ; Terhaard, CHJ; van den Bosch, S; Verhoef, LCG; Zwijnenburg, EM | 1 |
| Wan, DQ | 1 |
| Arunsingh, M; Dyker, KE; Prestwich, RJD; Scarsbrook, AF; Vaidyanathan, S; Zhong, J | 1 |
| Agarwal, JP; Arya, S; Budrukkar, A; Chatterjee, A; Ghosh-Laskar, S; Gupta, T; Murthy, V; Purandare, N; Rangarajan, V | 1 |
| Gundermann, P; Meyer, HJ; Surov, A | 1 |
| Amaral, S; Carvalho, J; Costa, M; Davies, M; Domingues, I; Eufrásio, J; Garcia, R; Khouri, L; Pinheiro, S; Pires, I; Pratas, E; Teixeira, M | 1 |
| Gray, BR; Koontz, NA | 1 |
| Berthelsen, AK; Friborg, J; Kjær, A; Loft, A; Loft, FC; Madsen, AR; Risør, LM; Vogelius, IR | 1 |
| Christensen, JT; Fischer, BM; Friborg, J; Håkansson, K; Jensen, JS; Löfgren, J; Rasmussen, JH; Vogelius, IR; von Buchwald, C; Zamani, M | 1 |
| Bunea, H; Carles, M; Grosu, AL; Majerus, L; Meyer, PT; Mix, M; Nicolay, NH; Sörensen, A; Stoykow, C; Vaupel, P; Wiedenmann, NE | 1 |
| Banks, KP; Christensen, CT; Peacock, JG | 1 |
| Agaimy, A; Fietkau, R; Haderlein, M; Hecht, M; Iro, H; Kitzsteiner, C; Kuwert, T; Müller, S; Schmidt, D; Semrau, S; Traxdorf, M | 1 |
| Bak, B; Cegła, P; Cholewinski, W; Kazmierska, J; Malicki, J; Piotrowski, T; Sowinska, A | 1 |
| Al-Ubaedi, A; Flygare, L; Mo, SJ; Öhman, W | 1 |
| Asch, DA; Goldenberg, D; Holsinger, FC; Lohia, S; Mitra, N; Myssiorek, D; Pou, AM; Roman, BR; Shea, JA; Wang, MB | 1 |
| Grosse, J; Hellwig, D | 1 |
| Welz, S; Zips, D | 1 |
| Dietlein, M; Drzezga, A; Klußmann, JP | 1 |
| Akazawa, T; Aoki, M; Asano, T; Inoue, N; Ito, Y; Kato, H; Kuze, B; Matsuo, M; Miyazaki, T; Ohashi, T; Shibata, H; Terasawa, K | 1 |
| Baek, S; Hong, JH; Kim, ES; Kim, HJ; Kwon, KH; Park, MW; Yoon, DY; Yun, EJ | 1 |
| Currie, S; Dyker, K; Prestwich, R; Scarsbrook, A; Sundersingh, M; Vaidyanathan, S; Zhong, J | 1 |
| Gao, Y; Huang, MW; Liu, SM; Wu, WJ; Zhang, JG; Zheng, L | 1 |
| Furuya, S; Hirata, K; Katoh, C; Kawauchi, K; Kobayashi, K; Manabe, O; Shiga, T; Watanabe, S | 1 |
| Chen, X; Chen, Y; Dang, H; Hou, B; Jin, Z; Shi, X; Xing, H; Xue, H; Zhang, Z; Zhu, X | 1 |
| Acosta, O; Castelli, J; Creff, G; Depeursinge, A; Devillers, A; Jegoux, F; Palard-Novello, X | 1 |
| Aubry, M; Cheze-le-Rest, C; Corcos, L; Dufour, X; Hatt, M; Key, S; Pradier, O; Schick, U; Simon, B; Tixier, F; Visvikis, D | 1 |
| Li, J; Pang, X; Song, F; Wei, Z; Zhang, X; Zhou, H | 1 |
| Chiu, KW; Du, R; Ho, JW; Lee, EY; Pang, HH; Vardhanabhuti, V; Xie, C | 1 |
| Arshad, H; Bogart, JA; Chowdhry, V; Degraaf, L; Farrugia, M; Gupta, V; Hahn, SS; Hicks, WL; Iovoli, A; Lacombe, MA; Mix, M; Platek, A; Platek, ME; Singh, AK; Wooten, K | 1 |
| Berthelet, E; DeVries, K; Godoy, T; Hamilton, S; Olson, R; Tran, E; Urban, R; Wilson, D; Wu, J | 1 |
| Al-Mamgani, A; Gouw, ZAR; La Fontaine, MD; Sonke, JJ; van de Kamer, JB; Vogel, WV | 1 |
| Li, W; Meng, Z | 1 |
| Dorgelo, B; Fazzi, M; Hanemaaijer, SH; Oosting, SF; Plaat, BEC; Steenbakkers, RJHM; Stormezand, GN; van der Laan, BFAM; van der Vegt, B; Witjes, MJH | 1 |
| Barney, CL; Bhatt, A; Blakaj, D; Diavolitsis, V; Eckstein, JM; Gamez, M; Grecula, JC; Healy, E; Jain, A; McElroy, JP; Miller, E; Mitchell, DL; Nolan, N; Washington, I; Wobb, JL; Wright, CL | 1 |
| Bohn, P; Damilleville-Martin, M; Decazes, P; Modzelewski, R; Thureau, S; Vera, P | 1 |
| Campbell, F; Crosbie, R; Easton, F; Grose, D; James, A; Lamb, C; McLoone, P; Paterson, C; Poon, WY; Rizwanullah, M; Schipani, S; Thomson, M; Wilson, C | 1 |
| Boura, J; LeRose, CC; Ramirez, CA | 1 |
| Cheon, GJ; Choi, SH; Hwang, I; Kang, KM; Kim, JH; Lee, EK; Lee, JY; Pak, K; Park, J; Ryoo, I; Sohn, CH; Yoo, RE; Yun, TJ | 1 |
| Ahmadvand, P; Bauer, C; Beichel, RR; Buatti, JM; Budzevich, MM; Gillies, RJ; Goldgof, D; Grkovski, M; Hamarneh, G; Kinahan, PE; Laymon, CM; Mountz, JM; Muzi, JP; Muzi, M; Nehmeh, S; Oborski, MJ; Smith, BJ; Sunderland, JJ; Ulrich, EJ; Zhao, B | 1 |
| Dempsey, MF; Grose, D; Hendry, F; James, A; Lamb, C; Lau, YC; Paterson, C; Rizwanullah, M; Rulach, R; Schipani, S; Stobo, D; Wilson, C; Zhou, S | 1 |
| Earls, P; Emmett, L; Gallagher, R; Ho, B; Lee, J; Matthews, T; Tang, R | 1 |
| Paterson, C; Rulach, R; Zhou, S | 1 |
| Abgral, R; Bourhis, D; Calais, J; Leclère, JC; Lucia, F; Salaün, PY; Schick, U; Vera, P | 1 |
| Aijun, Z; Benxin, Z; Chuanpei, X; Cong, H; Peng, W; Tian, Z; Vallières, M | 1 |
| Andersen, FL; Berthelsen, AK; Fischer, BM; Gothelf, AB; Håkansson, K; Hansen, AE; Kjaer, A; Ladefoged, CN; Olin, AB; Rasmussen, JH; Specht, L; Vogelius, IR | 1 |
| Boellaard, R; Castelijns, JA; de Bree, R; de Graaf, P; Koopman, T; Leemans, CR; Martens, RM; Noij, DP; Vergeer, MR; Zwezerijnen, G | 1 |
| Chakravorty, N; Chatterjee, S; Ghosh, S; Mallick, I; Maulik, S; Mukherjee, J | 1 |
| Eguchi, H; Fukusumi, T; Horie, M; Inohara, H; Isohashi, F; Komukai, S; Ogawa, K; Suzuki, M; Takai, E; Takemoto, N; Tanaka, H; Tatsumi, M; Yachida, S | 1 |
| Álvarez, O; García-Berrocal, JR; Mucientes, J; Rijo-Cedeño, J; Romero, J; Royuela, A; Seijas Marcos, S | 1 |
| Arnold, C; Dejaco, D; Kofler, B; Moser, P; Riechelmann, H; Riedl, D; Schartinger, VH; Steinbichler, TB; Uprimny, C; Virgolini, I; Widmann, G | 1 |
| Andreu-Arasa, VC; Fujima, N; Ito, K; Kaneda, T; Meibom, SK; Qureshi, MM; Sakai, O; Salama, AR; Takumi, K; Truong, MT | 1 |
| Broglie, MA; Hüllner, MW; Morand, GB; Stadler, TM | 1 |
| Bradford, C; Casper, KA; Chapman, CH; Chinn, SB; Chotchutipan, T; Eisbruch, A; Ibrahim, M; Malloy, KM; McLean, SA; Mierzwa, ML; Miller, JE; Prince, MEP; Rosen, BS; Rosko, AJ; Schonewolf, CA; Shah, JL; Shuman, AG; Spector, ME; Stucken, CL; Sun, Y; Swiecicki, PL; Wilkie, JR; Worden, FP | 1 |
| Christophi, C; Fang, C; Gan, H; Lee, ST; Liu, Z; Muralidharan, V; Pathmaraj, K; Sachinidis, J; Scott, AM; Tebbutt, N; Wong, P | 1 |
| Bartel, T; Chen, C; Duan, F; Lowe, VJ; Romanoff, J; Sicks, JD; Stack, BC; Subramaniam, RM | 1 |
| Wong, WL | 1 |
| Huellner, MW | 1 |
| Flavell, RR; Ha, PK; Strohl, MP; Yom, SS | 1 |
| Al-Farra, G; Dejanovic, D; Eriksen, JG; Grau, C; Hansen, CR; Jensen, K; Loft, A; Pameijer, FA; Zukauskaite, R | 1 |
| Baumann, M; Kotzerke, J; Krause, M; Löck, S; Seidlitz, A; Troost, EGC; Zips, D; Zöphel, K; Zschaeck, S | 1 |
| Flaus, A; Guy, JB; Magné, N; Nevesny, S; Prévot, N; Sotton, S | 1 |
| Fukusumi, T; Hanamoto, A; Inohara, H; Isohashi, F; Kishikawa, T; Michiba, T; Ogawa, K; Seo, Y; Suzuki, M; Takemoto, N; Tamari, K; Tanaka, H; Tatsumi, M | 1 |
| Ishibashi, K; Kato, I; Kimura, M; Nagao, T; Sone, Y; Umemura, M | 1 |
| Chen, B; Gao, S; Ji, B; Liu, D; Wang, X; Zhang, H | 1 |
| Arens, C; Eckert, A; Grosser, O; Pech, M; Surov, A; Wienke, A | 1 |
| Basso, L; Cavaliere, C; Garbino, N; Nicolai, E; Pace, L; Salvatore, M; Spinato, G | 1 |
| Larobina, M; Megna, R; Solla, R | 1 |
| de Almeida, JR; Ferris, RL; Forner, D; Goldstein, DP; Metser, U; Noel, CW; Waldron, J | 1 |
| Akcay, MC; Dincer, M; Entok, E; Etiz, D; Saylisoy, S; Tepe, M; Toprak, U | 1 |
| Benjamin, J; Hephzibah, J; Mathew, D; Oommen, R; Pavamani, S; Rajnikanth, J; Shanthly, N | 1 |
| Bommakanti, K; Coffey, C | 1 |
| Broglie, MA; Hüllner, MW; Morand, GB; Rupp, NJ; Stadler, TM | 1 |
| Andersen, FL; Bentzen, SM; Fischer, BM; Hansen, AE; Johannesen, HH; Kjaer, A; Lelkaitis, G; Olin, AB; Rasmussen, JH; Specht, L; Vogelius, IR; von Buchwald, C; Wessel, I | 1 |
| Furukawa, M; Hanai, N; Sato, Y; Shimode, Y; Terada, H | 1 |
| Hattori, S; Hirata, K; Hung, A; Ishibashi, M; Ishii, K; Kaida, H; Kitajima, K; Matsunaga, T; Minamimoto, R; Nakajo, M; Nakatani, K; Yasuda, T | 1 |
| Cai, J; Cheng, NM; Huo, Y; Lee, LY; Liao, CT; Lin, CY; Lu, L; Nogues, I; Wang, HM; Xiao, J; Yao, J; Ye, X; Yen, TC; Zhang, L; Zhao, K; Zhao, S; Zhou, W | 1 |
| Benlloch, R; Carbonell, S; García-Berrocal, JR; Mucientes, J; Rijo-Cedeño, J; Romero, J; Royuela, A; Seijas Marcos, S | 1 |
| Bernsdorf, M; Berthelsen, AK; Friborg, J; Gothelf, AB; Kjems, J; Kristensen, CA; Loft, A; Vogelius, IR; von Buchwald, C | 1 |
| Fan, Q; Su, M; Tian, R; Wang, R | 1 |
| Aringhieri, G; Bola, S; Faggioni, L; Garau, LM; Manca, G; Volterrani, D | 1 |
| Behr, S; Glastonbury, C; Heaton, C; House, AE; Jacobs, J; Knott, PD; Likhterov, I; Seth, R; Zebolsky, AL | 1 |
| Anjari, M; Bassett, P; Connor, S; Cook, G; Goh, V; Guerrero-Urbano, T; Lei, M; Sit, C; Szyszko, T | 1 |
| Guenette, JP | 1 |
| Beer, M; Kim, SY; Tshering Vogel, DW | 1 |
| Kawamura, H; Koyasu, S; Nakamoto, Y; Sugimoto, A | 1 |
| Irizarry, R; Mathews, F; Rosenfeld, R; Sundaram, K | 1 |
| Bray, V; Fowler, A; Holloway, L; Lai, K; Lee, CS; Lee, M; Lin, P; Min, M; Xuan, W; Yong, J | 1 |
| Agazzi, GM; Albano, D; Bertagna, F; Bosio, P; Farina, D; Giubbini, R; Grammatica, A; Lancini, D; Maroldi, R; Nicolai, P; Piazza, C; Ravanelli, M; Squassina, G; Zigliani, A | 1 |
| Dijkema, T; Doornaert, PA; Hoebers, FJ; Kaanders, JH; Kreike, B; Kunze-Busch, MC; Oyen, WJ; Raaijmakers, CP; Terhaard, CH; van den Bosch, S; Vergeer, MR; Wijers, OB | 1 |
| de Patoul, N; Denis, JM; Differding, S; Grégoire, V; Hermand, N; Lee, JA; Nuyts, S; Sterpin, E; Vanstraelen, B | 1 |
| Al-Mamgani, A; de Boer, J; de Ridder, M; Hamming-Vrieze, O; Jasperse, B; Klop, M; Smit, L; van den Brekel, M; Vogel, W | 1 |
| Bootz, F; Bundschuh, RA; Essler, M; Gaertner, FC; Kreppel, B; Send, T; Strunk, H | 1 |
| Guo, QY; Han, CB; Ma, JT; Sun, HZ; Xin, J; Zhang, SM; Zheng, JH | 1 |
| Castelijns, JA; de Bree, R; de Graaf, P; de Jong, MC; Hoekstra, OS; Jagesar, VA; Noij, DP | 1 |
| Bilbao, P; Cacicedo, J; de Zarate, RO; Del Hoyo, O; Escudero, J; Fernandez, I; Gomez-Iturriaga, A; Gomez-Suarez, J; Martinez-Indart, L; Navarro, A; Perez, JF; Pijoan, JI; Rades, D | 1 |
| Piotrowski, T; Ryczkowski, A; Skorska, M | 1 |
| Abdollahi, H; Bitarafan-Rajabi, A; Geramifar, P; Ghaffarian, P; Rahmim, A; Shiri, I | 1 |
| Alterio, D; Ciardo, D; Cremonesi, M; Ferrari, M; Garibaldi, C; Gilardi, L; Grana, CM; Jereczek-Fossa, BA; Kaanders, JHAM; Orecchia, R; Ronchi, S; Travaini, L | 1 |
| Choi, H; Na, KJ | 1 |
| Bird, D; Cosgrove, V; Gilson, D; Patel, C; Prestwich, RJD; Scarsbrook, AF; Thomas, E | 1 |
| Abraham, T; Bello, JA; Cho, JK; Gulko, E; Lee, AY; Lin, J; Moadel, RM; Neimark, M; Ow, TJ; Schiff, BA; Schlecht, NF; Shifteh, K; Smith, RV; Tassler, AB; Ustun, B; Valdivia, A | 1 |
| Chiou, YR; Chou, KT; Huang, TC; Yang, SN; Zhang, GG | 1 |
| Forstner, D; Fowler, A; Holloway, L; Lee, MT; Liney, G; Min, M; Rai, R; Rumley, CN | 1 |
| Goel, R; Khan, S; Moore, W; Sher, D; Subramaniam, RM; Sumer, B | 1 |
| Agha Hossein, F; Bakhshayesh Karam, M; Doroudinia, A; Kaghazchi, F; Mehrian, P; Safavi Nainee, A; Yousefi Koma, A | 1 |
| Carp, L; Helsen, N; Roothans, D; Stroobants, S; Van Den Heuvel, B; Van den Weyngaert, D; Van den Wyngaert, T | 1 |
| Aristophanous, M; Awan, MJ; Belal, AM; Brandon Gunn, G; Cardenas, CE; El-Gowily, AG; Fuller, CD; Garden, AS; Lai, SY; Mohamed, ASR; Rock, CD; Rosenthal, DI; Westergaard, SA | 1 |
| Becker, CD; Becker, M; Burkhardt, K; Caparrotti, F; Combescure, C; Delattre, BMA; Dulguerov, N; Dulguerov, P; Katirtzidou, E; Pusztaszeri, M; Rager, O; Ratib, O; Varoquaux, AD; Zaidi, H | 1 |
| de Bree, R; de Keizer, B; Ferlito, A; Forastiere, AA; Haigentz, M; Hartl, DM; Nixon, IJ; Rinaldo, A; Rodrigo, JP; Saba, NF; Suárez, C; Vermorken, JB; Wolf, GT | 1 |
| Bogowicz, M; Guckenberger, M; Riesterer, O; Stark, LS; Studer, G; Tanadini-Lang, S; Unkelbach, J | 1 |
| Berwouts, D; Bonte, K; Boterberg, T; De Neve, W; Deron, P; Duprez, F; Goethals, I; Huvenne, W; Madani, I; Olteanu, AL; Vercauteren, T | 1 |
| Alongi, F; Alongi, P; Fersino, S; Fiorentino, A; Giaj-Levra, N; Mazzola, R; Ricchetti, F; Salgarello, M | 1 |
| Carp, L; De Bree, R; Debruyne, PR; Hakim, S; Helsen, N; Hoekstra, OS; Hutsebaut, I; Lenssen, O; Maes, ALM; Martens, MJ; Meersschout, SAE; Stroobants, S; Van den Weyngaert, D; Van den Wyngaert, T; van Dinther, J; Van Laer, CG; Vermorken, JB | 1 |
| Khan, S; Son, H | 1 |
| Bae, WK; Cho, SH; Chung, IJ; Chung, WK; Hwang, JE; Kang, SR; Kim, KR; Kwon, SY; Park, KS; Shim, HJ | 1 |
| Boellaard, R; Brouwer, CL; Burgerhof, JGM; Langendijk, JA; Noordzij, W; Sijtsema, NM; Steenbakkers, RJHM; van Dijk, LV | 1 |
| Choi, YJ; Jang, JY; Ki, YK; Kim, H; Kim, IJ; Kim, SJ; Kim, WT; Pak, KJ; Seol, YM; Wang, SG; Yi, KI | 1 |
| Ammari, S; Bidault, F; Dercle, L; Hartl, D; Mokrane, FZ; Rozenblum-Beddok, L; Seban, RD; Yeh, R | 1 |
| Bogowicz, M; Guckenberger, M; Konukoglu, E; Lambin, P; Leijenaar, RTH; Pruschy, M; Riesterer, O; Studer, G; Tanadini-Lang, S; Unkelbach, J | 1 |
| Asmussen, JT; Bjørndal, K; Diaz, A; Døssing, H; Gerke, O; Godballe, C; Gyldenkerne, N; Høilund-Carlsen, PF; Johansen, J; Nielsen, AL; Rohde, M; Sørensen, JA; Thomassen, A | 1 |
| Britt, CJ; Hartig, GK; Kennedy, TA; Maas, AM | 1 |
| Bhide, SA; Dunlop, A; Harrington, KJ; Koh, DM; Leach, MO; Mcquaid, D; Murray, I; Newbold, KL; Nutting, CM; Oyen, WJ; Panek, R; Riddell, A; Welsh, LC; Wong, KH | 1 |
| Grégoire, V; Lee, JA; Thorwarth, D | 1 |
| Koch, CJ | 1 |
| Cammelli, S; Castellucci, P; Cilla, S; Fanti, S; Farina, A; Farina, E; Ferioli, M; Morganti, AG; Zanirato Rambaldi, G | 1 |
| Cuna, E; Eickhoff, J; Jeraj, R; Perlman, S; Scarpelli, M | 1 |
| Bockisch, A; Herrmann, K; Hoffmann, TK; Nagarajah, J; Poeppel, TD; Ruhlmann, V; Sauerwein, W; Umutlu, L; Veit, J | 1 |
| Apte, A; Crispin-Ortuzar, M; Deasy, JO; Grkovski, M; Humm, JL; Lee, NY; Oh, JH; Schöder, H | 1 |
| Chen, RY; Chen, SW; Hsieh, TC; Kao, CH; Lin, YC; Shen, WC; Yen, KY | 1 |
| Anderson, C; Bayon, R; Buatti, J; Clamon, G; Ginader, T; Hoover, A; Marquardt, M; Pagedar, N; Parkhurst, J | 1 |
| Bianchi, R; Bossi, P; Canevari, S; Clement, PM; Coropciuc, R; Crippa, F; De Cecco, L; de Saint Aubain, N; Duprez, T; Fortpied, C; Guzzo, M; Hauben, E; Lalami, Y; Lemort, M; Lhommel, R; Lia, M; Licitra, LF; Liu, Y; Machiels, JP; Menis, J; Quattrone, P; Quiriny, M; Schmitz, S | 1 |
| Carp, L; Helsen, N; Stroobants, S; Van den Wyngaert, T | 1 |
| Murata, H; Nagashima, Y; Ohtake, M; Tateishi, K; Yamamoto, T; Yamanaka, S | 1 |
| Alshehri, S; Gantet, P; Herbault-Barres, B; Hitzel, A; Julian, A; Lopez, R; Payoux, P | 1 |
| Abemayor, E; Chen, AM; St John, M; TenNapel, M; Velez, MA; Veruttipong, D; Wang, PC | 1 |
| Al-Mamgani, A; Dijkema, T; Kaanders, JHAM; Raaijmakers, CP; Terhaard, CHJ; van den Bosch, S; Vogel, WV | 1 |
| Gatidis, S; la Fougère, C; Leibfarth, S; Mönnich, D; Nikolaou, K; Schmidt, H; Schwenzer, NF; Thorwarth, D; Welz, S; Winter, RM; Zips, D; Zwirner, K | 1 |
| Baek, S; Han, YM; Kim, ES; Moon, JY; Seo, YL; Yoon, DY; Yun, EJ | 1 |
| Doi, H; Fujita, M; Fujiwara, M; Katsuura, T; Kitajima, K; Noguchi, K; Tamaki, Y; Terada, T; Tsuchitani, T; Uwa, N; Yamakado, K; Yoshida, R | 1 |
| Belli, ML; Bettinardi, V; Broggi, S; Calandrino, R; Cattaneo, GM; Dell'Oca, I; Di Muzio, N; Fallanca, F; Fiorino, C; Mori, M; Passoni, P; Picchio, M; Vanoli, EG | 1 |
| Colletti, PM; Wassef, HR | 1 |
| Dijkema, T; Hoebers, FJP; Kaanders, JHAM; Oyen, WJG; Philippens, MEP; Terhaard, CHJ; van den Bosch, S | 1 |
| Curchin, C; Robinson, M; Soyer, HP | 1 |
| Alves, MS; Andrade, LB; Barbosa, PNVP; Bes, PC; Calsavara, VF; Cezana, L; de Carvalho, GB; de Jesus, VHF; de Oliveira, TB; de Paiva, TF; Guimarães, APG; Kowalski, LP; Lima, ENP; Nicolau, UR; Pellizzon, ACA; Porto, GCLM; Silva, VS | 1 |
| Acosta, O; Bourhis, J; Campillo-Gimenez, B; Castelli, J; Chajon, E; De Bari, B; de Crevoisier, R; Depeursinge, A; Devillers, A; Dicente, Y; Gherga, E; Jegoux, F; Prior, JO; Sire, C; Sun, X | 1 |
| Meyer, HJ; Purz, S; Sabri, O; Surov, A | 1 |
| Bignardi, S; Comelli, A; Ippolito, M; Petrucci, G; Russo, G; Sabini, MG; Stefano, A; Yezzi, A | 1 |
| Anderson, NJ; Fahandej, M; Huynh, A; Jackson, JE; Joon, DL; Khoo, V; Lee, ST; Poulsen, M; Rolfo, M; Schneider, M; Wada, M | 1 |
| Assadsangabi, R; Lazor, JW; Lee, H; Shah, J | 1 |
| Chen, DL; Mittra, E; Nadel, H; Niederkohr, RD; Sanli, Y; Subramaniam, RM; Zukotynski, K | 1 |
| Connor, S; Cook, GJ; Dunn, J; Guerrero-Urbano, T; Jeannon, JP; Lei, M; Oakley, R; Pencharz, D; Siddiqui, A; Sriskandan, N; Szyszko, TA; Thavaraj, S | 1 |
| Casselden, E; Sheerin, F; Winter, SC | 1 |
| Abgral, R; Bourhis, D; Delcroix, O; Gobel, Y; Guezennec, C; Orlhac, F; Robin, P; Rousset, J; Salaün, PY; Schick, U | 1 |
| Eisele, DW; Fakhry, C; Gourin, CG; Motz, KM; Mydlarz, WK; Quon, H; Rooper, LM; Ryan, JF; Tan, M | 1 |
| Baeza, JA; Balcerzyk, M; Barbeiro, AR; García-Gómez, FJ; Jiménez-Ortega, E; Leal, A; Parrado-Gallego, Á; Ureba, A; Wals-Zurita, A | 1 |
| Ban, MJ; Lee, JW; Lee, SM; Park, JH | 1 |
| Bai, J; Duan, P; Wang, L | 1 |
| Chen, PY; Chen, S; Chinnaiyan, P; Krauss, DJ; Wilson, GD; Yan, D | 1 |
| Brotherston, D; Caldwell, CB; Conrad, T; Karam, I; Kiss, A; Le, T; Lee, J; Mendez, LC; Poon, I; Smith, B | 1 |
| Anderson, C; Graham, M; Mallak, N; Mayo, Z; Menda, Y; Mott, SL; Seyedin, SN | 1 |
| Cardoso, M; Estall, V; Forstner, D; Fowler, A; Holloway, L; Jameson, M; Min, M; Pogson, E; Rumley, C; Tang, S | 1 |
| Gafita, A; Hirata, K; Kroenke, M; Kuge, Y; Magota, K; Okamoto, S; Shiga, T; Tamaki, N; Watanabe, S | 1 |
| Bhatt, AD; Knopp, MV; Washington, IR; Wright, CL | 1 |
| Appold, S; Bandurska-Luque, A; Hoberück, S; Kohler, A; Kotzerke, J; Löck, S; Schreiber, A; Zips, D; Zöphel, K | 1 |
| Abgral, R; Bourhis, D; Corre, JB; Delcroix, O; Gobel, Y; Guezennec, C; Orlhac, F; Robin, P; Salaün, PY; Schick, U | 1 |
| Cegla, P; Joanna, K; Julian, M; Michal, S; Sebastian, G; Witold, C | 1 |
| Bone, TM; Byrd, JK; Groves, MW; Leto, CJ; Liebman, RM; Sharbel, D; Wang, CW | 1 |
| Bauer, C; Beichel, RR; Brown, B; Buatti, JM; Casavant, T; Graham, MM; Smith, BJ; Sunderland, JJ; Ulrich, EJ | 1 |
| Liu, Y | 2 |
| Branstetter Iv, BF; Cramer, JD; Ferris, RL | 1 |
| Andersen, FL; Beyer, T; Fischer, BM; Hansen, AE; Kjaer, A; Krogager, L; Olin, A; Rasmussen, JH; Specht, L | 1 |
| Amdal, CD; Bogsrud, TV; Dale, E; Malinen, E; Moan, JM; Svestad, JG | 1 |
| Abgral, R; Benoudiba, F; de Mones, E; Garcia, G; Garrel, R; Mouawad, F; Pondaven, S; Russ, G; Rysman, B; Tronche, S; Zerdoud, S | 1 |
| Charabi, B; Fischer, BM; Friborg, J; Gram, SB; Håkansson, K; Nøhr, A; Rasmussen, JH; Tvedskov, JF; von Buchwald, C; Wessel, I | 1 |
| Corcoran, M; Ross, P; Wong, WL | 1 |
| Ahmad, N; Burger, I; Haerle, SK; Hany, TF; Huber, GF; Schmid, DT | 1 |
| Ahmad, N; Haerle, SK; Hany, TF; Huber, GF; Kastrinidis, N; Kuhn, FP | 1 |
| Cook, GJ; Guerrero-Urbano, T; Jeannon, JP; Oakley, R; Simo, R; Ul-Hassan, F | 1 |
| Becker, CD; Becker, M; Dulguerov, P; Lovblad, KO; Masterson, K; Rager, O; Ratib, O; Varoquaux, A | 1 |
| Adams, G; Gundelach, R; Porceddu, SV; Pryor, DI | 1 |
| Jian, L; Jingui, L; Yongkui, L | 1 |
| Fardanesh, MR; Fatterpekar, G; Genden, EM; Kim, J; Kostakoglu, L; Park, EE; Patel, Z; Rangaswamy, B; Som, PM | 1 |
| Abgral, R; Le Roux, PY; Marianowski, R; Nowak, E; Querellou, S; Rousset, J; Salaün, PY; Tissot, V; Turzo, A; Valette, G | 1 |
| Bussu, F; Castaldi, P; Leccisotti, L; Miccichè, F; Rufini, V | 1 |
| Berwouts, D; De Gersem, W; De Neve, W; Duprez, F; Madani, I; Olteanu, LA; Van de Wiele, C; Vercauteren, T | 1 |
| Axelsson, J; Larsson, A; Riklund, K; Sundström, T; Wallstén, E | 1 |
| Cappoen, N; Duprez, T; Gillain, A; Hamoir, M; Hanin, FX; Lhommel, R; Lonneux, M; Machiels, JP; Magremanne, M; Michoux, N; Reychler, H; Rommel, D; Schmitz, S; Weynand, B | 1 |
| Cho, KJ; Joo, YH; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 2 |
| Agrawal, A; Karapinar, U; Naiboglu, B; Ozer, E; Ozer, HG; Schuller, DE | 1 |
| Dunsky, KA; Osman, MM; Thornberry, BM; Varvares, MA; Wehrmann, DJ | 1 |
| Hashimoto, K; Kariya, S; Naka, K; Nishizaki, K; Okano, M; Onoda, T; Ooue, T; Yamashita, Y | 1 |
| Berwouts, D; De Gersem, W; De Neve, W; Duprez, F; Madani, I; Olteanu, LA; Speleers, B; Vercauteren, T | 2 |
| Malinen, E; Rusten, E; Rødal, J; Skogmo, HK; Søvik, Å | 1 |
| Leibfarth, S; Mönnich, D; Schmidt, H; Schwenzer, N; Siegel, C; Thorwarth, D; Welz, S; Zips, D | 1 |
| Kanda, T; Kitajima, K; Konishi, J; Morimoto, K; Nibu, K; Otsuki, N; Saito, M; Sasaki, R; Suenaga, Y; Sugimura, K | 1 |
| Antke, C; Antoch, G; Boeck, I; Buchbender, C; Handschel, J; Heusch, P; Heusner, TA; Macht, S; Rieser, E; Scherer, A; Sproll, C; Terjung, J | 1 |
| Adams, G; Burmeister, B; Foote, M; Panizza, B; Porceddu, SV; Pryor, DI; Rowan, A | 1 |
| Ganeshan, D; Hanlon, R; Lewis-Jones, H; Prowse, PM; Prowse, SJ; Shaw, R; Wieshmann, H | 1 |
| Kaanders, JH; Merkx, MA; Oyen, WJ; Schinagl, DA; Slootweg, PJ; Span, PN; van den Hoogen, FJ | 1 |
| Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 1 |
| Bikhchandani, J; Richards, AT; Smith, RB; Wood, J | 1 |
| Busk, M; Horsman, MR; Iversen, AB; Jakobsen, S; Ji, X; Lee, DY; Mortensen, LS; Nordsmark, M; Overgaard, J; Raleigh, JR | 1 |
| Hanamoto, A; Hatazawa, J; Inohara, H; Nakahara, S; Shimosegawa, E; Takenaka, Y; Ymamamoto, Y; Yoshii, T | 1 |
| Alber, M; Kaanders, JH; Mönnich, D; Oyen, WJ; Thorwarth, D; Troost, EG; Zips, D | 1 |
| Castiglioni, I; Dell'Oca, I; Gallivanone, F; Gianolli, L; Kirienko, M; Mapelli, P; Messa, C; Picchio, M; Villa, E | 1 |
| Escott, EJ | 1 |
| Afify, AM; Farwell, DG; Ferrara, KW; Haynam, EM; Mahakian, LM; Poirier, B; Seo, JW; Shaye, D; Tinling, SP; Zhang, H | 1 |
| Doucette, J; Fardanesh, R; Genden, E; Gupta, V; Kostakoglu, L; Misiukiewicz, K; Park, E; Posner, M; Rao, S; Som, P; Stein, EG | 1 |
| Ekmekcioglu, O; Elicin, O; Halac, M; Uzel, EK; Uzel, OE | 1 |
| Alluri, K; Koch, W; Lam, S; Marur, S; Paidpally, V; Subramaniam, RM; Tahari, AK; Wahl, RL | 1 |
| Becker, CD; Becker, M; Delattre, BM; Dulguerov, N; Dulguerov, P; Poncet, A; Rager, O; Ratib, O; Varoquaux, A; Zaidi, H | 1 |
| Checkver, AN; De La Vega, G; Paes, FM; Palmquist, RA; Sidani, C; Singer, AD | 1 |
| Jin, GH; Kang, BS; Kim, HS; Lee, J; Lee, TS; Lyu, KY; Park, HH; Shin, JY | 1 |
| Haba, R; Hoshikawa, H; Iwasaki, A; Kudomi, N; Maeda, Y; Matsunaga, T; Nishiyama, Y; Norikane, T; Yamamoto, Y | 1 |
| Arana Yi, C; Axelrod, R; Machtay, M; McCue, P; Morris, GJ; Rosen, M | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, JW; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Abgral, R; Bourhis, D; Keromnes, N; Le Roux, PY; Marianowski, R; Palard, X; Robin, P; Rousset, J; Salaün, PY; Valette, G | 1 |
| Cervino, AR; Chondrogiannis, S; Colletti, PM; Evangelista, L; Maffione, AM; Marzola, MC; Muzzio, PC; Rubello, D | 1 |
| Fan, M; Liu, S; Liu, Y; Yi, X; Zhang, H | 1 |
| Boehm, A; Fuchs, J; Gawlitza, M; Kahn, T; Kluge, R; Kubiessa, K; Kühn, A; Purz, S; Sabri, O; Steinhoff, KG; Stumpp, P | 1 |
| Gao, S; Li, S; Tang, Q; Yang, X | 1 |
| Balm, AJ; Hamming-Vrieze, O; Lange, CA; Lodder, WL; Pameijer, FA; Van Den Brekel, MW; Van Velthuysen, ML; Vogel, WV | 1 |
| Barlier, A; Blanchet, EM; Chen, CC; Deveze, A; Fakhry, N; Gabriel, S; Loundou, A; Martucci, V; Millo, C; Pacak, K; Pertuit, M; Taïeb, D | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Park, JP; Roh, JL | 1 |
| Armstrong, J; Borel, S; Caldwell, C; Kusano, M; Poon, I; Sattarivand, M | 1 |
| Axente, M; Bass, CP; He, J; Pugachev, A; Sundaresan, G; Williamson, JF; Zweit, J | 1 |
| Huber, GF; Hüllner, M; Kastrinidis, N; Kollias, S; Kuhn, FP; Mader, CE; Veit-Haibach, P; von Schulthess, GK | 1 |
| Fujimoto, Y; Hasegawa, Y; Hiramatsu, M; Itoh, Y; Kato, K; Naganawa, S; Nakashima, T; Suzuki, H | 1 |
| Cooley, T; Mercier, G; Subramaniam, RM; Truong, MT; Yu, J | 1 |
| Boutros, PC; Bussink, J; Dubois, LJ; Hoeben, BA; Kaanders, JH; Lambin, P; Leijenaar, RT; Starmans, MH; van der Kogel, AJ | 1 |
| Huber, G; Hüllner, M; Kollias, S; Kuhn, F; Meerwein, C; Queiroz, MA; Veit-Haibach, P; von Schulthess, G | 1 |
| Aaløkken, TM; Bogsrud, TV; Geier, OM; Hagtvedt, T; Holte, H; Lund, KV; Løndalen, AM; Seierstad, T; Smith, HJ | 1 |
| Hayashida, K; Itoh, K; Kikuchi, M; Koyasu, S; Nakamoto, Y; Suzuki, K; Togashi, K | 1 |
| Borms, M; Cocquyt, V; D'Asseler, Y; Kruse, V; Maes, A; Mees, G; Van De Wiele, C | 1 |
| Almquist, H; Brun, E; Kjellén, E; Sjövall, J; Wahlberg, P | 1 |
| Berwouts, D; De Gersem, W; De Neve, W; Duprez, F; Madani, I; Olteanu, LA; Vercauteren, T | 1 |
| Beuthien-Baumann, B; Gudziol, V; Kitzler, HH; Kotzerke, J; Laniado, M; Maus, J; Platzek, I; Popp, M; Schneider, M; Schramm, G; van den Hoff, J | 1 |
| Boerhout, EJ; Castelijns, JA; Comans, EF; de Bree, R; de Graaf, P; Hoekstra, OS; Noij, DP; Oprea-Lager, D; Pieters-van den Bos, IC; Reinhard, R | 1 |
| Chiang, S | 1 |
| Aznar, MC; Bentzen, SM; Fischer, BM; Friborg, J; Håkansson, K; Kristensen, CA; Persson, GF; Rasmussen, JH; Specht, L; Vogelius, IR | 1 |
| Baltazart, B; Castetbon, V; de Monès, E; Digue, L; Fernandez, P | 1 |
| Deasy, JO; Jeong, J; Lee, NY; Oh, JH; Setton, JS | 1 |
| Xi, K; Xi, S; Xie, X | 1 |
| Chera, BS; Elston Lafata, J; Fishman, PA; Hornbrook, MC; Khandani, AH; Liu, TL; O'Keeffe Rosetti, MC; Ritzwoller, DP; Salloum, RG; VanderWalde, NA | 1 |
| Amin, M; Chunta, JL; Grills, IS; Huang, J; Lee, DY; Marples, B; Oliver Wong, CY; Wilson, GD; Yan, D | 1 |
| Harada, H; Hino, M; Imai, Y; Itoh, K; Kanazawa, Y; Kikuchi, M; Kishimoto, I; Koyasu, S; Naito, Y; Shinohara, S; Tona, R; Usami, Y | 1 |
| Eskola, O; Grénman, R; Komar, G; Lehtiö, K; Levola, H; Lindholm, P; Minn, H; Seppälä, J; Seppänen, M; Sipilä, H; Solin, O | 1 |
| Faulhaber, P; Gaeta, C; Kohan, A; Margevicius, S; Partovi, S; Robbin, MR; Rubbert, C; Schluchter, MD; Vercher-Conejero, JL | 1 |
| Choi, SH; Kim, JS; Kim, SY; Lee, HS; Nam, SY; Roh, JL | 1 |
| Ciarallo, A; Kang, H; Kiess, AP; Koch, W; Marcus, C; Mena, E; Subramaniam, RM; Tahari, AK; Wahl, RL | 1 |
| Abgral, R; Clodic, C; Gobel, Y; Marianowski, R; Mornet, E; Potard, G; Salaun, PY; Valette, G | 1 |
| Abele, J; Allegretto, M; Bedard, E; Hunt, I; Maquire, C; Patel, A; Perry, T | 1 |
| Hoermann, K; Klohr, S; Li, CY; Sadick, H; Sadick, M; Schoenberg, SO; Weiss, C | 1 |
| Differding, S; Geets, X; Grégoire, V; Janssens, G; Lee, JA; Sterpin, E | 1 |
| Aznar, MC; Bentzen, SM; Berthelsen, AK; Due, AK; Korreman, SS; Kristensen, CA; Loft, A; Specht, L; Vogelius, IR | 1 |
| Dyrvig, AK; Gerke, O; Godballe, C; Høilund-Carlsen, PF; Johansen, J; Nielsen, AL; Rohde, M; Sørensen, JA | 1 |
| Berthelsen, AK; Højgaard, L; Loft, A | 1 |
| Chen, SW; Chien, CR; Hsieh, TC; Kao, CH; Liang, JA; Wang, YC; Yang, SN; Yen, KY | 1 |
| Chirindel, A; Chung, CH; Koch, W; Paidpally, V; Quon, H; Richmon, J; Subramaniam, RM | 1 |
| Arias, F; Asín, G; Barrado, M; Caicedo, C; Chicata, V; Eito, C; Errasti, M; García-Bragado, F; García-Velloso, MJ; Hernández, I; Quilez, I; Saenz, J; Uzcanga, M; Viudez, A | 1 |
| Adkins, D; Dehdashti, F; Ley, J; Michel, L; Siegel, BA; Siegel, MJ; Trinkaus, K; Wildes, TM | 1 |
| Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Kim, SY; Nam, IC; Park, JO; Yoo, IR | 1 |
| Garcheva, M; Gocheva, L; Zlatareva, D | 1 |
| Abgral, R; Keromnes, N; Le Roux, PY; Marianowski, R; Palard, X; Potard, G; Robin, P; Rousset, J; Salaun, PY; Valette, G | 1 |
| Giraud, P; Servagi-Vernat, S | 1 |
| Bae, WJ; Baek, S; Cho, YK; Chung, EJ; Kwon, KH; Lim, KJ; Seo, YL; Yoon, DY; Yun, EJ | 1 |
| Chen, MK; Hong, SF; Lai, YS; Lee, KW | 1 |
| Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Kim, SY; Lee, YS; Nam, IC; Park, JO; Yoo, IeR | 1 |
| Boerman, OC; Bussink, J; Franssen, GM; Kaanders, JH; Lok, J; van Dijk, LK | 1 |
| Alluri, KC; Chung, CH; Koch, W; Subramaniam, RM; Tahari, AK; Wahl, RL | 1 |
| Burger, IA; Dinkelborg, L; Friebe, M; Graham, K; Haerle, SK; Hany, TF; Horn-Tutic, M; Kowal, K; Luurtsema, G; Maas, B; Pruim, J; Schaefer, NG; Schibli, R; Stephens, A; von Schulthess, GK; Wiegers, J; Zitzmann-Kolbe, S | 1 |
| Cheze Le Rest, C; Fayad, H; Fernandez, P; Lamare, F; Le Pogam, A; Pradier, O; Valette, G; Visvikis, D | 1 |
| Baschnagel, AM; Chunta, J; Fortier, LE; Galoforo, S; Huang, J; Marples, B; Oliver Wong, CY; Pruetz, BL; Thibodeau, BJ; Wilson, GD; Yan, D | 1 |
| Ameye, L; Awada, A; Flamen, P; Garcia, C; Lalami, Y; Paesmans, M | 1 |
| Bloemena, E; Boellaard, R; Braakhuis, BJ; Brakenhoff, RH; de Bree, R; Doornaert, PA; Hakim, S; Hoekstra, OS; Leemans, CR; Schouten, CS; Witte, BI | 1 |
| Ishiwata, K; Ito, K; Kubota, K; Minamimoto, R; Miyata, Y; Morooka, M; Okasaki, M; Toyohara, J; Yokoyama, J | 1 |
| Beer, AJ; Dinges, J; Eiber, M; Loeffelbein, DJ; Mücke, T; Pickhard, A; Ritschl, LM; Schwaiger, M; Souvatzoglou, M; Wankerl, V | 1 |
| Apostolova, I; Baumann, M; Brenner, W; Buchert, R; Hentschel, M; Hofheinz, F; Kotzerke, J; Lougovski, A; Steffen, IG; van den Hoff, J; Wedel, F; Zöphel, K | 1 |
| Eskola, O; Grénman, R; Grönroos, TJ; Kronqvist, P; Laine, J; Lehtiö, K; Minn, H; Söderström, KO; Solin, O; Viljanen, T | 1 |
| Gallet, P; Gavid, M; Martin, C; Prades, JM; Prevot-Bitot, N; Timoschenko, A | 1 |
| Atallah, I; Berta, E; Boyer, E; Karkas, A; Reyt, E; Righini, CA | 1 |
| Lauridsen, JK; Rohde, M; Thomassen, A | 1 |
| Aleknavičius, E; Burneckis, A; Daisne, JF; Grybauskas, M | 1 |
| Arai, Y; Hiroi, K; Honda, N; Itami, J; Kono, Y; Kumita, S; Kurihara, H; Murakami, R; Tani, H; Yoshimoto, M | 1 |
| Brandau, S; Franklin, C; Hermann, S; Jure-Kunkel, M; Kerem, A; Lang, S; Öztürk, E; Schäfers, M; Vahle, AK; Wildner, M | 1 |
| Ampil, F; Caldito, G; Devarakonda, S; Mills, G; Nathan, CA; Reiser, C; Takalkar, A | 1 |
| Chen, Y; Shi, Y; Wu, Z; Xiao, Y | 1 |
| Cho, K; Ki, Y; Kim, D; Kim, S; Kim, W; Lee, B; Lee, J; Nam, J | 1 |
| Fietkau, R; Haderlein, M; Iro, H; Kuwert, T; Lell, M; Schmidt, D; Semrau, S; Uder, M; Waldfahrer, F; Wolf, W | 1 |
| Fukumura, T; Hoshikawa, H; Kishino, T; Mori, N; Mori, T; Nishiyama, Y; Samukawa, Y; Yamamoto, Y | 1 |
| Castelijns, JA; de Bree, R; Hoekstra, OS; Leemans, CR; Peters, TT; Senft, A; Witte, BI | 1 |
| Burmeister, BH; Burmeister, E; Chua, B; Foote, MC; Panizza, B; Porceddu, SV; Pryor, D; Sjövall, J | 1 |
| Abakay, CD; Akpinar, T; Altay, A; Arslan, S; Ekinci, AS; Esbah, O; Kekilli, KE; Ozkan, L; Sen, F; Uslu, N | 1 |
| Chen, SW; Hsieh, TC; Kao, CH; Lin, YC; Wang, YC; Yang, SN; Yen, KY | 1 |
| Sun, R; Tang, X; Yang, Y; Zhang, C | 1 |
| Geng, J; Li, X; Nie, F; Zhang, B | 1 |
| Andersen, FL; Aznar, MC; Fischer, BM; Hansen, AE; Højgaard, L; Kjaer, A; Löfgren, J; Loft, A; Rasmussen, JH; Specht, L; Vogelius, IR | 1 |
| Hanai, N; Hasegawa, Y; Hirakawa, H; Nishio, M; Suzuki, H; Tamaki, T | 1 |
| Anderson, CM; Buatti, JM; Button, A; Chang, T; Graham, MM; Marquardt, MD; Menda, Y; Pagedar, NA; Smith, BJ; Sun, W | 1 |
| Huber, GF; Hüllner, M; Kollias, S; Meerwein, CM; Queiroz, M; Veit-Haibach, P | 1 |
| Alberts, FM; Bloemena, E; Castelijns, JA; Comans, EF; de Bree, R; de Graaf, P; Hoekstra, OS; Leemans, CR; Sanchez, E; Schouten, CS; Witte, BI | 1 |
| Boellaard, R; de Bree, R; Hoekstra, OS; Leemans, CR; Meeuwis, J; Witte, BI | 1 |
| Ang, KK; Foote, R; Garden, AS; Harari, P; Harris, J; Holland, J; Jones, CU; Le, QT; Levering, A; Opanowski, A; Rosenthal, DI; Schwartz, DL; Trotti, AM; Yao, M; Zhang, Q | 1 |
| Coleman, A; Collins, M; Corry, J; D'Costa, I; De Abreu Lourenco, R; Fua, T; Lau, E; Liu, C; Rischin, D; Shah, K; Te Marvelde, L | 1 |
| Borbély, K | 1 |
| Komatsu, M; Mori, M; Nishimura, G; Oridate, N; Taguchi, T; Takahashi, M; Yabuki, K | 1 |
| Akhtar, S; Alhuraiji, A | 1 |
| Fujiwara, K; Harada, H; Hino, M; Itoh, K; Kikuchi, M; Kishimoto, I; Naito, Y; Shinohara, S; Suehiro, A; Tona, R | 1 |
| Abgral, R; Keromnes, N; Le Roux, PY; Marianowski, R; Robin, P; Rousset, J; Salaün, PY; Valette, G | 1 |
| Adachi, S; Koizumi, M; Kojo, M; Kubota, K; Matsuno, S; Morioka, N; Nishimura, M; Nishioka, S; Seto, H; Yamamoto, H | 1 |
| Marcus, C; Sheikhbahaei, S; Subramaniam, RM | 1 |
| Kondo, T; Matoba, M; Oota, K; Shimode, Y; Tonami, H; Tuji, H | 2 |
| Barragán, AM; Differding, S; Janssens, G; Lee, JA; Sterpin, E | 1 |
| Mehranian, A; Zaidi, H | 1 |
| Carey, B; Forrester, R; Gopal, SV; McDermott, G; Prestwich, RJ; Roberts, N; Scarsbrook, AF; Sourbron, S; Speight, R; Subesinghe, M; Sykes, JR; Wilson, DJ | 1 |
| Howlett, DC; Kaya, G | 1 |
| Branstetter, BF; Hughes, MA; Kim, S; Leung, AS; Rath, TJ | 1 |
| Alvarez, J; Bilbao, P; Cacicedo, J; Del Hoyo, O; Dolado, A; Espinosa, JM; Fernandez, I; Gaafar, A; Gómez-Suarez, J; Hortelano, E; Pijoan, JI; Sancho, A | 1 |
| Aiello, M; Cavaliere, C; Cianelli, MS; Covello, M; Iorio, B; Mesolella, M; Nicolai, E; Rossi, A | 1 |
| Besenyi, Z; Csenki, M; Cserháti, A; Dobi, Á; Együd, Z; Gaál, S; Hideghéty, K; Lengyel, Z; Maráz, A; Mózes, P; Pávics, L; Rusz, O; Szántó, E; Varga, Z; Zag, L | 1 |
| Basile, C; Botta, F; Bracco, C; Brambilla, M; Castiglioni, I; Cavedon, C; Cremonesi, M; De Ponti, E; Fioroni, F; Gallivanone, F; Giri, M; Grassi, E; Matheoud, R; Morzenti, S; Pacilio, M; Pasetto, S; Stasi, M; Valzano, S; Zanni, D | 1 |
| Differding, S; Grégoire, V; Hanin, FX; Janssens, G; Lee, JA; Sterpin, E | 1 |
| Prestwich, RJ; Ramasamy, S; Scarsbrook, AF; Sen, M; Slevin, F; Subesinghe, M | 1 |
| Bray, V; Chicco, A; Forstner, D; Fowler, A; Lee, MT; Lin, M; Lin, P; Min, M; Shon, IH; Tieu, MT | 1 |
| Daisne, JF; Grégoire, V; Kramar, A; Lacornerie, T; Lartigau, E; Leclerc, M | 1 |
| Galoforo, S; Grills, IS; Kane, JL; Krueger, SA; Marples, B; Wilson, GD; Wobb, J | 1 |
| Cho, KJ; Choi, SH; Choi, YJ; Kim, JS; Kim, SY; Lee, JH; Lee, JR; Nam, SY; Roh, JL | 1 |
| Hata, H; Hirata, K; Imafuku, K; Inamura, Y; Kitamura, S; Sakashita, T; Shimizu, H | 1 |
| Ishihara, T; Kitajima, K; Kiyota, N; Minamikawa, T; Nibu, K; Otsuki, N; Sasaki, R; Suenaga, Y; Sugimura, K | 1 |
| Hoebers, FJ; Lambin, P; Mottaghy, FM; Öllers, MC; Troost, EG; van Elmpt, W; Zegers, CM | 1 |
| Antoch, G; Bergmann, C; Buchbender, C; Forsting, M; Heusch, P; Ruhlmann, M; Ruhlmann, V; Schaarschmidt, BM; Schlamann, M; Wetter, A | 1 |
| Bentzen, SM; Cullen, K; Fischer, BM; Ioffe, O; Rasmussen, GB; Rasmussen, JH; Schumaker, L; Specht, L; Therkildsen, MH; Vogelius, IR | 1 |
| Arai, Y; Chiba, Y; Hata, M; Komatsu, M; Nishimura, G; Oridate, N; Sano, D; Shiono, O; Taguchi, T; Takahashi, H; Takahashi, M; Yabuki, K | 2 |
| Ahmad, R; Chung, CH; Fakhry, C; Kiess, AP; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M | 1 |
| Chang, JT; Cheng, NM; Fang, YH; Lee, LY; Liao, CT; Ng, SH; Tsan, DL; Wang, HM; Yang, LY; Yen, TC | 1 |
| Castetbon, V; de Clermont-Galleran, H; de Monès, E; Digue, L; Fernandez, P; Ghafouri, A; Haaser, T; Sagardoy, T | 1 |
| Baschnagel, AM; Dilworth, JT; Eskandari, M; Pruetz, BL; Williams, L; Wilson, GD; Wobb, JL; Wu, D | 1 |
| Aznar, MC; Bentzen, SM; Christensen, CB; Fischer, BM; Friborg, J; Kristensen, CA; Loft, A; Rasmussen, JH; Specht, L; Vogelius, IR | 1 |
| de Bree, R; Hoekstra, OS; Leemans, CR; Senft, A; Witte, BI | 1 |
| Andersen, LJ; Brunø, AH; Carl, J; Sand, HM | 1 |
| Adam, AC; Guntinas-Lichius, O; Huebbers, CU; Klussmann, JP; Preuss, SF; Schiffer, T; Schilder, S; Schmidt, M; Wiesner, RJ | 1 |
| Glatz, S; Guckenberger, M; Hemmatazad, H; Huber, G; Ikenberg, K; Klöck, S; Lang, S; Nesteruk, M; Pruschy, M; Riesterer, O; Stieb, S; Studer, G; Veit-Haibach, P | 1 |
| Agrawal, N; Chan, JY; Mydlarz, WK; Qualliotine, JR; Wang, H; Zhou, X | 1 |
| Ahn, SJ; Fakhry, C; Kang, H; Moriarty, E; Sheikhbahaei, S; Subramaniam, RM | 1 |
| Barron, BJ; Brandon, DC; Corey, AS; Halkar, RK; Harrison, CE; Karagulle Kendi, AT; Plaxton, NA | 1 |
| Kitajima, K; Suenaga, Y; Sugimura, K | 1 |
| Bousquet, F; Cathelinaud, O; Fakhry, N; Giovanni, A; Morvan, JB; Rivière, D; Vatin, L; Verdalle, P | 1 |
| Bitencourt, AG; Chojniak, R; Kowalski, LP; Lima, EN; Martins, EB; Nicolau, UR | 1 |
| Adams, KT; Buchmann, I; Chen, CC; Fojo, AT; Herscovitch, P; Janssen, I; Kebebew, E; Millo, CM; Nambuba, J; Pacak, K; Patronas, NJ; Sadowski, SM; Taieb, D | 1 |
| Binns, D; Bressel, M; Graves, EE; Hicks, RJ; Le, QT; Peters, L; Rischin, D; Young, RJ | 1 |
| Kumar, R; Mittal, BR; Mukherjee, A | 1 |
| Choi, JW; Han, M; Kim, SY; Lee, SJ | 1 |
| Muzaffar, R; Osman, MM; Raslan, OA; Shetty, V | 1 |
| Forstner, D; Fowler, A; Gooneratne, D; Holloway, L; Lee, MT; Lin, P; Liney, G; Min, M; Rai, R; Wijesekera, Dj; Xuan, W | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Park, JT; Roh, JL | 1 |
| Anwar, B; George, MM; Homer, JJ; Mani, N; Nash, L | 1 |
| Eriksson, O; Haylock, AK; Mortensen, AC; Nestor, MV; Nilvebrant, J; Selvaraju, RK; Spiegelberg, D; Tolmachev, V | 1 |
| Bishop, JA; Bradley, PJ; Ferlito, A; Haigentz, M; Hamoir, M; Hartl, DM; López, F; Mendenhall, WM; Rinaldo, A; Robbins, KT; Rodrigo, JP; Shaha, AR; Silver, CE; Strojan, P; Suárez, C; Takes, RP; Werner, JA | 1 |
| de Galiza Barbosa, F; Haerle, SK; Hany, TF; Huber, GF; Hüllner, MW; Pietsch, C; Schmid, DT; Studer, G; Veit-Haibach, P | 1 |
| Chirla, R; Marcu, LG | 1 |
| Fliedner, FP; Hansen, AE; Jørgensen, JT; Kjær, A | 1 |
| Castelijns, JA; de Bree, R; Hoekstra, OS; Leemans, CR; Senft, A | 1 |
| Colletti, PM; Giammarile, F; Grassetto, G; Manca, G; Perkins, AC; Rubello, D; Vanzi, E; Volterrani, D; Wong, KK | 1 |
| Bray, V; Chicco, A; Forstner, D; Fowler, A; Ho Shon, I; Lee, M; Lin, M; Lin, P; Min, M; Tieu, MT | 1 |
| Abouzied, ME; Al-Bulushi, NK | 1 |
| Leibfarth, S; Mönnich, D; Schmidt, H; Schwenzer, N; Simoncic, U; Thorwarth, D; Welz, S; Zips, D | 1 |
| Chan, SC; Chang, JT; Fan, KH; Ko, SF; Liao, CT; Lin, CY; Lin, YC; Ng, SH; Wang, HM; Wang, JJ; Yang, LY; Yen, TC | 1 |
| Chang, JT; Chen, SH; Hsieh, CH; Kang, CJ; Liao, CT; Lin, CY; Wang, HM; Yang, LY; Yen, TC | 1 |
| Amegnizin, JL; Durand, P; Kerrou, K; Ohnona, J | 1 |
| Aznar, MC; Bentzen, SM; Fischer, BM; Friborg, J; Håkansson, K; Kristensen, CA; Loft, A; Rasmussen, JH; Specht, L; Vogelius, IR | 1 |
| Agrawal, N; Kang, H; Richmon, J; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Wray, R | 1 |
| Chang, CC; Chang, YH; Chien, CY; Chuang, HC; Fang, FM; Huang, SH; Hung, BT | 1 |
| Agnew, J; Bennett, O; Ravi Kumar, AS | 1 |
| Cammaroto, G; Caobelli, F; Di Mauro, F; Quartuccio, N | 1 |
| Burkill, GJ; Connor, SE; Evans, RM; Raman, VV | 1 |
| Asahi, S; Fujieda, S; Kimura, H; Kiyono, Y; Makino, A; Mori, T; Narita, N; Oh, M; Okazawa, H; Sato, Y; Tsuchida, T; Tsujikawa, T | 1 |
| Hirata, K; Kasai, K; Kuge, Y; Magota, K; Nishijima, KI; Okamoto, S; Onimaru, R; Shiga, T; Shirato, H; Tamaki, N; Tuchiya, K; Watanabe, S; Yasuda, K | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Ryu, IS | 1 |
| Boehm, A; Gawlitza, M; Höhn, AK; Kahn, T; Meyer, HJ; Purz, S; Sabri, O; Stumpp, P; Surov, A | 1 |
| Ferraro, R; Marcus, C; Rahmim, A; Sheikhbahaei, S; Subramaniam, RM; Wray, R; Zan, E | 1 |
| Igaki, H; Inaba, K; Itami, J; Ito, Y; Kobayashi, K; Kurihara, H; Murakami, N; Nakamura, S; Okamoto, H; Shigematsu, N; Takahashi, K; Umezawa, R; Wakita, A; Watanabe, Y; Yoshimoto, S | 1 |
| Caramella, D; Cernusco, LN; Delishaj, D; Faggioni, L; Ferrazza, P; Guidoccio, F; Morganti, R; Neri, E; Paiar, F; Seccia, V; Ursino, S; Volterrani, D | 1 |
| Deák, P; Fábián, G; Kahán, Z; Kovács, L; Mózes, P; Nagy, O; Pál, M; Reisz, Z; Rovó, L; Rusz, O; Szilágyi, É; Tiszlavicz, L; Tomisa, B; Varga, Z | 1 |
| Arya, S; Mahajan, A; Paul, PP | 1 |
| Chi, KK; Kader, I; Leavers, B; Shashinder, S; Sundaresan, P; Wylie, B | 1 |
| Abdulelah, H; Al-Hussaini, M; Al-Ibraheem, A; AlSharif, A | 1 |
| Derlin, T | 1 |
| de Melo, NS; Dos Anjos, DA; Dos Anjos, RF; Figueiredo, PTS; Leite, AF; Vieira, DL | 1 |
| Baek, KH; Cho, JK; Choi, JY; Choi, N; Hyun, SH; Jeong, HS; Kim, MJ; Lee, SH | 1 |
| Bittner, MI; Bucher, S; Grosu, AL; Hentschel, M; Kayser, G; Meyer, PT; Mix, M; Rücker, G; Weber, WA; Werner, M; Wiedenmann, N | 1 |
| Platzek, I | 1 |
| Bogsrud, TV; Dale, E; Moan, JM; Osnes, TA | 1 |
| Ahnesjö, A; Grönlund, E; Johansson, S; Montelius, A | 1 |
| Ahn, BC; Jeong, JH; Jeong, SY; Jung, JH; Kim, CY; Lee, CH; Lee, J; Lee, SW; Son, SH | 1 |
| Castelijns, JA; de Bree, R; Hoekstra, OS; René Leemans, C; Senft, A; Yildirim, G | 1 |
| Fujima, N; Hirata, K; Homma, A; Kudo, K; Sakashita, T; Shiga, T; Shirato, H | 1 |
| Mena, E; Pattanayak, P; Redy, S; Subramaniam, RM; Thippsandra, S; Yanamadala, A | 1 |
| Abadi, P; Gerke, O; Godballe, C; Høilund-Carlsen, PF; Johansen, A; Thomassen, A | 1 |
| Bourhis, J; Castelli, J; De Bari, B; de Crevoisier, R; Depeursinge, A; Devillers, A; Ozsahin, M; Prior, J; Roman Jimenez, G; Simon, A | 1 |
| Bray, V; Forstner, D; Fowler, A; Holloway, L; Lee, M; Lin, P; Min, M | 1 |
| Alhilahi, LM; Branstetter, BF; Fakhran, S; Hughes, MA; Rath, TJ; Seungwon, KW; Yankevich, U | 1 |
| Ahmadvand, P; Bauer, C; Beichel, RR; Buatti, JM; Budzevich, MM; Gillies, RJ; Goldgof, D; Grkovski, M; Hamarneh, G; Huang, Q; Kinahan, PE; Laymon, CM; Mountz, JM; Muzi, JP; Muzi, M; Nehmeh, S; Oborski, MJ; Smith, BJ; Sunderland, JJ; Tan, Y; Ulrich, EJ; Zhao, B | 1 |
| Appold, S; Bandurska-Luque, A; Baumann, M; Gudziol, V; Haase, R; Kotzerke, J; Krause, M; Leger, S; Löck, S; Richter, C; Schreiber, A; Zips, D; Zöphel, K; Zschaeck, S | 1 |
| Choi, JW; Han, M; Hyun, SH; Kim, JH; Lee, D; Lee, SJ | 1 |
| Alber, M; Thorwarth, D | 1 |
| Krohn, KA; Yeuh, B | 1 |
| Blodgett, T; Carlson, E; Faul, D; Lemmens, C; Long, M; Nahmias, C; Nuyts, J; Townsend, D | 1 |
| Arora, A; Deshpande, M; Pathak, S; Purandare, NC; Rangarajan, V; Shah, S; Sharma, AR; Singh, N | 1 |
| Eisbruch, A; Kessler, ML; Piert, M; Soto, DE | 1 |
| Tikkakoski, T | 1 |
| Hirai, T; Katsuragawa, S; Kawanaka, K; Murakami, R; Nishimura, R; Oya, N; Shiraishi, S; Tashiro, K; Tomiguchi, S; Toya, R; Uozumi, H; Yamashita, Y | 1 |
| Aimoni, C; Padovani, D; Paluzzi, A; Pastore, A; Zucchetta, P | 1 |
| Foster, E; Piert, M; Wong, KK | 1 |
| Nguyen, BD; Pockaj, BA; Roarke, MC | 1 |
| Cook, G; Harrington, KJ; Newbold, KL; Nutting, CM; Partridge, M; Rhys-Evans, P; Sharma, B | 1 |
| Krabbe, CA; Pruim, J; Rödiger, LA; Roodenburg, JL; van der Laan, BF | 1 |
| Csiki, Z; Garai, I; Sóvágó, J; Szabados, L; Tóth, C; Tóth, L | 1 |
| Beldì, D; Brambilla, M; Deantonio, L; Gambaro, G; Inglese, E; Krengli, M; Loi, G | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Geller, MD; Gerard, PS; Mattern, M | 1 |
| Angelini, AL; Barbieri, E; Bunkheila, F; Castellucci, P; Cecconi, A; Fuccio, C; Fuccio, L; Guido, A; Rombi, B; Spezi, E | 1 |
| Gönen, M; Greco, C; Humm, JL; Larson, SM; Lee, NY; Nehmeh, SA; Raphael, B; Schöder, H; Stambuk, HE | 1 |
| Enomoto, K; Hatazawa, J; Higuchi, I; Inohara, H; Inoue, T; Osaki, Y; Tomiyama, Y; Yoshii, T | 1 |
| Ahn, HY; Chang, SK; Hwang, HS; Kim, JH; Lee, IJ; Rho, YS; Yoon, DY | 1 |
| Huh, J; Jang, YJ; Kang, YK; Kim, JS; Kim, MR; Lee, BJ; Lee, JH; Roh, JL; Suh, C | 1 |
| Buatti, JM; Funk, GF; Graham, MM; Hoffman, HT; Lu, M; Menda, Y; Smith, RB; Yao, M | 1 |
| Byun, BH; Cheon, GJ; Choi, CW; Kang, HJ; Kim, KM; Lee, SS; Lim, SM; Na, II; Ryoo, BY; Yang, SH | 1 |
| Burmeister, BH; Hicks, RJ; Porceddu, SV | 1 |
| Bacharach, SL; Franc, BL; Hwang, AB; Quivey, JM; Weinberg, VK; Xia, P; Yom, SS | 1 |
| Abgral, R; Bizais, Y; Kraeber-Bodéré, F; Le Duc-Pennec, A; Le Roux, PY; Marianovski, R; Potard, G; Pradier, O; Querellou, S; Salaun, PY | 1 |
| Daum, O; Ferda, J; Ferdová, E; Kreuzberg, B; Mukensnabl, P; Walter, J; Záhlava, J | 1 |
| Andrel, J; Anne, PR; Hyslop, T; Intenzo, CM; Keane, W; Lavarino, J; Machtay, M; Natwa, M | 1 |
| Goyal, P; Hsu, JM; Kellman, RM | 1 |
| Bortoluzzi, L; Hürlimann, S; Schwarz, E; Soyka, JD; Strobel, K | 1 |
| Chang, FC; Chang, SY; Chu, PY; Huang, JL; Liu, RS; Tai, SK; Tsai, TL; Wang, YF | 1 |
| Batty, V; Wong, WL | 1 |
| Agarwala, SS; Argiris, A; Branstetter, BF; Childs, EE; Couture, LA; Egloff, AM; Gooding, WE; Grandis, JR; Johnson, JT; Johnson, R; Koppikar, P; Lai, SY; Lui, VW; Mills, G; Mountz, JM; Muthukrishnan, A; Myers, EN; Seethala, RR; Shin, DM; Thomas, SM | 1 |
| Haerle, SK; Hany, TF; Schrank, M; Soyka, JD; Stoeckli, SJ; Strobel, K; Veit-Haibach, P | 1 |
| Baldetorp, B; Bendahl, PO; Borg, A; Brun, E; Henriksson, E; Kjellén, E; Mertens, F; Ohlsson, T; Rennstam, K; Wahlberg, P; Wennerberg, J | 1 |
| Caldwell, C; Mah, K; Mozeg, D; Yu, H | 1 |
| Hoffmann, AL; Kaanders, JH; Oyen, WJ; Schinagl, DA; van Dalen, JA; Verstappen, SM; Vogel, WV | 1 |
| Chu, JN; Filion, EJ; Graves, EE; La, TH; Le, QT; Lee, P; Loo, BW; Maxim, P; Nguyen, K; Quon, A; Turnbull, BB | 1 |
| Futatsubashi, M; Kanno, T; Naitou, K; Ouchi, Y; Tanizaki, Y; Torizuka, T; Ueda, Y | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Hahn, S; Hamami, ME; Heusner, TA; Kögel, S; Stahl, AR | 1 |
| Dunn, J; Fisher, S; MacCabe, C; MacLennan, K; Mehanna, H; Nutting, C; Wong, WL | 1 |
| Cheng, KJ; Fan, J; Li, LF; Ling, L; Wang, SQ; Wu, QL; Zhao, K; Zhou, SH | 1 |
| Ang, KK; Cannon, BA; Chao, KS; Chronowski, GM; Frank, SJ; Garden, AS; Ginsberg, LE; Lee, JJ; Lippman, SM; Macapinlac, HA; Moeller, BJ; Morrison, WH; Rana, V; Rosenthal, DI; Schwartz, DL; Sturgis, EM; Weber, RS; Williams, MD | 1 |
| Horiuchi, C; Inoue, T; Lee, J; Nagashima, T; Suzuki, A; Tsukuda, M; Yoshida, K | 1 |
| Brizel, DM; Busse, PM; Dong, L; Eisbruch, A; Garden, AS; Haddad, RI; Kies, MS; Salama, JK; Tishler, RB; Trotti, AM | 1 |
| Fury, M; Kraus, D; Lee, N; Schöder, H | 1 |
| Chua, SC; O'Connor, SR; Rozalli, FI | 1 |
| Kurabayashi, T; Murata, Y; Nakamura, S; Okochi, K; Shibuya, H | 1 |
| Andrade, RS; Argiris, A; Branstetter, BF; Burton, S; Deeb, EL; Ferris, RL; Gooding, WE; Grandis, JR; Heron, DE; Johnson, JT; Karamouzis, M; Lai, SY; Mountz, JM | 1 |
| Kaanders, JH; Schinagl, DA; Troost, EG | 1 |
| De Keyzer, F; Dirix, P; Hermans, R; Nuyts, S; Stroobants, S; Vandecaveye, V | 1 |
| Bjurberg, M; Brun, A; Brun, E; Ekblad, L; Henriksson, E; Kjellén, E; Ohlsson, T | 1 |
| Genden, EM; Kao, J; Kostakoglu, L; Mocherla, B; Packer, S; Park, EE; Som, PM; Vu, HL | 1 |
| Fekésházy, A; Klinkó, T; Mayer, A; Nemeskéri, C; Sinkó, D; Tóth, V; Tóth, Z; Weisz, C | 1 |
| Aoyama, H; Homma, A; Nishioka, T; Onimaru, R; Shirato, H; Suzuki, K; Tamaki, N; Tsuchiya, K; Yasuda, M | 1 |
| Haerle, SK; Hany, TF; Sidler, D; Stoeckli, SJ; Strobel, K | 1 |
| Fan, CZ; Fan, QP; Li, FL; Li, L; Su, MG; Tian, R; Tian, Y; Yang, XC | 1 |
| Balogh, J; Caldwell, C; Khaouam, N; MacKenzie, R; Mah, K; Poon, I; Tirona, R; Yu, H | 1 |
| Castelijns, JA; de Bree, R; Hoekstra, OS; Leemans, CR | 1 |
| Abolmaali, N; Abramyuk, A; Appold, S; Baumann, M; Hentschel, M; Kotzerke, J; Schreiber, A; Zöphel, K | 1 |
| Bol, A; Castadot, P; Geets, X; Grégoire, V; Lee, JA | 1 |
| Bold, B; Ishida, R; Okada, N; Omura, K; Piao, Y; Shibuya, H; Tayier, A | 1 |
| Chu, HR; Hwang, HS; Kim, JH; Rho, YS; Yoon, DY | 1 |
| Barret, O; de Clermont-Gallerande, H; De-Mones-Del-Pujol, E; Demeaux, H; Fernandez, P; Henriques de Figueiredo, B; Kantor, G; Lagarde, P; Richaud, P | 1 |
| Eckstein, HH; Essler, M; Gee, MW; Gurdan, M; Maier, A; Mariss, J; Pelisek, J; Reeps, C; Wall, W | 1 |
| Boerman, OC; Bussink, J; Kaanders, JH; Oyen, WJ; Schinagl, DA; Troost, EG; van der Kogel, AJ | 1 |
| Horiuchi, C; Komatsu, M; Matsuda, H; Nishimura, G; Taguchi, T; Takahashi, M; Tsukuda, M; Watanabe, M | 1 |
| D'Asseler, Y; Deblaere, K; Dobbeleir, A; Goethals, I; Ham, H | 1 |
| Clark, JR; Iyer, NG; Singham, S; Zhu, J | 1 |
| Arisaka, Y; Endo, K; Hanaoka, H; Higuchi, T; Ishikita, T; Miyakubo, M; Miyashita, G; Nakasone, Y; Negishi, A; Oriuchi, N; Paudyal, B; Paudyal, P; Yokoo, S | 1 |
| Guo, W; Li, SJ; Liao, JX; Ren, GX | 1 |
| Concannon, R; Larcos, GS; Veness, M | 1 |
| Li, X; Lu, X; Zhang, B | 1 |
| Cho, GJ; Choi, YJ; Chung, JS; Kim, HJ; Kim, SJ; Kim, WT; Kwon, BR; Lee, BJ; Lee, JC; Seol, YM; Shin, HJ; Song, MK; Wang, SG; Yun, EY | 1 |
| de Bree, R; Hoekstra, OS; Leemans, CR; Senft, A; Uyl-de Groot, CA | 1 |
| Bridji, B; Calais, G; Digue, L; Duvillard, C; Grégoire, V; Hamoir, M; Lonneux, M; Maingon, P; Reychler, H; Toubeau, M | 1 |
| Malone, J; Robbins, KT | 1 |
| Alexopoulos, DK; Chen, CC; Jacobs, S; King, KS; Mattox, DE; Pacak, K; Reynolds, JC; Whatley, MA | 1 |
| Ito, K; Kubota, K; Matsuda, H; Morooka, M; Shiibashi, M; Yokoyama, J | 1 |
| Ceulemans, G; Everaert, H; Farrag, A; Storme, G; Voordeckers, M | 1 |
| Barbee, DL; Jeraj, R; Kissick, MW; McCall, KC | 1 |
| Argiris, A; Branstetter, BF; Ferris, RL; Gibson, MK; Grandis, JR; Heron, DE; Johnson, JT; Kim, SW; Lai, SY; Passero, VA; Shuai, Y | 1 |
| Fuwa, N; Inokuchi, H; Kodaira, T; Mizoguchi, N; Nakahara, R; Nakamura, T; Tachibana, H; Takada, A; Tamaki, T; Tomita, N | 1 |
| Bisdas, S; Bisdas, T; Chambron-Pinho, N; Ernemann, U; Hammerstingl, R; Mack, MG; Middendorp, M; Seitz, O; Vogl, TJ | 1 |
| Gambhir, SS; Iagaru, A; Mittra, ES | 1 |
| Comans, EF; de Bree, R; Golding, RP; Hoekstra, OS; Kuik, JD; Leemans, CR; Senft, A; Van Waesberghe, JH | 1 |
| Kavanagh, E; Moynagh, M; O'Dwyer, T; O'Neill, JP | 1 |
| Franceschi, D; Kaloudis, E; Matthews, R; Relan, N; Shrestha, P | 1 |
| Adachi, T; Fujiwara, K; Hori, SY; Imai, Y; Kikuchi, M; Naito, Y; Nakamoto, Y; Shinohara, S; Tona, Y; Usami, Y; Yamazaki, H | 1 |
| Goodchild, K; Kayani, I; Lemon, C; Meer, K; Moinuddin, SA; Moule, RN; Saunders, MI | 1 |
| Abolmaali, N; Abramyuk, A; Appold, S; Haberland, U; Koch, A; Shakirin, G; Tokalov, S; Wolf, G; Zöphel, K | 1 |
| Cohen, EE; de Souza, JA | 1 |
| Paleri, V; Zammit-Maempel, I | 1 |
| Blouet, A; Courbon, F; David, I; Filleron, T; Izar, F; Laprie, A; Metwally, H; Plat, G; Rives, M; Robert, A; Vial, J; Zerdoud, S | 1 |
| Agarwal, JP; Dinshaw, KA; Ghosh-Laskar, S; Gupta, T; Jain, S; Purandare, N; Rangarajan, V | 1 |
| Ishihara, K; Kumita, S | 1 |
| Champ, C; Dusing, RW; Fogh, S; Intenzo, C; Kubicek, GJ; Machtay, M; Reddy, E; Wang, F | 1 |
| Coghe, M; De Gersem, W; De Neve, W; Duprez, F; Madani, I | 1 |
| Chu, K; Fischbein, NJ; Graves, EE; La, TH; Le, QT; Loo, BW; Maxim, PG; Murphy, JD; Quon, A | 1 |
| Allal, BC; Brillouet, S; Canal, P; Caselles, O; Courbon, F; Delord, JP; Filleron, T; Rochaix, P; Thomas, F; Vergez, S | 1 |
| Cho, KJ; Cho, Y; Choi, SH; Kim, JS; Kim, SB; Kim, SY; Lee, JH; Lee, SW; Nam, SY; Roh, JL; Song, SY; Yoon, DH | 1 |
| Ahmad, N; Haerle, SK; Hany, TF; Huber, GF; Schmid, DT | 1 |
| de Bree, R; Hoekstra, OS | 2 |
| Bussink, J; Kaanders, JH; Oyen, WJ; Schinagl, DA; Troost, EG | 1 |
| Ferris, RL; Hagan, JL; Rabalais, A; Tauzin, M; Walvekar, RR; Wood, CG | 1 |
| Chen, SW; Chien, CR; Hsieh, TC; Kao, CH; Liang, JA; Wang, YC; Yang, SN; Yen, KY; Yu, CY | 1 |
| Horiuchi, C; Nishimura, G; Taguchi, T; Tsukuda, M; Yabuki, K | 1 |
| Ito, K; Kubota, K; Morooka, M; Yokoyama, J | 1 |
| de Bree, R | 1 |
| Ahmad, N; Buck, A; Fischer, DR; Haerle, SK; Huber, GF; Schmid, DT | 1 |
| Ahn, SD; Choi, EK; Choi, W; Im, KC; Jung, SH; Kim, JH; Kim, S; Lee, SW; Oh, SJ; Park, SH; Ryu, JS | 1 |
| Ceulemans, G; Everaert, H; Farrag, A; Storme, G; Verdries, D; Voordeckers, M | 1 |
| Brizel, DM; Hawk, TC; Higgins, KA; Hoang, JK; Roach, MC; Turkington, TG | 1 |
| De Potter, A; Deron, P; Goethals, I; Peeters, M; Van de Wiele, C; Vangestel, C; Vermeersch, H | 1 |
| Goodchild, K; Kayani, I; Lemon, C; Moule, RN; Prior, T; Sanghera, B; Saunders, MI; Wong, WL | 1 |
| de Bree, R; Heuveling, DA; van Dongen, GA | 1 |
| Kim, J; Visioni, A | 1 |
| Fu, Z; Li, M; Sun, X; Xie, P; Yu, J; Zhao, H | 1 |
| Fury, MG; Jansen, JF; Koutcher, JA; Lee, NY; Patel, SG; Pfister, DG; Schöder, H; Shah, JP; Shukla-Dave, A; Stambuk, HE; Wang, Y | 1 |
| Daşu, A; Johansson, S; Sörensen, J; Sun, A; Turesson, I | 1 |
| Morelec, I; Zenone, T; Zenou, E | 1 |
| Kaushik, A; Nguyen, NC; Osman, MM; Wolverson, MK | 1 |
| Brizel, DM; Chino, J; Higgins, KA; Hoang, JK; Roach, MC; Turkington, TG; Yoo, DS | 1 |
| Blumin, J; Campbell, BH; Maheshwari, M; Massey, BL; Michel, MA; Schultz, CJ; Wang, D; Wilson, JF; Wong, SJ; Zundel, MT | 1 |
| Bisdas, S; Boss, A; Claussen, CD; Kolb, A; Pfannenberg, C; Pfister, M; Pichler, BJ; Schwenzer, N; Stegger, L | 1 |
| Chiti, A; Grégoire, V | 1 |
| Graham, MM; Menda, Y | 3 |
| Abolmaali, N; Abramyuk, A; Appold, S; Baumann, M; Dörr, W; Hentschel, M; Kotzerke, J; Schreiber, A; Zöphel, K | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SB; Kim, SY; Lee, JH; Lee, SW; Nam, SY; Roh, JL; Yi, JS | 1 |
| Kaanders, JH; Oyen, WJ; Schinagl, DA; Span, PN | 1 |
| Cho, KJ; Choi, SH; Doo, H; Kim, JS; Kim, SY; Lee, H; Lee, JH; Nam, SY; Roh, JL | 1 |
| Beadsmoore, C; Geropantas, K; Loo, SW; Martin, WM; Montgomery, PQ; Roques, TW | 1 |
| Abdelmalik, AG; Altinyay, ME; Brickman, TM; Nguyen, NC; Osman, MM; Varvares, MA | 1 |
| Domae, S; Hamaya, K; Hirai, M; Miki, K; Nose, S; Noyama, Y; Orita, Y | 1 |
| De Bosschere, L; Klijanienko, J; Le Tourneau, C; Paulmier, B; Petras, S; Rodriguez, J | 1 |
| De Neve, W; Deron, P; Duprez, F; Goethals, I; Mertens, K; Rottey, S; Van de Wiele, C; Vermeersch, H | 1 |
| Beer, AJ; Dinges, J; Loeffelbein, DJ; Martinez-Möller, A; Schwaiger, M; Souvatzoglou, M; Wankerl, V | 1 |
| Haerle, SK; Haile, SR; Hany, TF; Schuknecht, B; Stoeckli, SJ; Strobel, K | 1 |
| Abgral, R; Cavarec, MB; Le Duc-Pennec, A; Le Roux, PY; Marianovski, R; Nowak, E; Potard, G; Querellou, S; Salaün, PY; Valette, G | 1 |
| Fujiwara, K; Imai, Y; Kanazawa, Y; Kikuchi, M; Kurihara, R; Naito, Y; Nakamoto, Y; Shinohara, S; Tona, Y; Yamazaki, H | 1 |
| Guan, DJ; He, ZY; Xu, GZ | 1 |
| Ahmad, N; Haerle, SK; Hany, TF; Schmid, DT; Stoeckli, SJ | 1 |
| Horiuchi, C; Komatsu, M; Matsuda, H; Mori, M; Niho, T; Nishimura, G; Sakuma, N; Shibata, K; Sugisaki, S; Taguchi, T; Takahashi, M; Tsukuda, M | 1 |
| Chang, KH; Choi, SH; Han, MH; Jang, JY; Kim, JH; Kim, KG; Kim, YJ; Paeng, JC; Pagsisihan, JR; Sohn, CH; Yun, TJ | 1 |
| Busk, M; Horsman, MR; Jakobsen, S; Mueller-Klieser, W; Overgaard, J; Steiniche, T; Walenta, S | 1 |
| Hoshikawa, H; Kishino, T; Mori, N; Nishiyama, Y; Yamamoto, Y; Yonezaki, M | 1 |
| Bonte, KM; Deron, PB; Van de Wiele, C; Vermeersch, HF | 1 |
| Abikhzer, G; Ciarallo, A; Laufer, J; Makis, W; Rush, C; Stern, J | 1 |
| Khandelwal, AR; Li, G; Takalkar, AM | 1 |
| Bonte, K; Boterberg, T; Coghe, M; De Gersem, W; De Neve, W; Deron, P; Duprez, F; Madani, I; Van de Wiele, C | 1 |
| Adams, KT; Alexopoulos, DK; Chen, CC; King, KS; Lando, H; Ling, A; Pacak, K; Patronas, N; Reynolds, JC; Stratakis, CA; Whatley, MA; Xekouki, P | 1 |
| Knudtsen, IS; Malinen, E; Rødal, J; Skogmo, HK; Søvik, Å | 1 |
| Agarwal, JP; Budrukkar, A; Ghsoh-Laskar, S; Gupta, T; Kannan, S; Master, Z; Murthy, V; Rangarajan, V | 1 |
| Chera, BS; Fried, D; Hackman, T; Hayes, N; Khandani, A; Rosenman, J; Shores, C; Weissler, M | 1 |
| Bailly, C; Bourry, N; Cachin, F; Lapeyre, M; Toledano, I | 1 |
| Beaulieu, S; Bélair, M; Boucher, L; Cohade, C; Coulombe, G; Delouya, G; Després, P; Filion, EJ; Hinse, M; Houle, A; Igidbashian, L; Martel, C; Nguyen-Tan, PF | 1 |
| Lam, S; Subramaniam, RM; Surasi, DS | 1 |
| Benjamin, RS; Debnam, JM; Garden, AS; Ginsberg, LE; Guha-Thakurta, N; Mahfouz, YM; Sturgis, EM | 1 |
| Davison, JM; Devaiah, AK; Imsande, HM; Mercier, GA; Ozonoff, AJ; Subramaniam, RM; Truong, MT | 1 |
| Abdel-Dayem, HM; Attia, I; Boktor, RR; Eltawdy, MH; Mousa, E; Omar, WS; Pitman, AG; Refaat, A | 1 |
| Kondo, N; Nishimura, G; Tsukuda, M | 1 |
| Fronczewska-Wieniawska, K; Królicki, L; Kuźmińska, M; Niemczyk, K; Osuch-Wójcikiewicz, E | 1 |
| Corry, J; Hicks, RJ; Lau, E; Mak, D; Rischin, D | 1 |
| Godballe, C; Grau, C; Johansen, J; Loft, A; Petersen, H | 1 |
| Arens, AI; Kaanders, JH; Oyen, WJ; Schinagl, D; Troost, EG | 1 |
| Gornik, G; Weber, W | 1 |
| Collyer, JC; Ghazali, N; Tighe, J | 1 |
| Ahmad, N; Crook, DW; Haerle, SK; Hany, TF; Huber, GF; Schmid, DT; Soyka, MB | 1 |
| Hsieh, TC; Hsu, CN; Kao, CH; Sun, SS; Wu, YC; Yang, CF; Yen, KY | 1 |
| Corry, J; Ferlito, A; Grégoire, V; Hamoir, M; Hanin, FX; Machiels, JP; Rinaldo, A; Robbins, KT; Schmitz, S; Silver, CE; Strojan, P; Takes, RP; Thariat, J; Weynand, B | 1 |
| Beswick, DM; Branstetter, BF; Ferris, RL; Gooding, WE; Maxwell, JH; Zhang, I | 1 |
| Fukushi, M; Ito, K; Kubota, K; Minamimoto, R; Mitsumoto, T; Morooka, M; Muramatsu, Y; Sasaki, T; Sato, T; Shimbo, T | 1 |
| Balasubramanian Harisankar, CN; Bhattacharya, A; Kashyap, R; Malhotra, P; Manohar, K; Rai Mittal, B; Singh, B; Varma, S | 1 |
| Akdemir, UO; Baykara, M; Benekli, M; Buyukberber, S; Cakir, T; Coskun, U; Demirci, U; Kapucu, O; Ozkan, S | 1 |
| De Gersem, W; De Neve, W; Madani, I; Olteanu, LA; Vercauteren, T | 1 |
| Farrell, R; Gharpurhy, A; Gollub, F; Goodchild, K; Lemon, C; Saunders, M; Sonoda, LI; Wellsted, D; Wong, WL | 1 |
| Eirini, L; Emmanouil, L; Hans-Günther, M; Liodaki, E; Liodakis, E; Machens, HG; Nikolaos, PA; Othonas, P; Papadopoulos, O; Papadopulos, NA | 1 |
| Chung, MK; Jackson, T; Mercier, G; Ozonoff, A; Subramaniam, RM | 1 |
| Agrawal, A; Meacham, R; Naiboğlu, B; Ozer, E; Ryoo, C; Schuller, DE | 1 |
| de Casso, C; Kane, T; Nigam, A; Soni-Jaiswall, A; Visvanathan, V | 1 |
| Huang, YT; Ravi Kumar, AS | 1 |
| Codreanu, I; Dasanu, CA; Divgi, C; Weinstein, GS | 1 |
| Chang, DT; Chu, KP; Graves, EE; Hsu, A; Iagaru, A; Krakow, TE; La, TH; Le, QT; Loo, B; Maxim, PG; Murphy, JD | 1 |
| Arai, Y; Komatsu, M; Matsuda, H; Nishimura, G; Sakuma, N; Sano, D; Taguchi, T; Takahashi, H; Takahashi, M | 1 |
| Ahn, YC; Baek, CH; Choi, JY; Kim, BT; Lee, HJ; Lee, KH; Moon, SH; Park, K; Son, YI | 1 |
| Fujibayashi, Y; Fujieda, S; Kimura, Y; Kiyono, Y; Kositwattanarerk, A; Kudo, T; Maruyama, R; Mori, T; Oh, M; Okazawa, H | 1 |
| Amin, M; Chunta, JL; Grills, IS; Huang, J; Lee, DY; Marples, B; Martinez, AA; Wilson, GD; Wong, CY; Yan, D | 1 |
| Fujiwara, K; Harada, H; Kanazawa, Y; Kikuchi, M; Kishimoto, I; Kurihara, R; Naito, Y; Nakamoto, Y; Shinohara, S; Yamazaki, H | 1 |
| Chera, BS; Cullip, T; Fried, D; Khandani, AH; Lawrence, M; Rosenman, J | 1 |
| Almadori, G; Autorino, R; Bussu, F; Castaldi, P; De Corso, E; Dinapoli, N; Galli, J; Giordano, A; Lago, M; Miccichè, F; Paludetti, G; Rufini, V; Valentini, V | 1 |
| Fukukura, Y; Kajiya, Y; Kamiyama, T; Koriyama, C; Matsuzaki, T; Nakajo, M; Nishimoto, K; Nomoto, M; Tani, A; Yonekura, R | 1 |
| Higashiyama, S; Kawabe, J; Kotani, K; Shiomi, S; Yoshida, A | 1 |
| Han, A; Hu, M; Wang, X; Xue, J; Zheng, J | 1 |
| Escobar, H; Folkens, JU; Hoffmann, R; Kontny, U; Pohl, M; van Buiren, M; Wild, D; Yoshimi, A | 1 |
| Colavolpe, C; Dessi, P; Fakhry, N; Giovanni, A; Michel, J; Varoquaux, A | 1 |
| Huh, SH; Jin, SM; Lee, SH; Park, CH; Rho, YS; Yoon, DY | 1 |
| Hashiguchi, H; Morimoto, M; Nakajima, A; Nakamura, S; Nishiyama, K; Suzuki, O; Tanaka, K; Yoshino, K | 1 |
| Baek, S; Chung, EJ; Koh, SH; Ku, YJ; Rho, YS; Seo, YL; Yoon, DY | 1 |
| Lin, M; Lin, P; Sam, S; Shon, IH; Vinod, SK | 1 |
| Carey, B; Dyker, KE; Prestwich, RJ; Scarsbrook, AF; Sen, M; Sykes, J | 1 |
| Chowdhury, FU; Gilbert, A; Prestwich, RJ; Scarsbrook, AF; Sen, M; Subesinghe, M | 1 |
| Kejariwal, D; Mansour, D | 1 |
| Cannon, B; Dong, L; Schwartz, DL | 1 |
| Belohlavek, O; Chrobok, V; Dolezel, M; Dusek, L; Jarkovsky, J; Kandrnal, V; Kolarova, I; Michalek, R; Odrazka, K; Petruzelka, L; Vanasek, J | 1 |
| Antoch, G; Bockisch, A; Buchbender, C; Forsting, M; Geiger, B; Heusner, TA; Lehnerdt, G; Mattheis, S; Treffert, J | 1 |
| Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Yi, JS | 1 |
| Monteiro, E; Pereira, G; Silva, JC | 1 |
| Campbell, PD; Carlson, ER; Long, M; McCoy, JM; Schaefferkoetter, J; Townsend, D | 1 |
| Grégoire, V; Jeraj, R; Lee, JA; O'Sullivan, B | 1 |
| Haerle, SK; Hany, TF; Huber, G; Schaefer, NG; Schmid, D; Seifert, B; Soyka, JD; Strobel, K; Studer, G; Veit-Haibach, P | 1 |
| Axelrod, R; Champ, C; Fogh, SE; Intenzo, C; Keane, WM; Kubicek, GJ; Machtay, MM | 1 |
| Dong, MJ; Lin, LL; Liu, JH; Lu, ZJ; Luo, XM; Yan, SX; Yang, SY; Zhao, K; Zhou, SH | 1 |
| Bellon-Guardia, M; Lozano-Martin, E; Perez-Romasanta, LA; Sanz-Martin, M; Torres-Donaire, J; Velasco-Jimenez, J | 1 |
| Goichot, B; Hubele, F; Imperiale, A; Rust, E; Taieb, D; Taquet, MC; Veillon, F | 1 |
| Hoshikawa, H; Kishino, T; Mori, N; Nishiyama, Y; Yamamoto, Y | 1 |
| Abgral, R; Gouders, D; Keromnes, N; Le Roux, PY; Leleu, C; Mollon, D; Nowak, E; Querellou, S; Rousset, J; Salaün, PY; Valette, G | 1 |
| Wiggins, RH; Zollinger, LV | 1 |
| Funk, GF | 1 |
| Doihara, H; Ikeda, H; Miyoshi, S; Nogami, T; Shien, K; Shien, T; Soh, J; Taira, N | 1 |
| Chan, SC; Hsu, CL; Liao, CT; Lin, CY; Lin, YJ; Ng, SH; Wang, HM; Yen, TC | 1 |
| Chen, JH; Wang, CC | 1 |
| Burmeister, BH; Porceddu, SV; Pryor, DI; Scuffham, PA; Thomas, PA; Whitty, JA | 1 |
| Caldito, GC; Ekshyyan, O; Nathan, CA; Sibley, D; Sunderland, J; Vascoe, C | 1 |
| Henderson, S; Walker-Dilks, C; Yoo, J | 1 |
| Beuthien-Baumann, B; Gudziol, V; Kotzerke, J; Langner, J; Laniado, M; Platzek, I; Schneider, M; Schramm, G; van den Hoff, J | 1 |
| Bogsrud, TV; Eilertsen, K; Evensen, JF; Glomset, OK; Løndalen, AM; Skretting, A | 1 |
| Bhide, SA; Borri, M; Cook, G; Harrington, KJ; Koh, DM; Newbold, KL; Nutting, CM; Partridge, M; Powell, C; Riddell, A; Schmidt, M | 1 |
| Kovalchuk, N; Schoenfeld, JD; Subramaniam, RM; Truong, MT | 1 |
| Kruse, V; Maes, A; Sathekge, M; Smeets, P; Van de Wiele, C | 1 |
| Aygun, N; Walden, MJ | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, MJ; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Humbert Vidan, L; Koopman, M; Newbold, K; Partridge, M; Powell, C | 1 |
| Kurabayashi, T; Nakamura, S; Okochi, K; Shibuya, H; Toriihara, A; Watanabe, H | 1 |
| Dierckx, RA; Halmos, GB; Langedijk, JA; Pruim, J; Roodenburg, JL; van der Laan, BF; Wedman, J | 1 |
| Akdemir, UO; Atasever, T; Benekli, M; Buyukberber, S; Cetin, B; Coskun, U; Senturk, S; Tufan, G; Turan, N | 1 |
| Essler, M; Hart, A; Lasser, T; Matthies, P; Navab, N; Okur, A; Shakir, DI; Ziegler, SI | 1 |
| Asakawa, I; Hasegawa, M; Inoue, K; Kajitani, C; Katayama, E; Kirita, T; Okamoto, H; Shirone, N; Tamamoto, T; Uto, F | 1 |
| Anderson, NJ; Chang, JH; Gan, HK; Gong, SJ; Gunawardana, DH; Khoo, V; Lee, ST; Lim Joon, D; O'Keefe, G; Sachinidis, J; Scott, AM; Wada, M | 1 |
| Akiyama, K; Hoshikawa, H; Inamoto, R; Kishino, T; Mori, N; Mori, T; Nishiyama, Y; Yamamoto, Y | 1 |
| Brizel, DM; Choudhury, KR; Das, SK; Hoang, JK; Yoo, DS | 1 |
| Hamming-Vrieze, O; Houweling, AC; van de Kamer, JB; van der Heide, UA; van Vliet-Vroegindeweij, C; Vogel, WV; Wolf, AL | 1 |
| Lowe, VJ; Stack, BC | 1 |
| Akhurst, T; Berlangieri, S; Chan, JG; Hannah, A; McKay, WJ; Price, D; Schelleman, T; Scott, AM; Sizeland, A; Smith, GJ; Tochon-Danguy, H | 1 |
| Brouwer, J; Comans, EF; de Bree, R; Hoekstra, OS; Leemans, CR; Pruim, J; Regelink, G; Roodenburg, JL; Vaalburg, W; van der Laan, BF; Vissink, A | 1 |
| Belhocine, T; De Labrassinne, M; Lahaye, T; Pierard, G; Rigo, P | 1 |
| Lin, EC | 1 |
| Cabrera Villegas, A; Gámez Cenzano, C; García Velloso, MJ | 1 |
| Borrego Dorado, I; Vázquez Albertino, R | 1 |
| Angelard, B; Kerrou, K; Lacau St Guily, J; Montravers, F; Périé, S; Talbot, JN; Tassart, M | 1 |
| Agoston, P; Esik, O; Fekésházy, A; Galuska, L; Kálvin, B; Lengyel, E; Lengyel, Z; Szakáll, S; Székely, J; Trón, L | 1 |
| Gonen, M; Kraus, DH; Larson, SM; Lin, DT; Patel, SG; Pfister, DG; Schöder, H; Shah, JP; Wolden, S; Wong, RJ | 1 |
| Goerres, GW; Hany, TF; Von Schulthess, GK | 1 |
| Buchwald, C; Eigtved, A; Hansen, HS; Johansen, J; Theilgaard, SA | 1 |
| Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y | 1 |
| Fogarty, GB; Hicks, RJ; Peters, LJ; Rischin, D; Scott, C; Stewart, J | 1 |
| Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y; Yoshida, M | 1 |
| Bachmann, LM; Goerres, GW; Mosna-Firlejczyk, K; Steurer, J; von Schulthess, GK | 1 |
| Galen, B; Gourgiotis, L; Guthrie, LC; Patronas, NJ; Reynolds, JC; Sarlis, NJ; Shawker, TH; Skarulis, MC | 1 |
| Goerres, GW; Mosna-Firlejczyk, K; Stoeckli, SJ | 1 |
| Aerts, J; Cataldo, D; Duysinx, B; Fassotte, MF; Foidart, J; Hustinx, R; Jerusalem, G; Lemaire, C; Luxen, A; Moreau, P | 1 |
| Brinkbäumer, K; Dresel, S; Grammerstorff, J; Hahn, K; Pfluger, T; Schmid, R; Schwenzer, K | 1 |
| Bourguet, P | 1 |
| Bandhauer, F; Goerres, GW; Huguenin, P; Schmid, DT; Schmid, S; Stoeckli, SJ; von Schulthess, GK | 1 |
| Kao, CH | 1 |
| Cho, SB; Chung, KY; Jung, J; Lee, KH; Yun, M | 1 |
| Blodgett, TM; Fukui, MB; Meltzer, CC | 1 |
| Hayashi, K; Honda, H; Kaneko, K; Koga, H; Kuwabara, Y; Matsuo, Y; Nakagawa, M; Sasaki, M | 1 |
| Chen, YK; Kao, CH; Liu, FY; Yen, RF | 1 |
| Bui, CD; Carlos, RC; Ching, AS; Mukherji, SK; Shreve, PD | 1 |
| Cohen, O; Goshen, E; Karasik, A; Oksman, Y; Rotenberg, G; Zwas, ST | 1 |
| Eyrich, GK; Grätz, K; Hugenin, P; Sigg, MB; Steinert, H; Stoeckli, S | 1 |
| Cook, TF; Fosko, SW; Hu, W; Lowe, VJ | 1 |
| Mukherji, SK; Wolf, GT | 1 |
| Ham, H; Loose, D; Otte, A; Van de Wiele, C; Vermeersch, H | 1 |
| Anzai, Y; Coltrera, M; Eary, J; Krohn, K; Rajendran, J; Schwartz, DL; Yueh, B | 1 |
| Saunders, M; Wong, WL | 2 |
| Fukuda, H; Itoh, M; Kubota, K; Ono, S; Qureshy, A; Yamaguchi, K; Yokoyama, J | 1 |
| Goldsmith, SJ; Kostakoglu, L | 1 |
| Cappellari, JO; Geisinger, K; Greven, KM; Keyes, JW; McGuirt, WF; Rogers, JW; Watson, NE; Williams, DW | 1 |
| Diehl, M; Döbert, N; Grünwald, F; Hamscho, N; Menzel, C; Zaplatnikov, K | 1 |
| Gonen, M; Kraus, D; Larson, SM; Schöder, H; Yeung, HW | 1 |
| Graham, M; Kubo, A; Nishitani, H; Otsuka, H | 1 |
| Endo, K; Higuchi, T; Oriuchi, N; Tian, M; Zhang, H | 1 |
| Barry, B; Baujat, B; Gehanno, P; Lazard, DS; Le Guludec, D | 1 |
| Eyrich, GK; Goerres, GW; Schmid, DT | 1 |
| Billheimer, D; Cmelak, AJ; Delbeke, D; Hallahan, DE; Lavely, WC; Martin, WH; Scarfone, C | 1 |
| Greven, KM | 1 |
| Bruschini, L; Bruschini, P; Cosottini, M; Fattori, B; Giorgetti, A; Mariani, G; Nacci, A; Ursino, F; Volterrani, D | 1 |
| Dietlein, M; Eschner, W; Jungehülsing, M; Schicha, H; Schmalenbach, M; Schmidt, M; Schröder, U; Stennert, E; Theissen, P | 1 |
| Schöder, H; Yeung, HW | 1 |
| Eskola, O; Grénman, R; Grönroos, T; Lehtiö, K; Minn, H; Oikonen, V; Sillanmäki, L; Viljanen, T | 1 |
| Buatti, JM; Dornfeld, KJ; Funk, GF; Graham, MM; Graham, SM; Hoffman, HT; Menda, Y; Skwarchuk, M; Smith, RB; Yao, M | 2 |
| Beitler, JJ | 1 |
| Allal, AS; Allaoua, M; Dulguerov, P; Kebdani, T; Lehmann, W; Slosman, DO | 1 |
| Conessa, C; Foehrenbach, H; Hervé, S; Poncet, JL | 1 |
| Li, XP; Liang, Y; Liu, X; Wang, QS; Wu, HB | 1 |
| He, F; Wang, Y; Yu, F | 1 |
| Bloom, DA; Chander, S; Joyrich, RN; Littrup, PJ; Webster, GC; Zak, IT; Zerin, JM; Zingas, AP | 1 |
| Burrell, SC; Case, MA; Haddad, RI; McCollum, AD; Norris, CM; Posner, MR; Tishler, RB; Van den Abbeele, AD | 1 |
| Corry, J; Hicks, RJ; Hogg, A; Matthews, JP; Peters, LJ; Porceddu, S; Rischin, D; Ware, RE | 1 |
| Endo, K; Higuchi, T; Kamada, H; Khan, N; Ninomiya, H; Oriuchi, N | 1 |
| Büll, U; Coenen, HH; Dimartino, E; Eble, MJ; Gagel, B; Hamacher, K; Maneschi, P; Pinkawa, M; Reinartz, P; Stanzel, S; Westhofen, M; Zimny, M | 1 |
| Aozasa, K; Hamada, K; Hatazawa, J; Higuchi, I; Inoue, A; Myoi, A; Tamai, N; Tomita, Y; Ueda, T; Yoshikawa, H | 1 |
| Alavi, A; Kumar, R; Mandel, S; Zhuang, H | 1 |
| Kanazawa, A; Kishimoto, C; Konishi, K; Takayama, M; Yamane, H | 1 |
| Baldetorp, B; Brun, E; Fallenius, G; Kjellén, E; Tennvall, J; Wennerberg, J | 1 |
| Agazaryan, N; Dahlbom, M; Goss, BW; Lee, SP; Solberg, TD | 1 |
| Berkhof, J; Franssen, EJ; Hoekstra, OS; Sturkenboom, MG | 1 |
| Agarwala, SS; Andrade, RS; Avril, N; Flickinger, J; Heron, DE; Johnson, J; Kalnicki, S; Wu, A | 1 |
| Hain, SF | 1 |
| Corry, J; Hicks, RJ; Jarmolowski, E; Peters, LJ; Porceddu, SV; Rischin, D; Ware, R; Weih, L | 1 |
| Anzai, Y; Coltrera, MD; Eary, J; Ford, E; Haynor, D; Kinahan, P; Krohn, K; Laramore, GE; Leblanc, M; Lewellyn, B; Mattes, D; Meyer, J; Phillips, M; Rajendran, J; Schwartz, DL; Virgin, J; Yueh, B | 1 |
| Buatti, JM; Dornfeld, KJ; Funk, GF; Graham, MM; Hoffman, HT; Smith, RB; Yao, M | 1 |
| DeYoung, BR; Funk, GF; Goldstein, DP; Graham, MM; Yao, M | 1 |
| Fukui, MB; Kapoor, V; McCook, BM | 2 |
| Farag, I; Hain, SF; Jones, J; McGurk, M | 1 |
| Kraus, DH; Kutler, DI; Wong, RJ | 1 |
| Miyabe, K; Nishiyama, Y; Ogawa, T; Ohkawa, M; Satoh, K; Toyama, Y; Yamamoto, Y; Yokoe, K | 1 |
| Bomanji, JB; Copland, C; Ell, PJ; Gacinovic, S; Groves, A; Hughes, S; Hydes, N; Kayani, I; Nagabhushan, N; Syed, R; Visvikis, D | 1 |
| Koshy, M; Paulino, AC; Rusthoven, KE | 1 |
| Davis, LW; Halkar, R; Howell, R; Koshy, M; Paulino, AC; Schuster, D | 1 |
| Ahn, SD; Choi, EK; Choi, SH; Im, KC; Kim, JH; Kim, JS; Kim, SB; Kim, SY; Lee, BJ; Lee, SW; Moon, DH; Nam, SY; Oh, SJ; Ryu, JS; Shin, SS; Yi, BY | 1 |
| Buatti, JM; Funk, GF; Graham, MM; Hoffman, HT; Smith, RB; Yao, M | 1 |
| Lonneux, M | 1 |
| Fee, WE; Le, QT; Pinto, HA; Ryan, WR | 1 |
| Davis, LW; Howell, R; Koshy, M; Paulino, AC; Schuster, D | 1 |
| Castaigne, C; Flamen, P; Muylle, K | 1 |
| Almeyda, R; Babar-Craig, H; Farrell, R; Gill, H; Wong, WL | 1 |
| Chang, P; Liu, HC; Tian, JH; Wang, T; Yao, SL | 1 |
| Blodgett, TM; Branstetter, BF; Johnson, JT; Meltzer, CC; Raman, S; Snyderman, CH; Zimmer, LA | 1 |
| Chan, SC; Chang, JT; Chang, YC; Chen, TM; Kang, CJ; Liao, CT; Lin, KJ; Ng, SH; See, LC; Wang, HM; Wu, YF; Yen, TC | 1 |
| Couch, ME; Shockley, WW; Shores, CG; Sutton, DK; Weissler, MC; Zanation, AM | 1 |
| Krabbe, PF; Oyen, WJ; van Dalen, JA; van den Hoogen, FJ; Vogel, WV; Wensing, BM | 1 |
| Grosu, AL; Jeremic, B; Molls, M; Picchio, M; Piert, M; Schratzenstaller, U; Schwaiger, M; Weber, WA; Zimmermann, FB | 1 |
| Goshen, E; Oksman, Y; Rotenberg, G; Talmi, YP; Yahalom, R; Zwas, ST | 1 |
| Ell, PJ | 1 |
| Macapinlac, HA | 1 |
| Buatti, JM; Chang, K; Dornfeld, KJ; Funk, GF; Graham, MM; Graham, SM; Hoffman, HT; Menda, Y; Smith, RB; Tan, H; Yao, M | 1 |
| Daisne, JF; Geets, X; Gregoire, V | 1 |
| Goodchild, K; Hain, S; Lemon, C; Lodge, MA; Lowe, J; Sanghera, B; Saunders, M; Stott, D; Wong, WL | 1 |
| Döbert, N; Engels, K; Grünwald, F; Hamscho, N; Kovács, AF; Menzel, C; Walendzik, H; Yuen Yuen, H | 1 |
| Ferlito, A; Genden, EM; Gourin, CG; Kowalski, LP; Leemans, CR; Lefebvre, JL; Lowry, J; Medina, JE; Pellitteri, PK; Rinaldo, A; Robbins, KT; Shah, JP; Shaha, AR; Suárez, C; Weber, RS; Wei, WI | 1 |
| Cavalcanti, MG; Chojniak, R; Dos Santos, DT; Pereira Lima, EN | 1 |
| Brouwer, J; Castelijns, JA; Comans, EF; de Bree, R; Golding, RP; Hoekstra, OS; Leemans, CR; Senft, A | 1 |
| Gor, DM; Langer, JE; Loevner, LA | 1 |
| Branstetter, BF; Johnson, JT; Nayak, JV; Zimmer, LA | 1 |
| Avram, AM; Brown, RK; Francis, IR | 1 |
| Bauer, D; Coenen, HH; Flüss, MO; Hamacher, K; Langen, KJ; Pauleit, D; Risse, J; Stoffels, G; Zimmermann, A | 1 |
| Bradford, CR; Mukherji, SK | 1 |
| Dietl, B; Kölbl, O; Kühnel, T; Marienhagen, J; Schaefer, C | 1 |
| Fukuda, K; Kaneda, T; Kubota, K | 1 |
| Aschoff, P; Bihl, H; Hagen, R; Schneider, K | 1 |
| Kraus, DH; Kutler, DI; Schoder, H; Wong, RJ | 1 |
| De Gersem, W; De Neve, W; Duthoy, W; Thierens, H; Vanderstraeten, B | 1 |
| Boellaard, R; Börjesson, PK; Castelijns, JA; Comans, EF; de Bree, R; Jauw, YW; Kummer, JA; Lammertsma, AA; Leemans, CR; Roos, JC; van Dongen, GA; Vosjan, MJ | 1 |
| Barberet, M; Fakhry, N; Giovanni, A; Jacob, T; Mundler, O; Paris, J; Zanaret, M | 1 |
| Bialkowski, M; Brown, WD; Campbell, BH; Jursinic, PA; Li, XA; Michel, MA; Rand, SD; Schultz, CJ; Wang, D; Wilson, JF; Wong, S; Zhu, XR | 1 |
| Berson, AM; Destian, S; Mitnick, RJ; Ng, T; Riegel, AC; Tena, LB; Wong, PS | 1 |
| Binns, D; Corry, J; Fisher, R; Hicks, RJ; Peters, LJ; Porceddu, S; Rischin, D | 1 |
| Weber, WA; Wieder, H | 1 |
| Dinh, M; Dinh, S; Guntinas-Lichius, O; Mueller, RP; Peter Klussmann, J; Schmidt, M; Semrau, R | 1 |
| Corstens, FH; Huisman, H; Kaanders, JH; Oyen, WJ; Schinagl, DA; van Dalen, JA; Vogel, WV | 1 |
| Brkovich, VS; Hussey, DH; Karnad, AB; McGuff, HS; Miller, FR; Otto, RA | 1 |
| He, Z; Ke, Z; Liu, M; Liu, Y; Zhang, W; Zhang, Y | 1 |
| Andrade, RS; Avril, N; Branstetter, BF; Degirmenci, B; Ferris, RL; Filho, PA; Heron, DE; Seethala, RR | 1 |
| Corstens, FH; de Geus-Oei, LF; Kaanders, JH; Oyen, WJ; Pop, LA | 1 |
| Buell, U; Coenen, HH; DiMartino, E; Eble, M; Gagel, B; Hamacher, K; Reinartz, P; Westhofen, M; Zimny, M | 1 |
| Alber, M; Eschmann, SM; Holzner, F; Paulsen, F; Thorwarth, D | 1 |
| Baehre, M; Gerl, J; Meller, B; Richter, E; Sommer, K; Surowiec, A; von Hof, K; Wollenberg, B | 1 |
| Balogova, S; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Périé, S; Saint Guily, JL; Talbot, JN | 1 |
| Grierson, JR; Krohn, KA; Ng, P; O'Sullivan, J; Peterson, LM; Rajendran, JG; Scharnhorst, J; Schwartz, DL | 1 |
| Benes, P; Koranda, P; Stárek, I | 1 |
| Beyer, T; Raupach, R; Schäfers, KP | 1 |
| Barberet, M; Cammilleri, S; Fakhry, N; Giovanni, A; Lussato, D; Mundler, O; Zanaret, M | 1 |
| Barberet, M; Deveze, A; Fakhry, N; Giovanni, A; Jacob, T; Mundler, O; Paris, J; Zanaret, M | 1 |
| Baek, CH; Jeong, HS; Ki Chung, M; Kim, BT; Kim, HJ; Kyung Lee, D; Son, YI; Young Choi, J | 1 |
| Choi, SH; Kim, JS; Kim, SY; Lee, JS; Nam, SY; Roh, JL; Ryu, CH | 1 |
| Choi, SH; Kim, JS; Kim, SB; Kim, SY; Lee, JC; Lee, JH; Lee, SW; Nam, SY | 1 |
| Rankin, SC | 1 |
| Bao, A; Goins, B; McGuff, HS; Miller, FR; Natarajan, M; Otto, RA; Phillips, WT; Santoyo, C; Woolley, FR; Zheng, X | 1 |
| Bertling, J; Cederblad, L; Johansson, S; Karlsson, M; Langström, B; Nilsson, P; Riklund, K; Sörensen, J; Sun, A; Turesson, I | 1 |
| Döbert, N; Engels, K; Grünwald, F; Kovács, AF; Kranert, WT; Menzel, C | 1 |
| Cabrera Martín, MN; Calvo Manuel, F; Carreras Delgado, JL; Pasamontes Pingarrón, JA; Pérez Castejón, MJ; Scola Yurrita, B | 1 |
| Goerres, GW; Paul, SA; Stoeckli, SJ; von Schulthess, GK | 1 |
| Clément, P; Conessa, C; Foehrenbach, H; Poncet, JL | 1 |
| Fischbein, NJ; Kaplan, MJ; Le, QT; Loo, BW; McDougall, IR; Pinto, H; Quon, A | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Yeo, NK | 1 |
| Allen-Auerbach, M; Czernin, J; Fueger, BJ; Halpern, BS; Lufkin, RB; Yeom, K | 1 |
| Cabrera Martín, MN; Calvo Manuel, F; Carreras Delgado, JL; Delgado Bolton, RC; Pasamontes Pingarrón, JA; Scola Yurrita, B | 1 |
| Dadras, SS; Leavitt, M; McDougall, IR; Niederkohr, RD | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Ryu, CH | 1 |
| Endo, K; Hirasawa, H; Hirasawa, S; Oriuchi, N; Takano, A; Takei, H; Taketomi-Takahashi, A; Tsushima, Y | 1 |
| Hirai, T; Katsuragawa, S; Murakami, D; Murakami, R; Nishimura, R; Ota, K; Oya, N; Shiraishi, S; Tomiguchi, S; Uozumi, H; Yamashita, Y | 1 |
| Ashamalla, H; Bieniek, E; Evola, A; Goswami, G; Guirgius, A; Mokhtar, B; Oldroyd, R; Parikh, K; Rafla, S | 1 |
| Besses, C; Calvo, N; Carrera, MJ; Conangla, M; Puget, G; Salar, A; Sitges-Serra, A; Trampal, C | 1 |
| Ahn, SD; Choi, EK; Im, KC; Kim, JH; Kim, JS; Kim, SY; Lee, SW; Nam, SY; Oh, SJ; Shin, SS | 1 |
| Choi, SH; Kim, JS; Kim, MR; Kim, SY; Nam, SY; Roh, JL | 1 |
| Eisbruch, A; Feng, M | 1 |
| Anniko, M; Blomquist, E; Ekberg, T; Engström, M; Sörensen, J; Sundin, A | 1 |
| Breen, SL; Brock, K; Cummings, B; Dawson, L; De Silva, S; Hendler, A; Keller, A; Kim, J; O'Sullivan, B; Pond, G; Publicover, J; Ringash, J; Waldron, J; Yu, E | 1 |
| Brown, R; Feiglin, D; Hsu, J; Koniarczyk, M; Newman, N; Pohar, S | 1 |
| Kaanders, JH; Oyen, WJ; Schinagl, DA; Van Dalen, JA; Vogel, WV | 1 |
| Alberini, JL; Banal, A; Gontier, E; Le Stanc, E; Pecking, AP; Tainturier, C; Vilain, D; Wartski, M | 1 |
| Fan, J; Li, LF; Wang, SQ; Wu, QL; Zhou, SH | 1 |
| Bol, A; Geets, X; Grégoire, V; Lee, JA; Lonneux, M | 1 |
| Bauters, W; Bonte, K; Boterberg, T; De Gersem, W; De Neve, W; Derie, C; Duthoy, W; Grégoire, V; Jacobs, F; Lonneux, M; Madani, I; Saerens, M; Thierens, H; Vakaet, L; Vanderstraeten, B | 1 |
| Alber, M; Eschmann, SM; Paulsen, F; Thorwarth, D | 1 |
| Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Coleman, RE; Hawk, TC; Turkington, TG; Wong, TZ; Yamamoto, Y | 1 |
| Adelstein, DJ; Carroll, MA; Esclamado, RM; Lorenz, RR; Rybicki, LA; Saxton, JP; Strome, M; Tan, A; Wood, BG | 1 |
| Buatti, JM; Chang, K; Graham, MM; Hoffman, HT; Luo, P; Menda, Y; Tan, H; Yao, M | 1 |
| Balink, H; de Visscher, JG; Krabbe, CA | 1 |
| Connell, CA; Corry, J; Hicks, RJ; Hogg, A; Milner, AD; Peters, LJ; Rischin, D | 1 |
| Nguyen, BD; Roarke, MC | 1 |
| Asadpour, B; Coenen, HH; Demirel, C; DiMartino, E; Eble, MJ; Gagel, B; Hamacher, K; Kaiser, HJ; Maneschi, P; Pinkawa, M; Piroth, M; Reinartz, P; Scholbach, T; Stanzel, S; Zimny, M | 1 |
| Bar-Shalom, R; Daitzchman, M; Golz, A; Gordin, A; Israel, O; Keidar, Z | 1 |
| Agrawal, A; Daly, BT; Fleming, AJ; Hall, NC; Paul, CM; Schuller, DE; Smith, SP | 1 |
| Hemandas, AK; Hickish, T; Robson, NK; Talbot, RW | 1 |
| Abgral, R; Bizais, Y; Couturier, O; Kraeber-Bodéré, F; Querellou, S; Salaun, PY; Valette, G | 1 |
| Gibson, D; Goodchild, K; Sanghera, B; Saunders, M; Wong, WL | 1 |
| Fujii, M; Ogawa, K; Ozawa, H; Sakamoto, K; Tagawa, T; Tomita, T; Yamaguchi, H | 1 |
| Huang, DQ; Li, WR; Ou, XY | 1 |
| Burger, C; Ciernik, IF; Davis, JB; El-Attar, I; El-Bassiouni, M; Goerres, GW; Reiner, B; Studer, GM | 1 |
| Basu, D; McDonald, DJ; Nussenbaum, B; Siegel, BA | 1 |
| Bybel, B | 1 |
| Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Yeo, NK | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Dahmen, G; Egelhof, T; Fischer, M; Luczak, C; Rosenbaum, S; Veit-Haibach, P; Wanke, I | 1 |
| Aupérin, A; Baudin, E; Bonniaud, G; Chami, L; Dromain, C; Giraudet, AL; Hartl, D; Lassau, N; Leboulleux, S; Lumbroso, J; Ny Tovo, N; Schlumberger, M; Travagli, JP; Vanel, D | 1 |
| Dietl, B; Kölbl, O; Kühnel, T; Marienhagen, J; Schreyer, A | 1 |
| Cai, S; Chan, K; Greco, C; Humm, JL; Lee, NY; Lin, Z; Ling, CC; Mechalakos, JG; Nehmeh, S; Schöder, H; Squire, OD; Zanzonico, PB | 1 |
| Branstetter, BF; Shah, VN | 1 |
| Brown, PD; Foote, RL; Garces, YI; Kasperbauer, JL; Lowe, VJ; Shintani, SA | 1 |
| Balogova, S; Chater, PE; Grahek, D; Hugentobler, A; Kerrou, K; Montravers, F; Périé, S; St Guily, JL; Susini, B; Talbot, JN | 1 |
| Collins, CD | 1 |
| Ahn, MI; Cho, KD; Park, YH; Son, JM; Yoo, J | 1 |
| Arima, S; Hasegawa, Y; Nakashima, T; Nishio, M; Ogawa, T; Ozawa, T; Suzuki, H; Suzuki, M; Tamaki, T; Terada, A | 1 |
| Buatti, JM; Dornfeld, K; Fath, MA; Graham, MM; Hichwa, RD; Mattson, DM; Simons, AL; Smith, BJ; Spitz, DR; Walsh, SA | 1 |
| Hoffmann, AL; Kaanders, JH; Oyen, WJ; Schinagl, DA; van Dalen, JA; Vogel, WV | 1 |
| Rödel, R | 1 |
| Hwang, BJ; Niederkohr, RD; Quon, A | 1 |
| Erdi, YE; Greco, C; Humm, JL; Larson, SM; Lee, NY; Ling, CC; Mageras, G; Nehmeh, SA; Pham, HS; Schröder, H; Squire, O; Zanzonico, PB | 1 |
| Chen, T; Guo, W; Huang, G; Li, SJ; Ren, GX; Song, SL | 1 |
| Buatti, J; Dornfeld, K; Dornfeld, M; Funk, G; Graham, M; Hopkins, S; Karnell, L; Karnell, M; Menda, Y; Simmons, J; Smith, R; Spitz, DR; Yao, M | 1 |
| Bilodeau, PA; Coleman, TA; Gourin, CG; Patel, VS; Watts, TL; Williams, HT | 1 |
| Demeaux, H; Fernandez, P; Gindre, A; Guyot, M; Laurentjoye, M; Majoufre-Lefebvre, C; Ricard, AS; Siberchicot, F | 1 |
| Buckley, AF; Eisele, DW; Glastonbury, CM; Hawkins, RA; Lee, TJ | 1 |
| Ahn, PH; Garg, MK | 1 |
| Campbell, BH; Maheshwari, M; Massey, BL; Michel, MA; Schultz, CJ; Vernon, MR; Wang, D; Wilson, JF; Wong, SJ | 1 |
| Carlson, D; Fury, M; Kraus, DH; Larson, SM; Lee, NY; Ong, SC; Patel, SG; Pfister, DG; Schöder, H; Shah, JP | 1 |
| Damrose, EJ | 1 |
| Lin, KH; Peng, NJ; Wang, JH | 1 |
| Flamen, P; Garcia, C | 1 |
| Cicone, F; Deron, P; Loose, D; Scopinaro, F; Signore, A; Van de Vyvere, F; Van de Wiele, C; Vermeersch, H | 1 |
| Angelberger, P; Becherer, A; Dudczak, R; Ewers, R; Kermer, C; Kletter, K; Linecker, A; Sulzbacher, I | 1 |
| de Bree, R; Golding, RP; Hoekstra, OS; Kuik, DJ; Leemans, CR; Oyen, WJ; Pruim, J; Roodenburg, JL; Senft, A; van den Hoogen, FJ | 1 |
| Nguyen, BD; Ram, PC; Roarke, MC | 1 |
| Cabrera Martín, MN; Carreras Delgado, JL; Delgado Bolton, RC; Fernández Pérez, C; Pasamontes Pingarrón, JA; Scola Yurrita, B | 1 |
| Macapinlac, HA; Schwartz, DL; Weber, RS | 1 |
| Denaxa-Kyza, D; Evangelou, E; Ioannidis, JP; Kyzas, PA | 1 |
| Ansari, SA; Mukherji, SK; Shah, GV; Wesolowski, JR | 1 |
| Wong, RJ | 1 |
| Inubushi, M; Kanegae, K; Kitagawa, Y; Notani, K; Saitoh, M; Takinami, S; Tamaki, N; Tei, K; Totsuka, Y; Yamazaki, Y | 1 |
| Imabayashi, E; Kuji, I; Matsuda, H; Minagawa, A; Miyauchi, T | 1 |
| Chevretton, E; Croft, D; McGurk, M; Wong, WL | 1 |
| Grénman, R; Haaparanta, M; Joensuu, H; Kurki, T; Lapela, M; Leskinen, S; Lindholm, P; Minn, H; Ruotsalainen, U | 1 |
| Cappellari, JO; Geisinger, KR; Greven, KM; Keyes, JW; McGuirt, WF; Watson, NE; Williams, DW | 1 |
| Arimizu, N; Imaseki, K; Itami, J; Okada, J; Oonishi, H; Uno, K; Yoshikawa, K | 1 |
| Boering, G; Braams, JW; Freling, NJ; Nikkels, PG; Pruim, J; Roodenburg, JL; Vaalburg, W; Vermey, A | 1 |
| Clavo, AC; Grénman, R; Minn, H; Wahl, RL | 1 |
| Drane, WE; Landau, S; Mancuso, AA; Mukherji, SK; Tart, RP | 1 |
| Dimitrakopoulou-Strauss, A; Haberkorn, U; Reisser, C; Seifert, E; Strauss, LG | 1 |
| Black, M; Gjedde, A; Yamamoto, YL; Zeitouni, AG | 1 |
| Drane, WE; Mancuso, AA; Mukherji, SK | 1 |
| Cappellari, JO; Geisinger, KR; Greven, KM; Keyes, JW; McGuirt, WF; Raben, M; Randall, ME; Watson, NE; Williams, DW | 1 |
| Anzai, Y; Chaiken, L; Choi, Y; Hoh, CK; Juillard, G; Lufkin, R; Maass, A; Maddahi, J; Phelps, ME; Rege, S | 1 |
| Haberkorn, U; Reisser, C; Strauss, LG | 1 |
| Anzai, Y; Chaiken, L; Choi, Y; Hawkins, RA; Hoh, CK; Juillard, G; Lufkin, R; Maddahi, J; Phelps, ME; Rege, SD | 1 |
| Anzai, Y; Hawkins, R; Huda, A; Lee, TH; Lufkin, RB; Rege, S | 1 |
| Chaiken, L; Choi, Y; Hawkins, R; Hoh, C; Jabour, B; Juillard, G; Parker, R; Rege, S | 1 |
| Bergman, J; Haaparanta, M; Joensuu, H; Lehikoinen, P; Leskinen-Kallio, S; Lindholm, P; Minn, H; Någren, K; Ruotsalainen, U; Teräs, M | 1 |
| Bailet, J; Chaiken, L; Choi, Y; Hanafee, WN; Hoh, CK; Jabour, BA; Lufkin, RB; Maddahi, J; Rege, SD; Soong, JC | 1 |
| Bergman, J; Joensuu, H; Leskinen-Kallio, S; Lindholm, P; Minn, H; Ruotsalainen, U | 1 |
| Dimitrakopoulou, A; Doll, J; Haberkorn, U; Helus, F; Oberdorfer, F; Reisser, C; Seiffert, E; Strauss, LG; van Kaick, G; Ziegler, S | 1 |
| Drane, WE; Mancuso, AA; Mendenhall, WM; Mukherji, SK; Parsons, JT; Stringer, S | 1 |
| Anzai, Y; Bradford, CR; Carroll, WR; Minoshima, S; Quint, DJ; Wahl, RL; Wolf, GT | 1 |
| Beaney, RP; Chevretton, EB; Walsh, RM; Wong, WL | 1 |
| Arweiler, D; Müller, S; Schipper, JH; Schrader, M; Sciuk, J | 1 |
| Wagner, HN | 2 |
| Clavo, AC; Minn, H; Wahl, RL | 1 |
| Nakai, Y; Ochi, H; Ohashi, Y; Okamura, T; Sakamoto, H | 1 |
| Baddeley, H; Beaney, R; Chevretton, EB; Davis, J; Hussain, K; Maisey, M; McGurk, M; Tierney, P; Wong, WL | 1 |
| Cronin, V; Galantowicz, P; Nabi, HA | 1 |
| Lapela, M; Leskinen, S; Lindholm, P; Minn, H | 1 |
| Greven, KM; Keyes, JW; McGuirt, WF; Watson, NE; Williams, DW | 1 |
| Boyd, JH; Dunleavy, T; Dunphy, CH; Dunphy, FR; Fletcher, JW; Kim, H; Lowe, VJ; McDonough, E; Minster, J; Varvares, M; Wittry, M | 1 |
| Bergman, J; Eronen, E; Grénman, R; Haaparanta, M; Joensuu, H; Klemi, PJ; Lapela, M; Leskinen, S; Lindholm, P; Minn, H | 1 |
| Lamonica, D; Myers, LL; Nabi, H; Simpson, GT; Wax, MK | 1 |
| Brun, E; Erlandsson, K; Kjellén, E; Ohlsson, T; Sandell, A; Strand, SE; Tennvall, J; Wennerberg, J | 1 |
| Cappellari, JO; Geisinger, KR; Greven, K; Keyes, JW; McGuirt, WF; Watson, N; Williams, D | 1 |
| Deters, EC; Gross, MD; Kison, PV; Shreve, PD; Steventon, RS; Wahl, RL | 1 |
| Hayashi, N; Ishii, Y; Nakaumra, S; Sadato, N; Takahashi, N; Tsuchida, T; Uematsu, H; Waki, A; Yonekura, Y | 1 |
| Adamietz, IA; Adams, S; Baum, RP; Bormeth, SB; Böttcher, HD; Hör, G; Mose, S; Rahn, AN; Sengupta, S | 1 |
| Adams, S; Baum, RP; Bitter, K; Hör, G; Stuckensen, T | 1 |
| AAssar, OS; Caputo, GR; Dillon, WP; Fischbein, NJ; Hawkins, RA; Kaplan, MJ; Price, DC; Singer, MI | 2 |
| Donald, PJ; Manolidis, S; Pounds, TR; Volk, P | 1 |
| Collignon, J; Deneufbourg, JM; Hustinx, R; Moreau, P; Paulus, P; Rigo, P; Sambon, A; Vivegnis, D | 1 |
| Hayashi, N; Ishii, Y; Nakamura, S; Sadato, N; Sugimoto, K; Tsuchida, T; Uematsu, H; Waki, A; Yamamoto, K; Yonekura, Y | 1 |
| Kawabe, J; Kitayama, H; Matsuda, M; Nakai, Y; Nasako, Y; Ochi, H; Ohashi, Y; Okamura, T; Sakamoto, H; Sakashita, T | 1 |
| Stokkel, MP; ten Broek, FW; van Rijk, PP | 2 |
| Hanasono, MM; Ku, GH; Kunda, LD; Segall, GM; Terris, DJ | 1 |
| Alavi, A; Benard, F; Chalian, AA; Farber, LA; Machtay, M; Rosenthal, DI; Smith, RJ; Weber, RS; Weinstein, GS | 1 |
| Bagatella, F; Ferlin, G; Mattei, R; Rubello, D | 1 |
| Greven, KM; Joyce, WT; Keyes, JW; McGuirt, WF; Williams, DW | 1 |
| Büll, U; Cremerius, U; Kaiser, HJ; Reinartz, P; Sabri, O; Schreckenberger, M; Zimny, M | 1 |
| Koh, JH; Pai, M; Park, CH; Suh, JH | 1 |
| Azuma, H; Ishii, Y; Kitagawa, Y; Ogasawara, T; Sadato, N; Yonekura, Y; Yoshida, M | 1 |
| Anzai, Y; Minoshima, S; Wahl, RL; Wolf, GT | 1 |
| Bacqai, F; Conti, PS; Durski, JM; Grafton, ST; Singer, PA | 1 |
| Bohuslavizki, KH; Clausen, M; Klutmann, S; Kröger, S; Mester, J; Sonnemann, U; Thoms, J; Werner, JA | 1 |
| Fazio, F; Gianolli, L; Gilardi, MC; Landoni, C; Lucignani, G; Magnani, P; Savi, A; Travaini, L | 1 |
| Brochhagen, HG; Jungehülsing, M; Theissen, P; Wittekindt, C | 1 |
| Alavi, A; Benard, F; Farber, LA; Hustinx, R; Machtay, M; Rosenthal, DI; Smith, RJ | 1 |
| Hordijk, GJ; Moons, KG; Stokkel, MP; ten Broek, FW; van Rijk, PP | 1 |
| Bongers, V; Hordijk, GJ; Stokkel, MP; van Rijk, PP | 1 |
| Alexiou, C; Arnold, W; Kau, RJ; Laubenbacher, C; Schwaiger, M; Werner, M | 1 |
| Birzgalis, AR; Collins, CD; Cowan, RA; Farrington, WT; Hastings, DL; Johnson, RJ; Slevin, NJ; Swindell, R; Waller, ML | 1 |
| Adam, G; Büll, U; Cremerius, U; Di Martino, E; Jänicke, S; Nowak, B; Reinartz, P; Zimny, M | 1 |
| Hordijk, GJ; Stokkel, MP; Terhaard, CH; van Rijk, PP | 1 |
| Boyd, JH; Collins, BT; Dunleavy, T; Dunphy, FR; Fletcher, JW; Hollenbeak, C; Kim, H; Lowe, VJ; Martin, D; Stack, BC | 1 |
| Hordijk, GJ; Koole, R; Stokkel, MP; ten Broek, FW; van Rijk, PP | 1 |
| Chen, MY; Greven, KM; Keyes, JW; McGuirt, WF; Watson, NE; Williams, DW | 1 |
| Al-Amro, A; Bakheet, SM; Larsson, SG; Mahassin, Z; Powe, J; Saleem, M | 1 |
| Meyer, MA; Nathan, CO | 1 |
| Smith, TA; Titley, J | 1 |
| Chaiken, L; Hoh, C; Juillard, G; Rege, S; Safa, AA; Withers, HR | 1 |
| Bjornskov, I; Bretlau, P; Eigtved, A; Friberg, L; Grénman, R; Holm, S; Jensen, M; Jyrkkiö, S; Kurki, T; Lapela, M; Lindholm, P; Minn, H; Nuutinen, J; Sand Hansen, H; Solin, O; Sutinen, E | 1 |
| Brenner, W; Czech, N; Henze, E; Kampen, WU | 1 |
| Büll, U; Cremerius, U; Di Martino, E; Hausmann, R; Krombach, GA; Nowak, B; Sellhaus, B; Westhofen, M | 1 |
| Grahek, D; Kerrou, K; Monceaux, G; Montravers, F; Périé, S; St Guily, JL; Talbot, JN | 1 |
| Damm, M; Eckel, H; Jungehülsing, M; Pietrzyk, U; Scheidhauer, K; Schicha, H; Stennert, E | 1 |
| Bausart, R; Ide, C; Lawson, G; Lonneux, M; Pauwels, S; Remacle, M | 1 |
| Ak, I; Pauwels, EK; Stokkel, MP | 1 |
| Chisin, R; Macapinlac, HA | 1 |
| Albrecht, SR; Allal, AS; Allaoua, M; Becker, M; Dulguerov, P; Goerres, GW; Haenggeli, CA; Lehmann, W; Slosman, DO | 1 |
| Alavi, A; Denittis, A; Li, P; Machtay, M; Mozley, PD; Smith, R; Yeh, D; Zhuang, H | 1 |
| D'Costa, I; Fisher, R; Hart, R; Hicks, R; Hughes, P; Peters, L; Rischin, D; Sexton, M; von Roemeling, R | 1 |
| Shih, WJ | 1 |
| Kato, T; Katoh, C; Kuge, Y; Mabuchi, M; Morita, K; Nakada, K; Shiga, T; Tamaki, N; Tsukamoto, E; Yoshinaga, K | 1 |
| Draisma, A; Pauwels, EK; Stokkel, MP | 1 |
| Gallowitsch, HJ; Gomez, I; Grünbacher, G; Heinisch, M; Kogler, D; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P; Raunik, W; Unterweger, O; Wiesser, S | 1 |
| Ang, KK; Byers, RM; Garden, AS; Gillenwater, AM; Morrison, WH; Nguyen, LN; Podoloff, DA; Schechter, NR | 1 |
| Chan, F; Chan, WL; Freund, J; McBride, B; Pocock, NA; Sorensen, BJ; Szeto, E | 1 |
| Courtois, A; De Dreuille, O; Foehrenbach, H; Gaillard, JF; Garcia, D; Kossowski, M; Maszelin, P; Merlet, P; Poncet, JL | 1 |
| Brinkbäumer, K; Dresel, S; Hahn, K; Pöpperl, G; Schmid, R; Schwenzer, K; Szeimies, U | 1 |
| Hollenbeak, CS; Lowe, VJ; Stack, BC | 1 |
| D'Agostino, RB; Greven, KM; Harkness, BA; Keyes, JW; McGuirt, WF; Watson, NE; Williams, DW | 1 |
| Lee, D; Marn, CS; Rosenthal, EL; Taylor, R; Teknos, TN | 1 |
| Kitagawa, Y; Maruta, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y | 1 |
| Allal, AS; Allaoua, M; Dulguerov, P; El-Ghazi, el A; Haenggeli, CA; Lehmann, W; Slosman, DO | 1 |
| Biassoni, L; Hain, SF; Halfpenny, W; Maisey, MN; McGurk, M; Sherman, JA | 1 |
| Brun, E; Kjellén, E; Ohlsson, T; Perfekt, R; Sandell, A; Strand, SE; Tennvall, J; Wennerberg, J | 1 |
| Choufani, G; Goldman, S; Hassid, S; Sheikholeslam-zadeh, R | 1 |
| Bomanji, JB; Costa, DC; Ell, PJ | 1 |
| Conessa, C; Foehrenbach, H; Gaillard, JF; Kossowski, M; Maszelin, P; Poncet, JL | 1 |
| Nabi, HA; Zubeldia, JM | 1 |
| Brink, I; Klenzner, T; Krause, T; Mix, M; Moser, E; Nitzsche, EU; Ross, UH | 1 |
| Buck, A; Goerres, GW; Hany, TF; Kamel, E; von Schulthess, GK | 1 |
| Gabalski, EC; Gona, JM; Husain, S; Myers, LL; Nabi, H; Wax, MK | 1 |
| Endo, K; Mogi, K; Nakasone, Y | 1 |
| Agoston, P; Esik, O; Fekésházy, A; Galuska, L; Kálvin, B; Lengyel, E; Lengyel, Z; Szakáll, S; Székely, J; Trón, L; Várady, E | 1 |
| Dimitrakopoulou, A; Haag, D; Haberkorn, U; Oberdorfer, F; Reisser, C; Rudat, V; Strauss, LG; van Kaick, G; Ziegler, S | 1 |
| Ahonen, A; Minn, H; Paul, R | 1 |
| Ahonen, A; Joensuu, H; Klemi, P; Minn, H | 1 |
171 review(s) available for fluorodeoxyglucose f18 and Cancer of Head
| Article | Year |
|---|---|
Diagnostic efficacy of combined CT and MRI in detecting nodal metastasis in patients with oral cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mouth Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
PET/CT and PET/MR Imaging of the Post-treatment Head and Neck: Traps and Tips.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Systematic review and meta-analysis of the diagnostic effectiveness of positron emission tomography-computed tomography versus magnetic resonance imaging in the post-treatment surveillance of head and neck squamous cell carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
PET/Computed Tomography: Post-therapy Follow-up in Head and Neck Cancer.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2022 |
Clinical Role of Positron Emission Tomography/Computed Tomography Imaging in Head and Neck Squamous Cell Carcinoma.
Topics: Carcinoma, Squamous Cell; COVID-19; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2022 |
PET/CT: Radiation Therapy Planning in Head and Neck Cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2022 |
PET Imaging of Oral Cavity and Oropharyngeal Cancers.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth; Neoplasm Staging; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Does PET scan have any role in the diagnosis of perineural spread associated with the head and neck tumors?
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2022 |
Pearls and Pitfalls of
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Contemporary Imaging and Reporting Strategies for Head and Neck Cancer: MRI, FDG PET/MRI, NI-RADS, and Carcinoma of Unknown Primary-
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Prognostic value of MTV and TLG of 18 F-FDG PET in patients with head and neck squamous cell carcinoma: A meta-analysis.
Topics: Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2022 |
Paraganglioma of the Head and Neck: A Review.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Paraganglioma; Paraganglioma, Extra-Adrenal; Succinate Dehydrogenase; Tomography, X-Ray Computed | 2023 |
Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer.
Topics: Carcinoma, Squamous Cell; Female; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms | 2023 |
Prognostic and predictive values of baseline and mid-treatment FDG-PET in oropharyngeal carcinoma treated with primary definitive (chemo)radiation and impact of HPV status: Review of current literature and emerging roles.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human Papillomavirus Viruses; Humans; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
A systematic review and meta-analysis of predictive and prognostic models for outcome prediction using positron emission tomography radiomics in head and neck squamous cell carcinoma patients.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Squamous Cell Carcinoma of Head and Neck | 2023 |
The use of positron emission tomography imaging to guide radiation therapy.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2023 |
Advances in Functional Imaging in the Assessment of Head and Neck Cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radioactive Tracers; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2019 |
Associations between FDG-PET and Ki 67-index in head and neck cancer: A meta-analysis.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Ki-67 Antigen; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck | 2019 |
Normal Patterns and Pitfalls of FDG Uptake in the Head and Neck.
Topics: Diagnostic Errors; Fluorodeoxyglucose F18; Head; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neck; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
RESISTing the Need to Quantify: Putting Qualitative FDG-PET/CT Tumor Response Assessment Criteria into Daily Practice.
Topics: Animals; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymphoma; Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2019 |
Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer: A Systematic Review.
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Survival Analysis | 2020 |
A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2020 |
Benefits of positron emission tomography scans for the evaluation of radiotherapy.
Topics: Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Neoplasms; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy, Adjuvant; Rectal Neoplasms; Treatment Outcome; Uterine Cervical Neoplasms | 2020 |
Correlation between fluorodeoxyglucose hotspots on preradiotherapy PET/CT and areas of cancer local relapse: Systematic review of literature.
Topics: Anatomic Landmarks; Esophageal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasms; Patient Positioning; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies | 2020 |
Metabolic tumor volume and total lesion glycolysis as prognostic factors in head and neck cancer: Systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2020 |
PET-CT for Staging and Detection of Recurrence of Head and Neck Cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
PET/MR in Head and Neck Cancer - An Update.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
PET/CT in Surgical Planning for Head and Neck Cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2021 |
Imaging for Target Delineation in Head and Neck Cancer Radiotherapy.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2021 |
18F-FDG PET cannot predict expression of clinically relevant histopathological biomarkers in head and neck squamous cell carcinoma: a meta-analysis.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Biomarkers, Tumor; Cell Proliferation; ErbB Receptors; Fluorodeoxyglucose F18; Genes, p53; Glucose Transporter Type 1; Head and Neck Neoplasms; Humans; Ki-67 Antigen; Microcirculation; Positron-Emission Tomography; Repressor Proteins; Squamous Cell Carcinoma of Head and Neck | 2022 |
Radiologic Evaluation of the Head and Neck Cancer Patient.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2021 |
Imaging in head and neck cancers: Update for non-radiologist.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
Systematic Review and Meta-Analysis of Post-Treatment PET/CT in HPV-Associated Oropharyngeal Cancer.
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
[PET-CT in head and neck cancer].
Topics: Evidence-Based Medicine; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Interim
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Time Factors; Treatment Outcome; Tumor Burden | 2017 |
Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2017 |
Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.
Topics: Carcinoma, Squamous Cell; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Molecular Imaging-Guided Radiotherapy for the Treatment of Head-and-Neck Squamous Cell Carcinoma: Does it Fulfill the Promises?
Topics: Carcinoma, Squamous Cell; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Molecular Imaging; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Image-Guided | 2018 |
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2017 |
FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Tumor Burden | 2018 |
Nuclear Medicine Imaging in the Dentomaxillofacial Region.
Topics: Acquired Hyperostosis Syndrome; Bone Neoplasms; Face; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hyperplasia; Infections; Mandibular Condyle; Maxilla; Osteitis Deformans; Periodontitis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sjogren's Syndrome; Technetium Tc 99m Medronate; Technology, Dental; Temporomandibular Joint Disorders; Tomography, X-Ray Computed | 2018 |
An Imager's Guide to Perineural Tumor Spread in Head and Neck Cancers: Radiologic Footprints on
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Invasiveness; Peripheral Nerves; Positron-Emission Tomography; Tomography, X-Ray Computed | 2019 |
Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.
Topics: Evaluation Studies as Topic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Squamous Cell Carcinoma of Head and Neck | 2018 |
Prognostic value of 18F-FDG PET/CT functional parameters in patients with head and neck cancer: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography | 2019 |
Emerging Opportunities for Digital PET/CT to Advance Locoregional Therapy in Head and Neck Cancer.
Topics: Biopsy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Patient Care Planning; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
18FDG-PET/CT for the detection of regional nodal metastasis in patients with primary head and neck cancer before treatment: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Meta-Analysis as Topic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2013 |
Rosai-Dorfman disease with extranodal involvement.
Topics: Biopsy, Needle; Brain Neoplasms; Craniotomy; Diagnosis, Differential; Diagnostic Imaging; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Histiocytosis, Sinus; Humans; Immunohistochemistry; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Neck Pain; Photomicrography; Positron-Emission Tomography; Prednisolone; Rare Diseases; Severity of Illness Index; Tomography, X-Ray Computed | 2014 |
Role of positron emission tomography/computed tomography (PET/CT) in head and neck cancer.
Topics: Contrast Media; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2013 |
Perineural spread in head and neck malignancies: clinical significance and evaluation with 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Patient Care Planning; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Comparison between anatomical cross-sectional imaging and 18F-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
18 FDG PET and PET-CT for the detection of bone metastases in patients with head and neck cancer. A meta-analysis.
Topics: Bone Neoplasms; Evidence-Based Medicine; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Nuclear medicine imaging studies in the diagnosis of head and neck disease.
Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Estimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local control.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2014 |
Meta-analysis of (18) fluorodeoxyglucose positron emission tomography-CT for diagnosis of lung malignancies in patients with head and neck squamous cell carcinomas.
Topics: Carcinoma, Squamous Cell; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Prospective Studies; Retrospective Studies; Sensitivity and Specificity | 2015 |
18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
Head and neck: normal variations and benign findings in FDG positron emission tomography/computed tomography imaging.
Topics: Artifacts; Fasting; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Patient Positioning; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
[Metabolic tailoring in radiotherapy for head and neck cancer].
Topics: Carcinoma, Squamous Cell; Cell Hypoxia; Clinical Trials as Topic; Diffusion Magnetic Resonance Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Misonidazole; Multimodal Imaging; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Tumor Burden | 2014 |
¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography in malignancies of the thyroid and in head and neck squamous cell carcinoma: a review of the literature.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
The value of fluorine-18 fluorodeoxyglucose PET/MRI in the diagnosis of head and neck carcinoma: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography | 2015 |
(18)FDG-PET/CT for the detection of regional nodal metastasis in patients with head and neck cancer: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Primary tumor standardized uptake value predicts survival in head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Incidence; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2015 |
[New trends and novel possibilities in the management of oncologic patients: clinical uses of PET/MRI].
Topics: Abdominal Neoplasms; Disease Management; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Medical Oncology; Multimodal Imaging; Neoplasms; Ovarian Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Thoracic Neoplasms | 2015 |
18F FDG PET/CT and Head and Neck Cancer: Patient Management and Outcomes.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Diagnostic Accuracy of Follow-Up FDG PET or PET/CT in Patients With Head and Neck Cancer After Definitive Treatment: A Systematic Review and Meta-Analysis.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Intratherapy or Posttherapy FDG PET or FDG PET/CT for Patients With Head and Neck Cancer: A Systematic Review and Meta-analysis of Prognostic Studies.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Characteristics and Limitations of FDG PET/CT for Imaging of Squamous Cell Carcinoma of the Head and Neck: A Comprehensive Review of Anatomy, Metastatic Pathways, and Image Findings.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2015 |
[Role of positron emission tomography and CT with 18F-FDG PET-CT in follow-up of patients treated for head and neck squamous cell carcinoma].
Topics: Carcinoma, Squamous Cell; Early Detection of Cancer; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Special Techniques in PET/Computed Tomography Imaging for Evaluation of Head and Neck Cancer.
Topics: Adrenergic beta-Antagonists; Benzodiazepines; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Multimodal Imaging; Phonation; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Valsalva Maneuver; Whole Body Imaging | 2016 |
Cervical lymph node metastases from remote primary tumor sites.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
PET-based quantification of statistical properties of hypoxic tumor subvolumes in head and neck cancer.
Topics: Animals; Chemoradiotherapy; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Image Processing, Computer-Assisted; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
(18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2016 |
Non-18F-FDG PET/CT in the management of patients affected by HNC: state-of-the-art.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Somatostatin | 2016 |
Effectiveness of FDG-PET/CT for evaluating early response to induction chemotherapy in head and neck squamous cell carcinoma: A systematic review.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2016 |
(18)F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer.
Topics: Fluorodeoxyglucose F18; Head; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neck; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Molecular Imaging and Precision Medicine in Head and Neck Cancer.
Topics: Biomarkers, Tumor; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Genomics; Head and Neck Neoplasms; Humans; Molecular Imaging; Molecular Targeted Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Precision Medicine; Prognosis; Radiopharmaceuticals | 2017 |
Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography | 2016 |
Novel imaging approaches to head and neck cancer.
Topics: Carcinoma, Squamous Cell; Cell Hypoxia; Diagnostic Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Misonidazole; Oxygen; Positron-Emission Tomography | 2008 |
[Metabolic imaging--PET, PET/CT--in oncologic surgery].
Topics: Breast Neoplasms; Cost-Benefit Analysis; Endocrine Gland Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Hungary; Lung Neoplasms; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Surgical Procedures, Operative; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
Role of functional imaging in head and neck squamous cell carcinoma: fluorodeoxyglucose positron emission tomography and beyond.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Monitoring, Physiologic; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2008 |
PET monitoring of therapy response in head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Imaging features of primary extranodal lymphomas.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Bone Neoplasms; Breast Neoplasms; Central Nervous System Neoplasms; Contrast Media; Diagnosis, Differential; Diagnostic Imaging; Digestive System Neoplasms; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Neoplasms; Tomography, X-Ray Computed; Urogenital Neoplasms | 2009 |
Advances in imaging in the work-up of head and neck cancer patients.
Topics: Carcinoma, Squamous Cell; Diagnostic Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
Innovations in radiotherapy planning of head and neck cancers: role of PET.
Topics: Cell Hypoxia; Cell Proliferation; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Proteins; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Regional Blood Flow; Tomography, X-Ray Computed | 2010 |
Standardized uptake value is of prognostic value for outcome in head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Disease-Free Survival; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2010 |
Neck dissection after chemoradiation for carcinoma of the upper aerodigestive tract: indications and complications.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Fibrosis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Postoperative Complications; Prognosis; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
[Radiologic diagnosis and nuclear medicine for head and neck cancers].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours.
Topics: Cell Hypoxia; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2010 |
Positron emission tomography for benign and malignant disease.
Topics: Breast Neoplasms; Colorectal Neoplasms; Dermatitis, Contact; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2011 |
PET-MRI fusion in head-and-neck oncology: current status and implications for hybrid PET/MRI.
Topics: Contrast Media; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Systems Integration | 2012 |
(18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
[Target volume delineation for head and neck cancer intensity-modulated radiotherapy].
Topics: Antineoplastic Agents; Combined Modality Therapy; Dose Fractionation, Radiation; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Organs at Risk; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Tumor Burden | 2011 |
Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Multimodal Imaging; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
FDG-PET/CT for detection of the unknown primary head and neck tumor.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
FDG-PET/CT in radiation treatment planning of head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2011 |
New tracers beyond FDG in head and neck oncology.
Topics: Amino Acids; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals | 2011 |
The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease.
Topics: Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Extranodal manifestations of lymphoma on [¹⁸F]FDG-PET/CT: a pictorial essay.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of occult primary head and neck cancers--an audit and review of published studies.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
PET scanning in plastic and reconstructive surgery.
Topics: Breast Neoplasms; Diabetic Foot; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Keloid; Male; Melanoma; Multimodal Imaging; Neoplasm Staging; Plastic Surgery Procedures; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Surgical Flaps; Tomography, X-Ray Computed | 2012 |
The role of FDG PET-CT in the therapeutic evaluation for HNSCC patients.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Improving target definition for head and neck radiotherapy: a place for magnetic resonance imaging and 18-fluoride fluorodeoxyglucose positron emission tomography?
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive?
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2012 |
A head and neck radiologist's perspective on best practices for the usage of PET/CT scans for the diagnosis and treatment of head and neck cancers.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Patient Care Planning; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
A head and neck surgeon's perspective on best practices for the use of PET/CT scans for the diagnosis and treatment of head and neck cancers.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Patient Care Planning; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer.
Topics: Evidence-Based Medicine; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals | 2013 |
Head and neck cancer.
Topics: Carcinoma, Squamous Cell; Diagnostic Imaging; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Alternative PET tracers in head and neck cancer. A review.
Topics: Amino Acids; Antibodies, Monoclonal; Carbon Radioisotopes; Carcinoma, Squamous Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Misonidazole; Nitroimidazoles; Nucleosides; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Esophageal cancer and head and neck cancer.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[Positron emission tomography (PET) in clinical oncology [Part III]].
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasms; Ovarian Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
[A proposal for the rational use of the PET in oncology].
Topics: Brain Neoplasms; Colorectal Neoplasms; Consensus; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Practice Guidelines as Topic; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Spain; Tomography, Emission-Computed | 2002 |
[Cost-effective PET investigations in oncology].
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Cost-Benefit Analysis; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hungary; Lung Neoplasms; Lymphoma; Medicare; Melanoma; Neoplasm Staging; Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed; United States | 2002 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract].
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
PET/CT imaging in recurrent head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray | 2003 |
Positron emission tomography for basal cell carcinoma of the head and neck.
Topics: Aged; Aged, 80 and over; Carcinoma, Basal Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.
Topics: Carcinoma, Squamous Cell; Clinical Trials as Topic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Nuclear Medicine; Radioisotopes; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus.
Topics: Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2004 |
[Positron-emission tomography in oncology].
Topics: Colorectal Neoplasms; Evidence-Based Medicine; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Clinical utility of FDG PET.
Topics: Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Neoplasms; Tomography, Emission-Computed | 2004 |
Positron-emission tomography for head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Positron emission imaging of head and neck cancer, including thyroid carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Prognosis; Radiography; Radiopharmaceuticals; Subtraction Technique; Thyroid Neoplasms; Tomography, Emission-Computed | 2004 |
Investigation of thyroid, head, and neck cancers with PET.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Treatment Outcome | 2004 |
Role of 18FFDG PET/CT in the treatment of head and neck cancers: principles, technique, normal distribution, and initial staging.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Staging; Radiography, Interventional; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
Role of 18FFDG PET/CT in the treatment of head and neck cancers: posttherapy evaluation and pitfalls.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiography, Interventional; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Functional imaging in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis | 2005 |
The role of PET-CT fusion in head and neck cancer.
Topics: Carcinoma; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Radiation Injuries; Tomography, X-Ray Computed | 2005 |
[Current applications and future developments of positron emission tomography in head and neck cancer].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2005 |
18F-fluoro-2-deoxy-D-glucose positron emission tomographic imaging: recent developments in head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Medical Oncology; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy | 2005 |
Inflammatory pseudotumour of the neck with multifocal sites on positron emission tomography scan imaging.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Granuloma, Plasma Cell; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Neck; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Positron emission tomography for radiation treatment planning.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasms; Neoplasms, Unknown Primary; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2005 |
PET/CT in oncology: a major technology for cancer care.
Topics: Brain Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neoplasms; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2005 |
Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
Topics: Carcinoma, Squamous Cell; Clinical Trials as Topic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all?
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neck Dissection; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed | 2006 |
Imaging of cervical lymph nodes in head and neck cancer: the basics.
Topics: Adult; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neck; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palpation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2005 |
[Recent progress in diagnosis of otorhinolaryngologic diseases: positron emission tomography of head and neck neoplasms].
Topics: Animals; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Otorhinolaryngologic Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
The current status of positron-emission tomography scanning in the evaluation and follow-up of patients with head and neck cancer.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Monitoring chemotherapy and radiotherapy of solid tumors.
Topics: Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Monitoring, Physiologic; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma; Uterine Cervical Neoplasms | 2006 |
[PET in head and neck cancers].
Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
[Impact of FDG-PET in therapeutic management of patients with suspected recurrence of head and neck cancer].
Topics: Aged; Carcinoma; Case Management; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Surveys and Questionnaires | 2006 |
[Positron emission tomography in head and neck squamous cell carcinomas].
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2006 |
Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Subtraction Technique; Systems Integration; Thyroid Neoplasms; Tomography, X-Ray Computed; United States; Whole Body Imaging | 2007 |
Future issues in highly conformal radiotherapy for head and neck cancer.
Topics: Carbon; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Proton Therapy; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2007 |
[The value of PET-CT imaging in malignant tumours of the head and neck].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
PET/CT in oncology: for which tumours is it the reference standard?
Topics: Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Positron emission tomography/computed tomography for target delineation in head and neck cancers.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2008 |
Role of positron emission tomography in the management of head and neck cancer in the molecular therapy era.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Lymph Nodes; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Conformal; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2008 |
[Systematic review and meta-analysis of diagnostic accuracy of 18F-FDG PET in suspected recurrent head and neck cancer].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis.
Topics: Confidence Intervals; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Neck; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2008 |
New directions in head and neck imaging.
Topics: Contrast Media; Diagnostic Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Radiopharmaceuticals | 2008 |
Current status of FDG-PET for head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2008 |
Metabolic imaging by positron emission tomography in oncology.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Neoplasms; Radiography; Tomography, Emission-Computed | 1997 |
PET scanning in head and neck oncology: a review.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 1998 |
Role of PET FDG in the management of head and neck squamous cell cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Patient Care Planning; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
The role of FDG PET in the clinical management of head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
[Diagnostic value of positron emission tomography (PET) in clinical oncology].
Topics: Brain Neoplasms; Breast Neoplasms; Diagnosis, Differential; Digestive System Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Urogenital Neoplasms | 2000 |
Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours.
Topics: Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasm Staging; Neoplasms; Ovarian Neoplasms; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
The indications of FDG-PET in neck oncology.
Topics: Carcinoma, Squamous Cell; Equipment Design; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms; Outcome Assessment, Health Care; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
Can positron emission tomography improve the quality of care for head-and-neck cancer patients?
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm, Residual; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Unknown primary detected by FDG-PET. A review of the present indications of FDG-PET in head and neck cancers.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Clinical role of positron emission tomography in oncology.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Clinical applications of (18)F-FDG in oncology.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
[Current status of nuclear medicine clinical application of FDG-PET for cancer diagnosis. Head and neck cancer].
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[Cost-effective PET scans in oncology].
Topics: Breast Neoplasms; Colorectal Neoplasms; Cost-Benefit Analysis; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hungary; Lung Neoplasms; Lymphoma; Medicare; Melanoma; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; United States | 2002 |
87 trial(s) available for fluorodeoxyglucose f18 and Cancer of Head
| Article | Year |
|---|---|
Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell Carcinoma.
Topics: Alphapapillomavirus; Biomarkers; Carcinoma, Squamous Cell; Circulating Tumor DNA; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kinetics; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma.
Topics: Aged; Biomarkers, Tumor; Exome Sequencing; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Ipilimumab; Male; Middle Aged; Neoadjuvant Therapy; Nivolumab; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck | 2021 |
Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers.
Topics: Carcinoma, Squamous Cell; Epithelial Cells; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Immunotherapy; Mouth Neoplasms; Nivolumab; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Panitumumab; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Zirconium | 2022 |
Identifying the location of locoregional recurrences after definitive radiotherapy for head and neck cancer using metabolic parameters of baseline and mid-treatment 18F-FDG-PET scans.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Squamous Cell Carcinoma of Head and Neck | 2023 |
Development and Testing of a Machine Learning Model Using
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human Papillomavirus Viruses; Humans; Machine Learning; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2023 |
Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of
Topics: Chemoradiotherapy; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Positron-Emission Tomography; Prospective Studies | 2020 |
[PET/CT and PET/MRI in Head and Neck Cancer].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Quality of Life; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Single-Blind Method | 2017 |
Radiation dose escalation based on FDG-PET driven dose painting by numbers in oropharyngeal squamous cell carcinoma: a dosimetric comparison between TomoTherapy-HA and RapidArc.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Research Design; Squamous Cell Carcinoma of Head and Neck | 2017 |
Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2017 |
Long-term outcome of
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Treatment Outcome | 2017 |
Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN).
Topics: Adult; Afatinib; Aged; Antineoplastic Agents; Biomarkers; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Squamous Cell Carcinoma of Head and Neck | 2018 |
Early metabolic 18F-FDG PET/CT response of locally advanced squamous-cell carcinoma of head and neck to induction chemotherapy: A prospective pilot study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Papillomaviridae; Pilot Projects; Positron Emission Tomography Computed Tomography; Progression-Free Survival; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2018 |
Prognostic value of dual-time-point 18F-FDG PET-CT imaging in patients with head and neck squamous cell carcinoma.
Topics: Age Factors; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sex Factors; Time Factors; Tomography, X-Ray Computed | 2013 |
Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial.
Topics: Aged; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organs at Risk; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Tumor Burden | 2013 |
Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; ErbB Receptors; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2013 |
Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors.
Topics: Animals; Biomarkers, Tumor; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Positron-Emission Tomography; Xenograft Model Antitumor Assays | 2014 |
Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Diffusion Magnetic Resonance Imaging; Doxorubicin; Early Diagnosis; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Young Adult | 2015 |
A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early fluorodeoxyglucose positron emission tomography-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Sorafenib; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome; Young Adult | 2016 |
Lesion regression rate based on RECIST: prediction of treatment outcome in patients with head and neck cancer treated with chemoradiotherapy compared with FDG PET-CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Alterations in anatomic and functional imaging parameters with repeated FDG PET-CT and MRI during radiotherapy for head and neck cancer: a pilot study.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed | 2015 |
Diffusion-Weighted MRI in the Assessment of Early Treatment Response in Patients with Squamous-Cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasm Staging; Non-Randomized Controlled Trials as Topic; Outcome Assessment, Health Care; Positron-Emission Tomography; Prospective Studies; Remission Induction; Time Factors; Tomography, X-Ray Computed | 2015 |
RGD-K5 PET/CT in patients with advanced head and neck cancer treated with concurrent chemoradiotherapy: Results from a pilot study.
Topics: Adult; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Integrin alphaVbeta3; Male; Middle Aged; Oligopeptides; Pilot Projects; Positron Emission Tomography Computed Tomography; Protein Transport | 2016 |
Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Squamous Cell Carcinoma of Head and Neck | 2016 |
The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy.
Topics: Adult; Aged; Dose Fractionation, Radiation; Down-Regulation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tumor Hypoxia | 2016 |
Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?
Topics: Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms.
Topics: Aged; Carcinoma, Squamous Cell; DNA, Antisense; ErbB Receptors; Female; Fluorodeoxyglucose F18; Genetic Therapy; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; STAT3 Transcription Factor | 2009 |
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2009 |
Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Quality of Life; Radiation Injuries; Radiopharmaceuticals; Radiosurgery; Radiotherapy Dosage; Remission Induction; Retreatment; Tomography, X-Ray Computed; Tumor Burden | 2009 |
Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.
Topics: Carcinoma, Squamous Cell; Contrast Media; Diffusion Magnetic Resonance Imaging; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Computer-Assisted; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2009 |
Serial FDG-PET on patients with head and neck cancer: implications for radiation therapy.
Topics: Adult; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Time Factors; Tumor Burden | 2009 |
Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy.
Topics: Aged; Aged, 80 and over; Biological Transport; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cost-Benefit Analysis; Costs and Cost Analysis; Diagnostic Errors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
18F-FDG versus 11C-choline PET/CT for the imaging of advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy: the time period during which PET/CT can reliably detect non-recurrence.
Topics: Aged; Carbon Radioisotopes; Choline; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Reproducibility of Results; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
The potential advantages of (18)FDG PET/CT-based target volume delineation in radiotherapy planning of head and neck cancer.
Topics: Aged; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Diagnostic performance of response assessment FDG-PET/CT in patients with head and neck squamous cell carcinoma treated with high-precision definitive (chemo)radiation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Adaptive dose painting by numbers for head-and-neck cancer.
Topics: Algorithms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer.
Topics: Adolescent; Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Dosage; Time Factors; Treatment Outcome; Tumor Burden; Young Adult | 2011 |
Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2011 |
Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated | 2011 |
Evaluation of deformable image coregistration in adaptive dose painting by numbers for head-and-neck cancer.
Topics: Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Workflow and radiation safety implications of (18)F-FDG PET/CT scans for radiotherapy planning.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Multimodal Imaging; Nuclear Medicine; Occupational Exposure; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Safety; Tomography, X-Ray Computed | 2012 |
Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Delayed Diagnosis; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Tumor volume delineation in head and neck cancer with 18-fluor-fluorodeoxiglucose positron emission tomography: adaptive thresholding method applied to primary tumors and metastatic lymph nodes.
Topics: Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorodeoxyglucose F18; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Utility of 18F-fluoride PET/CT and 18F-FDG PET/CT in the detection of bony metastases in heightened-risk head and neck cancer patients.
Topics: Bone Neoplasms; Fluorides; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Risk; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Changes in (18)F-fluorothymidine and (18)F-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy.
Topics: Aged; Aged, 80 and over; Chemoradiotherapy; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Doxorubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Doxorubicin; False Negative Reactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Sensitivity and Specificity; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Treatment Outcome | 2003 |
In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
Topics: Bone Neoplasms; Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Octreotide; Pentetic Acid; Pleural Neoplasms; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
Topics: Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Organ Specificity; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
[18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Tomography, Spiral Computed | 2003 |
The clinical impact of 18F-FDG gamma PET in patients with recurrent well differentiated thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting | 2003 |
FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Drug Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Brain Neoplasms; Carbon Radioisotopes; Child; Choline; Diagnosis, Differential; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms | 2004 |
[Is coincidence detection emission tomography (CDET) as reliable as positron emission tomography (PET) in head and neck cancer?].
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Topics: Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Misonidazole; Oximetry; Oxygen; Oxygen Consumption; Polarography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
A feasibility study of 18F-fluorodeoxyglucose positron emission tomography targeting and simultaneous integrated boost for intensity-modulated radiosurgery and radiotherapy.
Topics: Brain Neoplasms; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2004 |
FDG PET as a procedure for detecting simultaneous tumours in head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole-Body Counting | 2005 |
Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
Topics: Adult; Carcinoma, Squamous Cell; Case-Control Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Optimised PET reconstruction of the head and neck area: improved diagnostic accuracy.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Potential novel application of dual time point SUV measurements as a predictor of survival in head and neck cancer.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; United Kingdom | 2005 |
The prognostic value of FDG PET in head and neck cancer. Correlation with histopathology.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cisplatin; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2005 |
18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Squamous Cell; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2006 |
[18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer.
Topics: Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated | 2006 |
Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncolog
Topics: Cell Hypoxia; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Prognosis; Tirapazamine; Treatment Failure; Triazines | 2006 |
Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer.
Topics: Adult; Aged; Disease-Free Survival; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Treatment Failure | 2007 |
Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucous Membrane; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Pet-FDG imaging in the clinical evaluation of head and neck cancer.
Topics: Aged; Deoxyglucose; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Tomography, Emission-Computed | 1995 |
Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography.
Topics: Carcinoma, Medullary; Carcinoma, Papillary, Follicular; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Comparison of dual-head coincidence PET versus ring PET in tumor patients.
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Thoracic Neoplasms; Tomography, Emission-Computed | 1999 |
Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Inflammation; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Surveillance for recurrent head and neck cancer using positron emission tomography.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; False Positive Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiopharmaceuticals; Salvage Therapy; Tomography, Emission-Computed | 2000 |
FDG PET evaluation of head and neck cancer: value of imaging the thorax.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed | 2000 |
Use of a coincidence gamma camera to detect primary tumor with 18fluoro-2-deoxy-glucose in cervical lymph node metastases from an unknown origin.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Prospective Studies; Radionuclide Imaging | 2000 |
Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography.
Topics: Algorithms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Recurrence; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Hypoxia; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Drug Administration Schedule; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Misonidazole; Radiation-Sensitizing Agents; Radiopharmaceuticals; Survival Analysis; Tirapazamine; Tomography, Emission-Computed; Triazines | 2001 |
Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms, Second Primary; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
829 other study(ies) available for fluorodeoxyglucose f18 and Cancer of Head
| Article | Year |
|---|---|
Comparison of PET-CT, CT and MRI scan in initial staging and management of head and neck cancers.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Correlation between tumor voxel dose response matrix and tumor biomarker profile in patients with head and neck squamous cell carcinoma.
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck | 2021 |
Improved prognostic stratification of patients with pN3b oral cavity cancer based on maximum standardized uptake value of metastatic nodes, lymph node ratio, and level of cervical nodal metastases.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Node Ratio; Lymph Nodes; Mouth Neoplasms; Neoplasm Staging; Prognosis; Retrospective Studies | 2021 |
[
Topics: Animals; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tissue Distribution | 2022 |
Head and neck tumor segmentation in PET/CT: The HECKTOR challenge.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tumor Burden | 2022 |
Laterality on FDG-PET/CT in clinically node-negative early-stage oral squamous cell carcinoma: a retrospective analysis of patients with late neck metastasis.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2022 |
PET/CT versus triple endoscopy in initial workup of HPV+ oropharyngeal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Endoscopy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
FDG-PET/CT for oral focus assessment in head and neck cancer patients.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2022 |
Head and Neck Cancer and PET/Computed Tomography.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
Survival benefit associated with postoperative PET-CT before adjuvant radiotherapy or chemoradiotherapy in patients with oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiotherapy, Adjuvant; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Artificial Intelligence in Head and Neck Imaging.
Topics: Artificial Intelligence; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
18F-FDG-PET/CT can be used to predict distant metastasis in hypopharyngeal squamous cell carcinoma.
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Squamous Cell Carcinoma of Head and Neck | 2022 |
Qualitative and quantitative methods in post-chemoradiation PET for head and neck cancer.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.
Topics: Alphapapillomavirus; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neck Dissection; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers.
Topics: Adult; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
Utility and limitations of metabolic parameters in head and neck cancer: finding a practical segmentation method.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial.
Topics: CD8-Positive T-Lymphocytes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunotherapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
Pseudoprogression during Immunotherapy in Metastatic Head and Neck Squamous Cell Carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunotherapy; Squamous Cell Carcinoma of Head and Neck | 2022 |
Prognostic significance of conventional and volumetric PET parameters with and without partial volume correction in the assessment of head and neck squamous cell carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2022 |
Histogram analysis of
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2022 |
Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis.
Topics: Carcinoma, Squamous Cell; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Mouth Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2022 |
Deep learning based time-to-event analysis with PET, CT and joint PET/CT for head and neck cancer prognosis.
Topics: Canada; Deep Learning; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2022 |
Exploring the impact of metabolic imaging in head and neck cancer treatment.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2022 |
Maximum standardised uptake value is prognostic in patients with early-stage squamous cell carcinoma of the tongue.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tongue | 2022 |
Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Frequency and malignancy rate of incidental focal salivary gland lesions identified by 18F-fluorodeoxyglucose-positron emission tomography.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Mouth Neoplasms; Parotid Gland; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Prognosis; Squamous Cell Carcinoma of Head and Neck; Tumor Microenvironment | 2022 |
Discordance Between Oncology Clinician-Perceived and Radiologist-Intended Meaning of the Postradiotherapy Positron Emission Tomography/Computed Tomography Freeform Report for Head and Neck Cancer.
Topics: Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiologists; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Post-Treatment Neck Dissection of Tonsillar and Base of Tongue Squamous Cell Carcinoma in the Era of PET-CT, HPV, and p16.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neck Dissection; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tongue; Tongue Neoplasms; Tonsillar Neoplasms | 2022 |
Prognostic Value of
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human Papillomavirus Viruses; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2023 |
Early post-treatment
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypothyroidism; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2022 |
The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection.
Topics: Adult; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Oropharyngeal Neoplasms; Patient Selection; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Robotic Surgical Procedures; Squamous Cell Carcinoma of Head and Neck | 2022 |
[18F]-FDG PET and MRI radiomic signatures to predict the risk and the location of tumor recurrence after re-irradiation in head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Re-Irradiation | 2023 |
Clinical Value of Diffusion-Weighted Whole-Body Imaging with Background Body Signal Suppression (DWIBS) for Staging of Patients with Suspected Head and Neck Cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Multimodal Imaging; Sensitivity and Specificity; Whole Body Imaging | 2022 |
Hyoepiglottic Rheumatoid Nodule Mimicking Head and Neck Malignancy on 18 F-FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rheumatoid Nodule | 2023 |
Diagnostic efficacy of positron emission computerized tomography scans in suspicious laryngeal findings postorgan preservation treatment.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Larynx; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
PET/MR versus PET/CT for locoregional staging of oropharyngeal squamous cell cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Neoplasms, Squamous Cell; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
Prediction of extranodal extension in oropharyngeal cancer patients and carcinoma of unknown primary: value of metabolic tumor imaging with hybrid PET compared with MRI and CT.
Topics: Extranodal Extension; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasms, Unknown Primary; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2023 |
Incidental Finding of a Tongue Schwannoma Mimicking Local Recurrence of Squamous Cell Carcinoma on a Systematic Follow-up 18F-FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Incidental Findings; Neurilemmoma; Positron Emission Tomography Computed Tomography; Tongue | 2023 |
Validation of the
Topics: Biomarkers; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Parotid Gland; Positron-Emission Tomography; Xerostomia | 2023 |
Clinical utility of combined assessments of 4D volumetric perfusion CT, diffusion-weighted MRI and
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Head and Neck Neoplasms; Humans; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2023 |
Assessing the variability and correlation between SUV and ADC parameters of head and neck cancers derived from simultaneous PET/MRI: A single-center study.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2023 |
Diagnostic Performance of Response Assessment FDG-PET/CECT in HNSCC Treated With Definitive Radio(chemo)therapy Using NI-RADS.
Topics: Adult; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Improvement of Imaging Conditions to Improve the Detection Rate of Head and Neck Cancer by Positron Emission Tomography/Computed Tomography Examination.
Topics: Bayes Theorem; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
A prediction model of nodal metastasis in cN0 oral squamous cell carcinoma using metabolic and pathological variables.
Topics: Carcinoma, Squamous Cell; China; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Prognostic value of initial [ 18 F]FDG PET/computed tomography volumetric and texture analysis-based parameters in patients with head and neck squamous cell carcinoma.
Topics: Adult; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2023 |
PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy.
Topics: Carcinoma; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer in [Formula: see text]F]FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Tumor Burden | 2023 |
Volume-based 18F-fluorodeoxyglucose positron emission tomography/computed tomography parameters correlate with delayed neck metastasis in clinical early-stage oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
Obstructive Sialadenitis from Oral Squamous Cell Carcinoma: [
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Sialadenitis; Squamous Cell Carcinoma of Head and Neck | 2023 |
Diagnostic performance of FDG PET/MRI for cervical lymph node metastasis in patients with clinically N0 head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
Post-treatment 18F-fludeoxyglocuse-positron emission tomography in human papillomavirus-associated oropharyngeal cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human Papillomavirus Viruses; Humans; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Retrospective Studies | 2023 |
Mid-treatment 18F-FDG PET imaging changes in parotid gland correlates to radiation-induced xerostomia.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Parotid Gland; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiation Injuries; Radiotherapy Dosage; Xerostomia | 2023 |
Association Between 18F-Fluorodeoxyglucose Uptake and Mutation Status of Epidermal Growth Factor Receptor in Sinonasal Tract Cancer.
Topics: Carcinoma, Squamous Cell; ErbB Receptors; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Mutation; Paranasal Sinuses; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2023 |
Classification of head and neck cancer from PET images using convolutional neural networks.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neural Networks, Computer; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2023 |
Changes in serial multiparametric MRI and FDG-PET/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multiparametric Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2023 |
A comparison of loco-regional relapse pattern in HPV positive vs negative oropharyngeal cancers following radiotherapy; relation to pretreatment FDG-PET and radiotherapy target volumes.
Topics: Chronic Disease; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Squamous Cell Carcinoma of Head and Neck | 2023 |
Prognostic significance of the harmonized maximum standardized uptake value of 18F-FDG-PET/CT in patients with resectable oral tongue squamous cell carcinoma: a multicenter study.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2023 |
PET/CT and PET/MRI Evaluation of Post-treatment Head and Neck.
Topics: Fluorodeoxyglucose F18; Head; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neck; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
An Intensive 18F-Fludeoxyglucose-Positron Emission Tomography With Computed Tomography-Based Strategy of Follow-Up in Patients Treated for Head and Neck Squamous Cell Carcinoma Who Are Clinically Asymptomatic.
Topics: Adult; Case-Control Studies; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck | 2023 |
Amygdalar activity measured using FDG-PET/CT at head and neck cancer staging independently predicts survival.
Topics: Aged; Amygdala; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
[Value of PET imaging in head and neck cancer].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
The Effects of Human Papillomavirus Status and Treatment on the Positive Predictive Value of Post-radiotherapy
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human Papillomavirus Viruses; Humans; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Contribution of FDG-PET in the diagnostic assessment of cervical lymph node metastasis in Oral Cavity Squamous Cell Carcinoma (OCSCC).
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Head and Neck Cancer Segmentation in FDG PET Images: Performance Comparison of Convolutional Neural Networks and Vision Transformers.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
MRI and PET/CT in the assessment of lymph node metastases in head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2023 |
[Value of PET imaging in head and neck cancer].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2023 |
Topics: Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate | 2020 |
Second-look PET-CT following an initial incomplete PET-CT response to (chemo)radiotherapy for head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2020 |
Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma.
Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2022 |
Case Report: Sarcoidosis mimicking head and neck cancer progression.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sarcoidosis | 2019 |
FDG-PET/CT in the surveillance of head and neck cancer following radiotherapy.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Population Surveillance; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2020 |
High nodal FDG uptake increases risk of distant metastasis in patients with oropharyngeal squamous cell carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
Classification of three prognostically different groups of head and neck cancer patients based on their metabolic response to induction chemotherapy (IC-1).
Topics: Adult; Aged; Carboplatin; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Patient Selection; Positron Emission Tomography Computed Tomography; Retrospective Studies; Surgical Procedures, Operative; Survival Analysis; Treatment Outcome | 2020 |
Assessment of tumour hypoxia, proliferation and glucose metabolism in head and neck cancer before and during treatment.
Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Chemoradiotherapy; Cisplatin; Dideoxynucleosides; Disease-Free Survival; Drug Administration Schedule; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Misonidazole; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiation-Sensitizing Agents; Treatment Outcome; Tumor Hypoxia | 2020 |
Distant metastases and synchronous malignancies on FDG-PET/CT in patients with head and neck cancer: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sweden | 2020 |
Perceived value drives use of routine asymptomatic surveillance PET/CT by physicians who treat head and neck cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Physicians; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2020 |
[FDG-PET/CT for exclusion of cervical lymph node metastases in clinically N0 head and neck tumors].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
[18F-FDG PET/CT in head and neck tumors].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2020 |
The importance of FDG-PET/CT parameters for the assessment of the immune status in advanced HNSCC.
Topics: Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; C-Reactive Protein; Female; Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Inflammation; Lactic Acid; Leukocyte Count; Lymphocyte Count; Macrophages; Male; Middle Aged; Monocytes; Neutrophils; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Cell Surface; Squamous Cell Carcinoma of Head and Neck | 2020 |
Intra-parotid lymph node metastasis in patients with non-cutaneous head and neck cancers: clinical and imaging features for differentiation from simultaneous parotid primary tumor.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Post-treatment FDG PET-CT in head and neck carcinoma: comparative analysis of 4 qualitative interpretative criteria in a large patient cohort.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Young Adult | 2020 |
Diagnostic value of navigation-guided core needle biopsy in deep regions of the head and neck with focal FDG uptake on
Topics: Biopsy, Large-Core Needle; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
A convolutional neural network-based system to classify patients using FDG PET/CT examinations.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Artificial Intelligence; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neural Networks, Computer; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Thoracic Neoplasms; Young Adult | 2020 |
Application of integrated positron emission tomography/magnetic resonance imaging in evaluating the prognostic factors of head and neck squamous cell carcinoma with positron emission tomography, diffusion-weighted imaging, dynamic contrast enhancement and
Topics: Carcinoma, Squamous Cell; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2020 |
Transcriptomics in cancer revealed by Positron Emission Tomography radiomics.
Topics: Adult; Aged; Cell Cycle; DNA Repair; Extracellular Matrix; Female; Fluorodeoxyglucose F18; Gene Expression; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Signal Transduction; Tomography, X-Ray Computed; Transcriptome | 2020 |
Effect of machine learning re-sampling techniques for imbalanced datasets in
Topics: Cohort Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Machine Learning; Progression-Free Survival | 2020 |
Evaluation of radiation treatment volumes for unknown primaries of the head and neck in the era of FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiation Dosage; Survival Analysis; Treatment Outcome | 2020 |
FDG-PET/CT scan assessment of response 12 weeks post radical radiotherapy in oropharynx head and neck cancer: The impact of p16 status.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharynx; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer.
Topics: Aged; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Squamous Cell Carcinoma of Head and Neck | 2020 |
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Genetic Testing; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
Primary vs nodal site PET/CT response as a prognostic marker in oropharyngeal squamous cell carcinoma treated with intensity-modulated radiation therapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
Comparative cohort study of volumetric modulated arc therapy for squamous cell cancer of unknown primary in the head and neck-Involved neck only versus mucosal irradiation.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucositis; Neoplasms, Unknown Primary; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Xerostomia | 2020 |
Investigating the Reliability of Fluorodeoxyglucose 18 Positive Emission Tomography-Computed Tomography Detection of Regional Lymph Node Metastasis in Head and Neck Malignancy.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Diagnostic Accuracy and Confidence of [18F] FDG PET/MRI in comparison with PET or MRI alone in Head and Neck Cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2020 |
Multisite Technical and Clinical Performance Evaluation of Quantitative Imaging Biomarkers from 3D FDG PET Segmentations of Head and Neck Cancer Images.
Topics: Bayes Theorem; Biomarkers, Tumor; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Reproducibility of Results; Tomography, X-Ray Computed | 2020 |
Positron Emission Tomography-Computed Tomography Surveillance after (Chemo)Radiotherapy in Advanced Head and Neck Squamous Cell Cancer: Beyond the PET-NECK Protocol.
Topics: Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate | 2020 |
Prospective evaluation of the impact of human papilloma virus status and small node size on the diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for primary head and neck squamous cell carcinoma.
Topics: Alphapapillomavirus; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Papillomaviridae; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2020 |
Letter to editor regarding Urban et al., FDG-PET/CT scan assessment of response 12 weeks post radical radiotherapy in oropharynx head and neck cancer: The impact of p16 status.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharynx; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
FDG-PET/CT Radiomics Models for The Early Prediction of Locoregional Recurrence in Head and Neck Cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
Feasibility of Multiparametric Positron Emission Tomography/Magnetic Resonance Imaging as a One-Stop Shop for Radiation Therapy Planning for Patients with Head and Neck Cancer.
Topics: Deep Learning; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neural Networks, Computer; Patient Positioning; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Computer-Assisted; Tomography, X-Ray Computed | 2020 |
Adherence to pretreatment and intratreatment imaging of head and neck squamous cell carcinoma patients undergoing (chemo) radiotherapy in a research setting.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2021 |
Prediction of survival outcome based on clinical features and pretreatment
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2020 |
Circulating tumor HPV DNA complements PET-CT in guiding management after radiotherapy in HPV-related squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Circulating Tumor DNA; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human papillomavirus 16; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Papillomavirus Infections; Positron Emission Tomography Computed Tomography | 2021 |
Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
Topics: Adult; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2020 |
Risk assessment of osteoradionecrosis associated with periodontitis using
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Osteoradionecrosis; Periodontitis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Assessment | 2020 |
Predictive value of suvmax changes between two sequential post-therapeutic FDG-pet in head and neck squamous cell carcinomas.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Topics: Biomarkers; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2021 |
Prevalence of hypoxia and correlation with glycolytic metabolism and angiogenic biomarkers in metastatic colorectal carcinoma.
Topics: Biomarkers; Colorectal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Misonidazole; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals | 2021 |
FDG-PET/CT and Pathology in Newly Diagnosed Head and Neck Cancer: ACRIN 6685 Trial, FDG-PET/CT cN0.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Young Adult | 2021 |
Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer.
Topics: Cell Hypoxia; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Inflammation; Misonidazole; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tumor Hypoxia | 2021 |
Positron emission tomography for radiotherapy planning in head and neck cancer: What impact?
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiotherapy Planning, Computer-Assisted | 2021 |
Response Evaluation Criteria in Solid Tumors (RECIST) and PET Response Criteria in Solid Tumors (PERCIST) for response evaluation of the neck after chemoradiotherapy in head and neck squamous cell carcinoma.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2021 |
Texture Analysis Using Preoperative Positron Emission Tomography Images May Predict the Prognosis of Patients With Resectable Oral Squamous Cell Carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2021 |
Diagnostic performance of 18F-FDG PET/CT for the detection of occult primary tumors in squamous cell carcinoma of unknown primary in the head and neck: a single-center retrospective study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity | 2021 |
Prognostic value of 18F-FDG PET/MRI in patients with advanced oropharyngeal and hypopharyngeal squamous cell carcinoma.
Topics: Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Tumor Burden | 2021 |
Comparison of three freeware software packages for
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Radiographic Image Enhancement; Software Validation | 2021 |
Elective neck dissection versus positron emission tomography-computed tomography-guided management of the neck in clinically node-negative early oral cavity cancer: A cost-utility analysis.
Topics: Cost-Benefit Analysis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Neck Dissection; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
Comparison Between the Maximum Standard Uptake Value and the Ratio of Lymph Node to Primary Tumor Attenuation in Head and Neck Cancers: A Prospective Study.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Prospective Studies | 2021 |
F-18 FDG PET-CT for response evaluation in head and neck malignancy: Experience from a tertiary level hospital in south India.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; India; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tertiary Care Centers; Treatment Outcome; Young Adult | 2021 |
Herpes zoster reactivation during head and neck cancer therapy: interpreting post-treatment positron emission tomography/CT imaging.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Herpes Zoster; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
FDG-PET-CT/MRI in head and neck squamous cell carcinoma: Impact on pretherapeutic N classification, detection of distant metastases, and second primary tumors.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2021 |
Intratumor heterogeneity is biomarker specific and challenges the association with heterogeneity in multimodal functional imaging in head and neck squamous cell carcinoma.
Topics: Biomarkers; Biomarkers, Tumor; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2021 |
The Utility of Ultrasonography in the Diagnosis of Cervical Lymph Nodes after Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Ultrasonography | 2021 |
Predicting tumor response and prognosis to neoadjuvant chemotherapy in esophageal squamous cell carcinoma patients using PERCIST: a multicenter study in Japan.
Topics: Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Japan; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
Deep Learning for Fully Automated Prediction of Overall Survival in Patients with Oropharyngeal Cancer Using FDG-PET Imaging.
Topics: Cohort Studies; Deep Learning; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Survival Rate | 2021 |
Adding value to tumor staging in head and neck cancer: The role of metabolic parameters as prognostic factors.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2021 |
FDG-PET/CT identified distant metastases and synchronous cancer in squamous cell carcinoma of the head and neck: the impact of smoking and P16-s.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Smoking; Squamous Cell Carcinoma of Head and Neck | 2022 |
Primary Intraosseous Squamous Cell Carcinoma of the Mandible Mimicking Inflammation on FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Inflammation; Male; Mandible; Middle Aged; Positron Emission Tomography Computed Tomography | 2022 |
Correlation between 18F-FDG PET/CT and diffusion-weighted MRI parameters in head and neck squamous cell carcinoma at baseline and after chemo-radiotherapy. A retrospective single institutional study.
Topics: Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Beyond the
Topics: Carcinoma, Squamous Cell; Electrons; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck | 2022 |
Surveillance Imaging Following Head and Neck Cancer Treatment and Microvascular Reconstruction.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Microsurgery; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
The ability of post-chemoradiotherapy DWI ADC
Topics: Aged; Cell Transformation, Viral; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Squamous Cell Carcinoma of Head and Neck; Time Factors; Treatment Outcome | 2021 |
Two Cases of Epstein-Barr Virus-Positive Mucocutaneous Ulcer Mimicking Head and Neck Cancers in 18F-FDG PET/CT.
Topics: Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Herpesvirus 4, Human; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Ulcer | 2022 |
Mid-treatment Fluorodeoxyglucose Positron Emission Tomography in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma Treated with Primary Radiotherapy: Nodal Metabolic Response Rate can Predict Treatment Outcomes.
Topics: Alphapapillomavirus; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2021 |
Value of [18F]FDG PET-CT in the follow-up of surgically treated oral tongue squamous cell carcinoma: single centre cohort analysis on 87 patients.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2021 |
Unknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy.
Topics: Aged; Analysis of Variance; Carcinoma, Squamous Cell; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Netherlands; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome | 2017 |
Hybrid PET/MRI-based delineation of gross tumor volume in head and neck cancer and tumor parameter analysis.
Topics: Adult; Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tumor Burden | 2017 |
Detection of residual head and neck squamous cell carcinoma after (chemo)radiotherapy: a pilot study assessing the value of diffusion-weighted magnetic resonance imaging as an adjunct to PET-CT using
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm, Residual; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2017 |
Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate | 2017 |
Comparison of dose distribution for head and neck cancer patients with and without dose painting escalation during radiotherapy realized with tomotherapy unit.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiation Dosage; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tumor Burden | 2017 |
The impact of image reconstruction settings on 18F-FDG PET radiomic features: multi-scanner phantom and patient studies.
Topics: Adult; Aged; Algorithms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Tumor Metabolic Features Identified by
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gene Regulatory Networks; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tumor Microenvironment; Young Adult | 2018 |
Evaluation of clinical target volume expansion required for involved site neck radiotherapy for lymphoma to account for the absence of a pre-chemotherapy PET-CT in the radiotherapy treatment position.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma; Male; Middle Aged; Observer Variation; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Young Adult | 2017 |
Preoperative
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2017 |
The clinical outcome correlations between radiation dose and pretreatment metabolic tumor volume for radiotherapy in head and neck cancer: A retrospective analysis.
Topics: Adult; Aged; Chemoradiotherapy; Disease-Free Survival; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiometry; Radiotherapy Dosage; Retrospective Studies; Treatment Outcome; Tumor Burden | 2017 |
Multiparametric magnetic resonance imaging in mucosal primary head and neck cancer: a prospective imaging biomarker study.
Topics: Biomarkers; Clinical Protocols; Combined Modality Therapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Mucous Membrane; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Treatment Outcome | 2017 |
Role of FDG PET/CT Scan in Head and Neck Cancer Patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iran; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Young Adult | 2017 |
18F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2017 |
Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Treatment Failure; Tumor Burden | 2017 |
Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2018 |
18F-Fluorodeoxyglucose-PET/CT in locally advanced head and neck cancer can influence the stage migration and nodal radiation treatment volumes.
Topics: Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2017 |
Spinal Metastasis Characterized on FDG PET/CT in Head and Neck Squamous Cell Carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Spinal Neoplasms | 2017 |
The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer.
Topics: Biomarkers, Tumor; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Treatment Outcome | 2018 |
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Logistic Models; Male; Middle Aged; Parotid Gland; Positron-Emission Tomography; Predictive Value of Tests; Radiation Injuries; Xerostomia; Young Adult | 2018 |
Differential Prognostic Value of Metabolic Heterogeneity of Primary Tumor and Metastatic Lymph Nodes in Patients with Pharyngeal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Time Factors; Treatment Outcome; Young Adult | 2017 |
Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Peripheral Nervous System Neoplasms; Pilot Projects; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2018 |
Post-radiochemotherapy PET radiomics in head and neck cancer - The influence of radiomics implementation on the reproducibility of local control tumor models.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Prognosis; Reproducibility of Results; Squamous Cell Carcinoma of Head and Neck | 2017 |
Up-front PET/CT changes treatment intent in patients with head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Decision Making; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Palliative Care; Patient Care Team; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2018 |
Incidental Findings on FDG PET/CT in Head and Neck Cancer.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Wisconsin | 2018 |
Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2018 |
Invited editorial for the paper by Silvoniemi et al. "Repeatability of tumor hypoxia imaging using [
Topics: Etanidazole; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Hypoxia | 2018 |
Optimal transformations leading to normal distributions of positron emission tomography standardized uptake values.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Normal Distribution; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Diagnostic accuracy of
Topics: Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Misonidazole; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tumor Hypoxia | 2018 |
Associations of Tumor PD-1 Ligands, Immunohistochemical Studies, and Textural Features in
Topics: B7-H1 Antigen; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Programmed Cell Death 1 Receptor; Reproducibility of Results; ROC Curve; Squamous Cell Carcinoma of Head and Neck | 2018 |
Utility of 3-Month Surveillance F-18 FDG PET/CT in Surgically Resected Oral Squamous Cell Carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Dimensional Measurement Accuracy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iowa; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Surgical Procedures, Operative; Tomography, X-Ray Computed | 2018 |
Succinate Dehydrogenase B Subunit-Negative Jugular Foramen Paraganglioma Manifesting Malignant Progression with Pseudohypoxia-Related Atypical Uptake of [
Topics: Biomarkers, Tumor; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia, Brain; Middle Aged; Paraganglioma; Protein Subunits; Skull Base; Succinate Dehydrogenase | 2018 |
Value of PET/CT 3D visualization of head and neck squamous cell carcinoma extended to mandible.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Male; Mandible; Mandibular Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography | 2018 |
FDG-PET metabolic tumor parameters for the reirradiation of recurrent head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Re-Irradiation; Retrospective Studies; Survival Rate; Treatment Outcome | 2018 |
Assessment of image quality of a radiotherapy-specific hardware solution for PET/MRI in head and neck cancer patients.
Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Patient Positioning; Positron-Emission Tomography; Prospective Studies | 2018 |
Detection of loco-regional recurrence in malignant head and neck tumors: a comparison of CT, MRI, and FDG PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2019 |
Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Young Adult | 2018 |
Quantifying the robustness of [
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2018 |
Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of
Topics: Adult; Aged; Cervical Cord; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Regression Analysis; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2019 |
Unexpected positron emission tomography/computed tomography uptake in benign dermal naevus.
Topics: Aged; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Nevus; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Scalp; Skin Neoplasms | 2019 |
PET-based prognostic survival model after radiotherapy for head and neck cancer.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies | 2019 |
Relationships between histogram analysis of ADC values and complex 18F-FDG-PET parameters in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2018 |
A smart and operator independent system to delineate tumours in Positron Emission Tomography scans.
Topics: Algorithms; Brain Neoplasms; Diagnosis, Computer-Assisted; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Neoplasm Metastasis; Neoplasms; Observer Variation; Pattern Recognition, Automated; Phantoms, Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Software; Tomography, X-Ray Computed | 2018 |
Topics: Adult; Aged; Aged, 80 and over; Enteral Nutrition; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Time Factors; Treatment Outcome; Tumor Burden; Young Adult | 2019 |
Palatine tonsil SUVmax on FDG PET-CT as a discriminator between benign and malignant tonsils in patients with and without head and neck squamous cell carcinoma of unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Palatine Tonsil; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2019 |
Incidental findings on 18-FDG PET-CT in head and neck cancer. A retrospective case-control study of incidental findings on 18-FDG PET-CT in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2019 |
Prognostic value of textural indices extracted from pretherapeutic 18-F FDG-PET/CT in head and neck squamous cell carcinoma.
Topics: Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2019 |
The Impact of a Stepwise Approach to Primary Tumor Detection in Squamous Cell Carcinoma of the Neck With Unknown Primary.
Topics: Aged; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngoscopy; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Robotic Surgical Procedures; Survival Rate; Tonsillectomy | 2019 |
Accurate, robust and harmonized implementation of morpho-functional imaging in treatment planning for personalized radiotherapy.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Precision Medicine; Radiographic Image Interpretation, Computer-Assisted; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2019 |
Visceral adipose tissue volume and CT-attenuation as prognostic factors in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Intra-Abdominal Fat; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Young Adult | 2019 |
Tumor Voxel Dose-Response Matrix and Dose Prescription Function Derived Using
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Dose-Response Relationship, Radiation; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Radiation Tolerance; Radiopharmaceuticals; Radiotherapy Dosage | 2019 |
Prospective evaluation of pretreatment and intratreatment FDG PET-CT SUV stability in primary head and neck cancer.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2019 |
Clinical Utility of Pretreatment and 3-Month
Topics: Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2019 |
Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; New South Wales; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2019 |
Voxel based comparison and texture analysis of 18F-FDG and 18F-FMISO PET of patients with head-and-neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiation Tolerance; Radiopharmaceuticals; Tumor Hypoxia | 2019 |
Comparison of subjective evaluation versus objective algorithm in the interpretation of follow-up FDG-PET/CT scans after radiochemotherapy in head and neck cancer patients.
Topics: Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies | 2019 |
Inter-observer and segmentation method variability of textural analysis in pre-therapeutic FDG PET/CT in head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; Signal-To-Noise Ratio; Software | 2019 |
Correlation between tumour biology status measured in triple-tracer 18F-fluorodeoxyglucose-18F-fluorothymidine- 18F-fluoromisonidazole-PET/CT study and human papillomavirus status in patients with head and neck cancer.
Topics: Aged; Aged, 80 and over; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Misonidazole; Papillomaviridae; Positron Emission Tomography Computed Tomography; Radioactive Tracers | 2019 |
Workup of Suspected Chest Metastases on
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Patient Care Planning; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thorax; Time-to-Treatment; United States | 2019 |
FDG PET based prediction of response in head and neck cancer treatment: Assessment of new quantitative imaging features.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Retrospective Studies; Young Adult | 2019 |
FDG PET/CT for metastatic squamous cell carcinoma of unknown primary of the head and neck.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Positron Emission Tomography/Computed Tomography in Evaluation of the Clinically N0 Neck in Head and Neck Squamous Cell Carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Squamous Cell Carcinoma of Head and Neck | 2019 |
Preparing data for multiparametric PET/MR imaging: Influence of PET point spread function modelling and EPI distortion correction on the spatial correlation of [
Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Multimodal Imaging; Positron-Emission Tomography | 2019 |
The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Tumor Burden | 2019 |
Cystic form of cervical lymphadenopathy. Guidelines of the French Society of Otorhinolaryngology - Head and Neck Surgery (SFORL). Part 1: Diagnostic procedures for lymphadenopathy in case of cervical mass with cystic aspect.
Topics: Adult; Biopsy, Fine-Needle; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image-Guided Biopsy; Lymphadenopathy; Magnetic Resonance Imaging; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2019 |
PET/CT prior to salvage surgery in recurrent head and neck squamous cell carcinoma.
Topics: Antineoplastic Protocols; Bone Neoplasms; Denmark; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2019 |
Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer from Ontario and guidelines in general--some observations.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Physiologic [18F]fluorodeoxyglucose uptake of floor of mouth muscles in PET/CT imaging: a problem of body position during FDG uptake?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mouth Floor; Multimodal Imaging; Muscles; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Supine Position; Tomography, X-Ray Computed | 2013 |
18F-FDG-PET/CT for the assessment of the contralateral neck in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2013 |
Can (18)F-FDG PET/CT reliably assess response to primary treatment of head and neck cancer?
Topics: Adult; Aged; Aged, 80 and over; False Negative Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2013 |
Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Differentiation; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Observer Variation; Radionuclide Imaging; Recurrence; Reproducibility of Results; Retrospective Studies; Young Adult | 2013 |
Does fluorodeoxyglucose PET add to the management of the neck following curative radiotherapy in head and neck cancer compared with computed tomography?
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neck; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Improvement in the detection of locoregional recurrence in head and neck malignancies: F-18 fluorodeoxyglucose-positron emission tomography/computed tomography compared to high-resolution contrast-enhanced computed tomography and endoscopic examination.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Endoscopy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2013 |
Subcentimeter tumor lesion delineation for high-resolution 18F-FDG PET images: optimizing correction for partial-volume effects.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Phantoms, Imaging; Positron-Emission Tomography; Tumor Burden | 2013 |
Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Alphapapillomavirus; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human papillomavirus 16; Humans; In Situ Hybridization; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 2014 |
Clinicopathological determinants of positron emission tomography computed tomography fluorodeoxyglucose standardised uptake value in head and neck carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2013 |
PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient.
Topics: Adult; Aged; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Survival Analysis; Tomography, X-Ray Computed | 2013 |
Deformation field validation and inversion applied to adaptive radiation therapy.
Topics: Algorithms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Phantoms, Imaging; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Reproducibility of Results; Tomography, X-Ray Computed | 2013 |
Functional imaging to monitor vascular and metabolic response in canine head and neck tumors during fractionated radiotherapy.
Topics: Animals; Cone-Beam Computed Tomography; Dog Diseases; Dogs; Dose Fractionation, Radiation; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated | 2013 |
A strategy for multimodal deformable image registration to integrate PET/MR into radiotherapy treatment planning.
Topics: Algorithms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Tomography, X-Ray Computed | 2013 |
Value of retrospective image fusion of ¹⁸F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Diagnostic accuracy of ultrasound, ¹⁸F-FDG-PET/CT, and fused ¹⁸F-FDG-PET-MR images with DWI for the detection of cervical lymph node metastases of HNSCC.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Prospective Studies; Radiography; Radionuclide Imaging; Ultrasonography | 2014 |
Outcomes after primary chemoradiotherapy for N3 (>6 cm) head and neck squamous cell carcinoma after an FDG-PET--guided neck management policy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2014 |
The added value of 18F-fluorodeoxyglucose positron emission tomography computed tomography in patients with neck lymph node metastases from an unknown primary malignancy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Standardized uptake value and resection margin involvement predict outcomes in pN0 head and neck cancer.
Topics: Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Time Factors | 2013 |
Pathology-based validation of FDG PET segmentation tools for volume assessment of lymph node metastases from head and neck cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Prognostic value of preoperative 18F-FDG PET/CT for primary head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymph Nodes; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Multivariate Analysis; Neck; Pharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Young Adult | 2014 |
No benefit in staging fluorodeoxyglucose-positron emission tomography in clinically node-negative head and neck cutaneous melanoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms | 2014 |
PET imaging of tumor hypoxia using 18F-labeled pimonidazole.
Topics: Animals; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Mice, Nude; Nitroimidazoles; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tumor Cells, Cultured | 2013 |
Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; Young Adult | 2013 |
Correlation between tumor oxygenation and 18F-fluoromisonidazole PET data simulated based on microvessel images.
Topics: Animals; Carcinoma, Squamous Cell; Computer Simulation; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mice; Microvessels; Misonidazole; Oxygen; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tumor Cells, Cultured | 2013 |
Predictive value of pre-therapy (18)F-FDG PET/CT for the outcome of (18)F-FDG PET-guided radiotherapy in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Endpoint Determination; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiotherapy, Image-Guided; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
Comparison of PET imaging with 64Cu-liposomes and 18F-FDG in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch model of oral dysplasia and squamous cell carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Brain; Carcinoma, Squamous Cell; Copper Radioisotopes; Cricetinae; Disease Models, Animal; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Heart; Liposomes; Mouth Neoplasms; Positron-Emission Tomography | 2014 |
Early detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Early Diagnosis; Endoscopy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Squamous Cell; Positron-Emission Tomography; Radiography; Survival Analysis | 2013 |
Is FDG -PET-CT a valuable tool in prediction of persistent disease in head and neck cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2013 |
Addition of 18F-FDG PET/CT to clinical assessment predicts overall survival in HNSCC: a retrospective analysis with follow-up for 12 years.
Topics: Adult; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neoplasms, Squamous Cell; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Time Factors; Tomography, X-Ray Computed | 2013 |
Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
A study on the artifacts generated by dental materials in PET/CT image.
Topics: Adult; Artifacts; Dental Implants; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Correlation of (18)F-fluoromisonidazole PET findings with HIF-1α and p53 expressions in head and neck cancer: comparison with (18)F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Tumor Suppressor Protein p53 | 2014 |
Sarcoidosis mimicking metastatic bone disease in head and neck cancer.
Topics: Adenocarcinoma, Clear Cell; Adult; Bone Neoplasms; Diagnosis, Differential; Ethmoid Sinus; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
(18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Young Adult | 2013 |
Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Detection of extranodal spread in head and neck cancer with [18F]FDG PET and MRI: improved accuracy?
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2015 |
18F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Child; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Genotype; Head and Neck Neoplasms; Humans; Male; Membrane Proteins; Middle Aged; Mitochondrial Proteins; Multimodal Imaging; Multivariate Analysis; Neoplastic Syndromes, Hereditary; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Radiopharmaceuticals; Succinate Dehydrogenase; Tomography, X-Ray Computed; Von Hippel-Lindau Tumor Suppressor Protein; Young Adult | 2014 |
18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iohexol; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Uncertainty in measurements of ¹⁸F blood concentration and its effect on simplified dynamic PET analysis.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Uncertainty | 2014 |
An alternative approach to histopathological validation of PET imaging for radiation therapy image-guidance: a proof of concept.
Topics: Animals; Autoradiography; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Mice; Mice, Nude; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided | 2014 |
Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 2014 |
Prognostic value of (18)F-fluorodeoxyglucose uptake before treatment for pharyngeal cancer.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Pharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Survival Rate; Tomography, X-Ray Computed | 2014 |
Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Computer Simulation; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Induction Chemotherapy; Male; Middle Aged; Models, Biological; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Burden | 2014 |
PET/MRI and PET/CT in follow-up of head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2014 |
Reproducibility of FDG PET based metabolic tumor volume measurements and of their FDG distribution within.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2015 |
Radiotherapy response in head and neck cancer - evaluation of the primary tumour site.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Endoscopy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Comparative dosimetry of three-phase adaptive and non-adaptive dose-painting IMRT for head-and-neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2014 |
FDG PET/MR for lymph node staging in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2014 |
Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
Topics: Aged; Carcinoma, Squamous Cell; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Prognostic value of 18F-fludeoxyglucose uptake in 287 patients with head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cohort Studies; Denmark; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hospitals, University; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome | 2015 |
Diagnosis of squamous cell carcinoma metastasis with 18F-FDG PET/CT in stoma after percutaneous endoscopic gastrostomy: a rare and poorly known iatrogenic cause of spread of head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Gastrostomy; Head and Neck Neoplasms; Humans; Iatrogenic Disease; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Surgical Stomas; Tomography, X-Ray Computed | 2014 |
Positron emission tomography and stage migration in head and neck cancer.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models | 2014 |
Early treatment response monitoring using 2-deoxy-2-[ 18F]fluoro-D-glucose positron emission tomography imaging during fractionated radiotherapy of head neck cancer xenografts.
Topics: Animals; Cell Line, Tumor; Dose Fractionation, Radiation; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Heterografts; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Xenograft Model Antitumor Assays | 2014 |
Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cone-Beam Computed Tomography; Cyclin-Dependent Kinase Inhibitor p16; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Tomography, X-Ray Computed; Tumor Suppressor Protein p53 | 2015 |
Prognostic value of tumour blood flow, [¹⁸F]EF5 and [¹⁸F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy.
Topics: Adult; Aged; Chemoradiotherapy; Etanidazole; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hydrocarbons, Fluorinated; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Survival Analysis; Tomography, X-Ray Computed; Young Adult | 2014 |
Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2014 |
Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Proportional Hazards Models; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Interpretation of suspect head and neck fixations seen on PET/CT in lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2014 |
Should We Routinely Investigate Incidental Head and Neck Findings on 18-Fluorodeoxyglucose Positron Emission Tomography in Patients Being Staged for Non-small Cell Lung Cancer? A Retrospective Analysis.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lung Neoplasms; Male; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2015 |
Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
Generation of prescriptions robust against geometric uncertainties in dose painting by numbers.
Topics: Algorithms; Carcinoma, Squamous Cell; Confidence Intervals; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasms; Normal Distribution; Positron-Emission Tomography; Prescriptions; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Uncertainty | 2015 |
Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
Interim FDG PET/CT for predicting the outcome in patients with head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma.
Topics: Biomarkers, Tumor; Biopsy; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2014 |
Impact of initial FDG PET/CT in the management plan of patients with locally advanced head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease Management; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
The value of preoperative 18F-FDG PET/CT for the assessing contralateral neck in head and neck cancer patients with unilateral node metastasis (N1-3).
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Positron emission tomography combined with computed tomography for diagnosis of synchronous tumors.
Topics: Aged; Carcinoma, Neuroendocrine; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2015 |
Incidental focal FDG uptake in the parotid glands on PET/CT in patients with head and neck malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Incidental Findings; Male; Middle Aged; Parotid Gland; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2015 |
Efficiency of three-dimensional Doppler ultrasonography in assessing nodal metastasis of head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Comparative Effectiveness Research; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neck; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2015 |
Association between the standardized uptake value and high-risk HPV in hypopharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Papillomavirus Infections; Positron-Emission Tomography; Preoperative Care; Proportional Hazards Models; Retrospective Studies; Risk Assessment; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2014 |
Early response monitoring with 18F-FDG PET and cetuximab-F(ab')2-SPECT after radiotherapy of human head and neck squamous cell carcinomas in a mouse model.
Topics: Animals; Antibodies, Monoclonal, Humanized; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Disease Models, Animal; ErbB Receptors; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Immunoglobulin Fragments; Immunohistochemistry; Mice; Mice, Inbred BALB C; Multimodal Imaging; Neoplasm Transplantation; Positron-Emission Tomography; Radiotherapy; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Papillomaviridae; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Tumor Burden | 2014 |
First clinical results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.
Topics: Adult; Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Inflammation; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2014 |
Influence of partial volume correction in staging of head and neck squamous cell carcinoma using PET/CT.
Topics: Aged; Algorithms; Artifacts; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Glucose metabolism gene expression patterns and tumor uptake of ¹⁸F-fluorodeoxyglucose after radiation treatment.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Gene Expression; Glucose; Glucose Transporter Type 1; Head and Neck Neoplasms; Heterografts; Hexokinase; Immunohistochemistry; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation; RNA, Messenger; Tumor Burden | 2014 |
Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2016 |
Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-¹¹C]-thiothymidine with 2-deoxy-2-¹⁸F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Ki-67 Antigen; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Squamous Cell Carcinoma of Head and Neck; Thionucleosides; Thymidine; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Diagnostic value of retrospective PET-MRI fusion in head-and-neck cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2014 |
Increased evidence for the prognostic value of primary tumor asphericity in pretherapeutic FDG PET for risk stratification in patients with head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET.
Topics: Biomarkers; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Immunohistochemistry; Neoplasm Grading; Neoplasm Staging; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Burden | 2014 |
[18F]-FDG PET-CT prediction of response to induction chemotherapy in head and neck squamous cell carcinoma: preliminary findings.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
The role of tonsillectomy in the initial diagnostic work-up of head and neck squamous cell carcinoma of unknown primary.
Topics: Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Diseases; Male; Middle Aged; Neoplasm Invasiveness; Neoplasms, Unknown Primary; Palatine Tonsil; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tonsillectomy | 2014 |
Early prediction of response to cetuximab and radiotherapy by FDG-PET/CT for the treatment of a locoregionally advanced squamous cell carcinoma of the hypopharynx.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2014 |
Correlation of (18)F-BPA and (18)F-FDG uptake in head and neck cancers.
Topics: Adult; Aged; Boron Compounds; Boron Neutron Capture Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Phenylalanine; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Multimodal imaging analysis of an orthotopic head and neck cancer mouse model and application of anti-CD137 tumor immune therapy.
Topics: 4-1BB Ligand; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Immunohistochemistry; Immunotherapy; Longitudinal Studies; Magnetic Resonance Imaging; Mice; Mice, Inbred C3H; Mouth Neoplasms; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Squamous Cell Carcinoma of Head and Neck | 2016 |
The prognostic utility of (18)F-FDG-PET metabolic tumor response after chemoradiotherapy for locally advanced head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Prognosis | 2015 |
Pretreatment maximum standardized uptake value of (18)F-fluorodeoxyglucose positron emission tomography as a predictor of distant metastasis in adenoid cystic carcinoma of the head and neck.
Topics: Adult; Aged; Carcinoma, Adenoid Cystic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Analysis; Young Adult | 2016 |
Single-cycle induction chemotherapy followed by chemoradiotherapy or surgery in patients with head and neck cancer: what are the best predictors of remission and prognosis?
Topics: Chemoradiotherapy; Endoscopy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Surgical Procedures, Operative; Survival Analysis; Tomography, Spiral Computed; Treatment Outcome | 2015 |
Prognostic value comparison between (18)F-FLT PET/CT and (18)F-FDG PET/CT volume-based metabolic parameters in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Pretreatment screening on distant metastases and head and neck cancer patients: Validation of risk factors and influence on survival.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed | 2015 |
Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Role of PET/CT in treatment planning for head and neck cancer patients undergoing definitive radiotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2014 |
Risk stratification of metastatic neck nodes by CT and PET in patients with head and neck cancer receiving definitive radiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease-Free Survival; Drug Therapy; Female; Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Risk; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Reproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR.
Topics: Adult; Aged; Algorithms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2015 |
Correlation between 18F-FDG-uptake and in vitro chemosensitivity of cisplatin in head and neck cancer.
Topics: Antineoplastic Agents; Cisplatin; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospecti
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Inflammation; Lymph Nodes; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Regression Analysis; Solitary Pulmonary Nodule; Statistics, Nonparametric; Time Factors; Tomography, X-Ray Computed | 2015 |
Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Population Surveillance; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
18FDG SUV in the primary tumor and lymph node metastases is not predictive for development of distant metastases in high risk head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Body Mass Index; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Radionuclide Imaging; Retrospective Studies | 2015 |
Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.
Topics: Adult; Aged; Blood Glucose; Chemoradiotherapy; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Phenotype; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Safety and cost analysis of an (18)FDG-PET-CT response based follow-up strategy for head and neck cancers treated with primary radiation or chemoradiation.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hospital Costs; Humans; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2015 |
Long-term results of survival analysis after a 5-year follow-up: Efficacy of fluoro-2-deoxy-D-glucose positron emission tomography to evaluate responses to concurrent chemoradiotherapy for head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2015 |
Untreated Hodgkin Lymphoma With Skin Infiltration and Satellite Skin Nodule in a 15-Year-Old Female Adolescent.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hodgkin Disease; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed; Vinblastine | 2015 |
Detection of subclinical recurrence or second primary cancer using (18) F-FDG PET/CT in patients treated curatively for head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2016 |
Prognostic evaluation of percentage variation of metabolic tumor burden calculated by dual-phase (18) FDG PET-CT imaging in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphoma; Male; Melanoma; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2015 |
Feasibility and robustness of dose painting by numbers in proton therapy with contour-driven plan optimization.
Topics: Carcinoma, Squamous Cell; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Organs at Risk; Oropharyngeal Neoplasms; Pattern Recognition, Automated; Positron-Emission Tomography; Proton Therapy; Protons; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tomography, X-Ray Computed | 2015 |
Clinical Assessment of Emission- and Segmentation-Based MR-Guided Attenuation Correction in Whole-Body Time-of-Flight PET/MR Imaging.
Topics: Algorithms; Body Mass Index; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Likelihood Functions; Magnetic Resonance Imaging; Middle Aged; Models, Statistical; Multimodal Imaging; Normal Distribution; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
The diagnosis of parotid lesions.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Male; Parotid Gland; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Optimal timing of first posttreatment FDG PET/CT in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Failure; Young Adult | 2016 |
Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Simultaneous PET/MR head-neck cancer imaging: Preliminary clinical experience and multiparametric evaluation.
Topics: Diffusion Magnetic Resonance Imaging; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
[Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
Topics: Adult; Aged; Aged, 80 and over; Cancer Care Facilities; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hungary; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2015 |
An Adaptive Thresholding Method for BTV Estimation Incorporating PET Reconstruction Parameters: A Multicenter Study of the Robustness and the Reliability.
Topics: Algorithms; Computational Biology; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Linear Models; Models, Statistical; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2015 |
Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated | 2016 |
Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Prognostic role of metabolic parameters of (18)F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parotid Gland; Positron-Emission Tomography; Prospective Studies; Radiometry; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
The Effects of Pulsed Radiation Therapy on Tumor Oxygenation in 2 Murine Models of Head and Neck Squamous Cell Carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Coloring Agents; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Heterografts; Mice; Mice, Nude; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles; Oxygen Consumption; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2015 |
Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2015 |
Positron emission tomography-computed tomography can be useful in the early detection of metastases in primary mucinous carcinoma of the skin on the head and neck.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Contrast Media; Face; Female; Fluorodeoxyglucose F18; Head; Head and Neck Neoplasms; Humans; Image Enhancement; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2016 |
Imaging of tumour hypoxia and metabolism in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Image Interpretation, Computer-Assisted; Imidazoles; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Triazoles | 2015 |
Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Immunohistochemical biomarkers and FDG uptake on PET/CT in head and neck squamous cell carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p16; ErbB Receptors; Fluorodeoxyglucose F18; Glutathione Transferase; Head and Neck Neoplasms; Humans; Immunohistochemistry; Ki-67 Antigen; Multimodal Imaging; Multivariate Analysis; Neoplasm Proteins; Positron-Emission Tomography; Proto-Oncogene Proteins c-bcl-2; Radiopharmaceuticals; Tomography, X-Ray Computed; Tubulin; Tumor Suppressor Protein p53 | 2015 |
Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2016 |
Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; ErbB Receptors; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Squamous Cell Carcinoma of Head and Neck | 2016 |
Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
The association of (18)F-FDG PET and glucose metabolism biomarkers GLUT1 and HK2 in p16 positive and negative head and neck squamous cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; ErbB Receptors; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Head and Neck Neoplasms; Human papillomavirus 16; Humans; Kinesins; Male; Middle Aged; Papillomavirus Infections; Positron-Emission Tomography; Prognosis; Treatment Outcome | 2015 |
Spatio-temporal stability of pre-treatment 18F-Fludeoxyglucose uptake in head and neck squamous cell carcinomas sufficient for dose painting.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed | 2015 |
Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm.
Topics: Adult; Aged; Algorithms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2016 |
Correlation between pretreatment FDG-PET biological target volume and location of T-site failure after definitive radiation therapy for head and neck cancers.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Treatment Failure; Tumor Burden | 2015 |
High glucose uptake unexpectedly is accompanied by high levels of the mitochondrial ß-F1-ATPase subunit in head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitochondria; Mitochondrial Proton-Translocating ATPases; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck | 2015 |
Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Comparing staging by positron emission tomography with contrast-enhanced computed tomography and by pathology in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Squamous Cell; Cohort Studies; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiographic Image Enhancement; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI.
Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Organometallic Compounds; Paraganglioma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Succinate Dehydrogenase; Tomography, X-Ray Computed | 2016 |
Quantitative and qualitative analysis of [(18)F]FDG and [(18)F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcome.
Topics: Adult; Aged; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nitroimidazoles; Papillomavirus Infections; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
The Correlations Between MRI Perfusion, Diffusion Parameters, and 18F-FDG PET Metabolic Parameters in Primary Head-and-Neck Cancer: A Cross-Sectional Analysis in Single Institute.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cross-Sectional Studies; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2015 |
Image findings of cranial nerve pathology on [18F]-2- deoxy-D-glucose (FDG) positron emission tomography with computerized tomography (PET/CT): a pictorial essay.
Topics: Adult; Aged; Cranial Nerve Neoplasms; Cranial Nerves; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Assessment of serial multi-parametric functional MRI (diffusion-weighted imaging and R2*) with (18)F-FDG-PET in patients with head and neck cancer treated with radiation therapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Tumor Burden | 2016 |
(18)F FDG PET/CT versus CT/MR Imaging and the Prognostic Value of Contralateral Neck Metastases in Patients with Head and Neck Squamous Cell Carcinoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
Topics: Carcinoma, Squamous Cell; Endoscopy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2016 |
Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma.
Topics: Animals; Antibodies, Monoclonal; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Immunoglobulin Fab Fragments; Mice; Mice, Inbred BALB C; Mice, Nude; Positron-Emission Tomography; Radioimmunodetection; Radiopharmaceuticals; Recombinant Proteins; Tissue Distribution | 2016 |
Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Young Adult | 2016 |
Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2015 |
The use of matrigel has no influence on tumor development or PET imaging in FaDu human head and neck cancer xenografts.
Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Collagen; Drug Combinations; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laminin; Mice; Mice, Nude; Neoplasm Transplantation; Positron-Emission Tomography; Proteoglycans; Radiography; Tumor Burden; Tumor Microenvironment | 2016 |
Pretreatment screening for distant metastases in the Dutch head and neck centers: 10 years later.
Topics: Attitude of Health Personnel; Carcinoma, Squamous Cell; Early Detection of Cancer; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Health Care Surveys; Humans; Neoplasm Metastasis; Netherlands; Positron Emission Tomography Computed Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Surgeons; Tomography, X-Ray Computed | 2016 |
Prognostic Value of 2-[(18)F] Fluoro-2-deoxy-D-glucose Positron Emission Tomography-Computed Tomography Scan Carried out During and After Radiation Therapy for Head and Neck Cancer Using Visual Therapy Response Interpretation Criteria.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2016 |
Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Young Adult | 2016 |
Analysis of pairwise correlations in multi-parametric PET/MR data for biological tumor characterization and treatment individualization strategies.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Precision Medicine | 2016 |
Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2016 |
Silicone Granuloma in the Buttocks Incidentally Detected by 18F-FDG PET/CT 30 Years After Free Liquid Silicone Injections.
Topics: Buttocks; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Granuloma; Head and Neck Neoplasms; Humans; Incidental Findings; Injections, Intramuscular; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Silicones; Squamous Cell Carcinoma of Head and Neck; Transgender Persons | 2016 |
FDG PET/CT in Patients With Head and Neck Squamous Cell Carcinoma After Primary Surgical Resection With or Without Chemoradiation Therapy.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2016 |
The proposed physiology-based FDG PET/CT criteria in reducing false-positive results in advanced head and neck cancer after chemoradiotherapy.
Topics: Adult; Aged; Chemoradiotherapy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies | 2018 |
Intensity modulated arc therapy implementation in a three phase adaptive (18)F-FDG-PET voxel intensity-based planning strategy for head-and-neck cancer.
Topics: Adult; Aged; Algorithms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Middle Aged; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Reproducibility of Results | 2016 |
Focal Inflammatory Myositis on 18F-FDG PET/CT.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Myositis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma | 2016 |
Modern Radiology in the Management of Head and Neck Cancer.
Topics: Carcinoma, Squamous Cell; Diagnostic Imaging; Disease Management; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
Assessment of the Tumor Redox Status in Head and Neck Cancer by 62Cu-ATSM PET.
Topics: Aged; Coordination Complexes; Copper Radioisotopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Organometallic Compounds; Oxidation-Reduction; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Thiosemicarbazones | 2016 |
Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
Topics: Aged; Carcinoma, Squamous Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2016 |
Simultaneous (18)F-FDG-PET/MRI: Associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2016 |
Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2016 |
In vivo spatial correlation between (18)F-BPA and (18)F-FDG uptakes in head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Role of perfusion CT in the evaluation of functional primary tumour response after radiochemotherapy in head and neck cancer: preliminary findings.
Topics: Blood Flow Velocity; Blood Volume; Chemoradiotherapy; Contrast Media; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2016 |
The Expression of Checkpoint and DNA Repair Genes in Head and Neck Cancer as Possible Predictive Factors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; DNA Damage; DNA Repair; Docetaxel; Down-Regulation; Female; Fluorodeoxyglucose F18; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Radiotherapy Dosage; Squamous Cell Carcinoma of Head and Neck; Taxoids; Up-Regulation | 2017 |
Should (18)F FDG PET/CT Really Be Indicated in Routine Clinical Practice for Detecting Contralateral Neck Node Metastasis in Head and Neck Squamous Cell Carcinoma?
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Synchronous or metachronous lymphoma and metastatic cutaneous squamous cell carcinoma in the head and neck region: a diagnostic and management dilemma.
Topics: Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Positron-Emission Tomography | 2016 |
Synchronous presentation of nasopharyngeal carcinoma and abdominal paraganglioma with avid 18F-FDG and 68Ga-DOTA-TOC uptake in PET/CT by both tumours.
Topics: Abdominal Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasms, Multiple Primary; Organometallic Compounds; Paraganglioma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tissue Distribution | 2016 |
[(18)F-FDG PET/CT: Image-guided surveillance in advanced head and neck cancer as an alternative to neck dissection].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neck Dissection; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Prognostic significance of clinical and
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Young Adult | 2016 |
Analysis of relation between hypoxia PET imaging and tissue-based biomarkers during head and neck radiochemotherapy.
Topics: Adult; Aged; Biomarkers, Tumor; Carbonic Anhydrase IX; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Immunohistochemistry; Ku Autoantigen; Male; Middle Aged; Misonidazole; Papillomavirus Infections; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Hypoxia | 2016 |
Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Dose painting by numbers based on retrospectively determined recurrence probabilities.
Topics: Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Probability; Radiotherapy Dosage; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2017 |
Clinical impact of
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Adenoid Cystic; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Radiographic Image Enhancement; Retrospective Studies; Risk Assessment; ROC Curve; Survival Analysis; Tomography, X-Ray Computed | 2017 |
The adverse impact of surveillance intervals on the sensitivity of FDG-PET/CT for the detection of distant metastases in head and neck cancer patients.
Topics: Adult; Aftercare; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2017 |
Glucose Metabolism and Its Complicated Relationship with Tumor Growth and Perfusion in Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Proliferation; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Perfusion; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Spin Labels; Squamous Cell Carcinoma of Head and Neck | 2016 |
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphocele; Lymphoma; Male; Middle Aged; Necrosis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Treatment Outcome | 2017 |
The role of changes in maximum standardized uptake value of FDG PET-CT for post-treatment surveillance in patients with head and neck squamous cell carcinoma treated with chemoradiotherapy: preliminary findings.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2017 |
PET/CT for Head and Neck Squamous Cell Carcinoma: Should We Routinely Include the Head and Abdomen?
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Pennsylvania; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Skull Neoplasms; Squamous Cell Carcinoma of Head and Neck | 2017 |
Multi-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data.
Topics: Datasets as Topic; Equipment Design; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Pattern Recognition, Automated; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Software; Tumor Burden | 2017 |
FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2017 |
Intratumoural heterogeneity measured using FDG PET and MRI is associated with tumour-stroma ratio and clinical outcome in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2017 |
[Individualised radiotherapy on the basis of functional imaging with FMISO PET].
Topics: Diagnostic Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Kinetics; Neoplasms; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiotherapy | 2008 |
Does reducing CT artifacts from dental implants influence the PET interpretation in PET/CT studies of oral cancer and head and neck cancer?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Dental Implants; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
Percutaneous endoscopic gastrostomy site metastases in head and neck cancer: use of FDG PET-CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Gastroscopy; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Statistics, Nonparametric; Tomography, X-Ray Computed; Treatment Failure; Tumor Burden | 2008 |
Impact of FDG-PET/CT fused imaging on tumor volume assessment of head-and-neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2008 |
Impact of FDG-PET/CT fused imaging on tumor volume assessment of head-and-neck squamous cell carcinoma: intermethod and interobserver variations.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Larynx; Male; Middle Aged; Mouth; Observer Variation; Pharynx; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2008 |
18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma.
Topics: Aged; Aged, 80 and over; Biopsy, Fine-Needle; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prospective Studies; Risk Assessment; Sensitivity and Specificity | 2009 |
F-18 FDG PET/CT study showing cervical extension of thymic tissue.
Topics: Child, Preschool; Choristoma; Connective Tissue Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Thymus Gland; Thymus Neoplasms; Tomography, X-Ray Computed | 2008 |
Desmoplastic melanoma: true positive and false negative findings on F-18 FDG-PET/CT.
Topics: Aged, 80 and over; False Negative Reactions; Female; Fibroma, Desmoplastic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2008 |
FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Topics: Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Synchronicity.
Topics: Carcinoma, Papillary; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Squamous Cell; Positron-Emission Tomography; Radiography; Scalp; Skin Neoplasms; Thyroid Neoplasms | 2008 |
Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2009 |
Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Computer Simulation; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
The role of CT and ¹⁸F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
CT, MR, US,18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2009 |
Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Survival Rate; Young Adult | 2008 |
Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report.
Topics: Adult; Aged; Aged, 80 and over; False Negative Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Treatment Outcome; Young Adult | 2009 |
Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Incidence; Korea; Lymphoma, B-Cell; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate | 2008 |
Can positron emission tomography (PET) or PET/Computed Tomography (CT) acquired in a nontreatment position be accurately registered to a head-and-neck radiotherapy planning CT?
Topics: Algorithms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2009 |
(18)F-FDG-PET/CT of orofacial tumors, a value of whole-body imaging approach.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2009 |
Effect of 18F-fluorodeoxyglucose positron emission tomography on the management of patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Postoperative Care; Preoperative Care; Radiotherapy, Adjuvant; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2008 |
FDG-positive Warthin's tumors in cervical lymph nodes mimicking metastases in tongue cancer staging with PET/CT.
Topics: Adenolymphoma; Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neck; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tongue Neoplasms | 2009 |
Positron emission tomography in surveillance of head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Role of PET/CT in maxillo-facial surgery.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Neoplasms, Squamous Cell; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Chromosome Banding; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorodeoxyglucose F18; Gene Expression; Genes, p53; Head and Neck Neoplasms; Humans; Mutation; Radiopharmaceuticals | 2009 |
Coregistered FDG PET/CT-based textural characterization of head and neck cancer for radiation treatment planning.
Topics: Algorithms; Area Under Curve; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Pattern Recognition, Automated; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Statistics, Nonparametric; Survival Analysis; Tumor Burden; Young Adult | 2009 |
Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals | 2009 |
Incidental head and neck (18)F-FDG uptake on PET/CT without corresponding morphological lesion: early predictor of cancer development?
Topics: Adenoids; Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Head; Head and Neck Neoplasms; Humans; Larynx; Male; Middle Aged; Mouth; Neck; Palatine Tonsil; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Thyroid Gland; Tomography, X-Ray Computed; Young Adult | 2009 |
Advanced head and neck cancer: is there a role for fluorodeoxyglucose PET/computed tomography?
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm, Residual; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Clinical significance of FDG single-photon emission computed tomography: Computed tomography in the diagnosis of head and neck cancers and study of its mechanism.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
Staging primary head and neck cancers with (18)F-FDG PET/CT: is intravenous contrast administration really necessary?
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer.
Topics: Combined Modality Therapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Nutrition Assessment; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Remission Induction; Tomography, X-Ray Computed; Tumor Burden | 2009 |
[18F]Fluorodeoxyglucose-PET/CT differentiation between physiological and pathological accumulations in head and neck.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neck; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2009 |
"Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer": in regard to Guido et al. (Int J Radiat Oncol Biol Phys 2009;73:759-763).
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2009 |
Early changes in 2-deoxy-2-[18F]fluoro-D-glucose metabolism in squamous-cell carcinoma during chemotherapy in vivo and in vitro.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Monitoring; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphocytes; Mice; Mice, Inbred BALB C; Mice, Nude; Necrosis; Radionuclide Imaging; Xenograft Model Antitumor Assays | 2009 |
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
[PET/CT based radiotherapy treatment planning in head and neck cancers].
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2009 |
Value of fluorodeoxyglucose positron emission tomography before radiotherapy for head and neck cancer: does the standardized uptake value predict treatment outcome?
Topics: Adenoma, Pleomorphic; Adult; Aged; Aged, 80 and over; Apoptosis; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitosis; Neoplasm Staging; Pharynx; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Young Adult | 2009 |
(18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Endoscopy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
[Differentiation of malignant and benign superficial lymph nodes by dual time point 18F-FDG PET].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2009 |
Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 2009 |
[Potential place of FDG-PET for the GTV delineation in head and neck and lung cancers].
Topics: Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2009 |
Evaluation of 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck Dissection; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Additional diagnostic value of (18)F-FDG PET-CT in detecting retropharyngeal nodal metastases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Retroperitoneal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2009 |
Glucose metabolism in the vessel wall correlates with mechanical instability and inflammatory changes in a patient with a growing aneurysm of the abdominal aorta.
Topics: Aortic Aneurysm; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Male; Melanoma; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2009 |
[The role and limitations of FDG-PET in head and neck cancer].
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
The effect of acquisition time on visual and semi-quantitative analysis of F-18 FDG-PET studies in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Electronic Data Processing; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Signal Processing, Computer-Assisted; Time Factors | 2010 |
Role of pretreatment 18FDG-PET/CT in surgical decision-making for head and neck cancers.
Topics: Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Squamous Cell; Cohort Studies; Decision Making; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Retrospective Studies; Sensitivity and Specificity | 2010 |
[Evaluation of fluorodeoxyglucose-position-emission tomography-computer tomography imaging on head and neck squamous cell carcinomas including primary tumors and lymph node metastases].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia.
Topics: Aged; Aged, 80 and over; Carcinoma, Merkel Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; New South Wales; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2010 |
Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Retrospective Studies; Tumor Burden | 2010 |
Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2010 |
The use of functional imaging in a patient with head and neck paragangliomas.
Topics: Adult; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Can 18F-FDG-PET response during radiotherapy be used as a predictive factor for the outcome of head and neck cancer patients?
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Survival Analysis; Time Factors; Treatment Outcome | 2010 |
PET imaging for the quantification of biologically heterogeneous tumours: measuring the effect of relative position on image-based quantification of dose-painting targets.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Models, Biological; Neoplasms; Positron-Emission Tomography; Radiation Dosage; Tomography, X-Ray Computed; Uncertainty; Whole Body Imaging | 2010 |
Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2010 |
Clinical usefulness of [18F] fluoro-2-deoxy-D-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Tumor Burden; Young Adult | 2011 |
An exploratory pilot study into the association between microcirculatory parameters derived by MRI-based pharmacokinetic analysis and glucose utilization estimated by PET-CT imaging in head and neck cancer.
Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Kinetics; Magnetic Resonance Imaging; Male; Microcirculation; Middle Aged; Muscles; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
FDG-PET/CT in cancers of the head and neck: what is the definition of whole body scanning?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2011 |
Interobserver variability in chest CT and whole body FDG-PET screening for distant metastases in head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Neoplasm Metastasis; Observer Variation; Positron-Emission Tomography; Radiography, Thoracic; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Prospective, blinded trial of whole-body magnetic resonance imaging versus computed tomography positron emission tomography in staging primary and recurrent cancer of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Whole Body Imaging; Young Adult | 2010 |
Head and neck cancers: post-therapy changes in muscles with FDG PET-CT.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neck Muscles; Positron-Emission Tomography; Radiography; Tomography, Emission-Computed | 2010 |
Sequential FDG-PET/CT after neoadjuvant chemotherapy is a predictor of histopathologic response in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2011 |
Setting an SUV cut-off value is misleading and meaningless in the differentiation between physiological and pathological accumulations in the head and neck.
Topics: Biological Transport; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Reference Values | 2009 |
Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors.
Topics: Aged; Carcinoma, Squamous Cell; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Injections, Intravenous; Iohexol; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed | 2010 |
[18F]Fluorodeoxyglucose positron emission tomography in the initial staging of squamous cell carcinoma of the head and neck: promise, evidence, and reality.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Survival Analysis | 2010 |
Pretreatment positron emission tomography with [18F]fluorodeoxyglucose for head and neck squamous cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multicenter Studies as Topic; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hodgkin Disease; Humans; Male; Mediastinal Neoplasms; Observer Variation; Positron-Emission Tomography; Prednisone; Procarbazine; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden; Vinblastine; Vincristine | 2011 |
FDG-PET staging and importance of lymph node SUV in head and neck cancer.
Topics: Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2010 |
Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Young Adult | 2011 |
Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancer.
Topics: Aged; Animals; Blotting, Western; Cell Line, Tumor; Erlotinib Hydrochloride; Female; Fluorescent Antibody Technique; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Mice; Mice, Nude; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Xenograft Model Antitumor Assays | 2010 |
Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving sequential induction chemotherapy followed by concurrent chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Combinations; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Squamous Cell; Oxonic Acid; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Remission Induction; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tegafur; Treatment Outcome | 2011 |
Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Predictive value of fluorodeoxyglucose uptake in head and neck cancer: importance of standardization: editorial on EAORL-D-10-00277.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Treatment Outcome | 2010 |
PET-CT staging of the neck in cancers of the oropharynx: patterns of regional and retropharyngeal nodal metastasis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2010 |
18F-FDG PET/CT-based gross tumor volume definition for radiotherapy in head and neck cancer: a correlation study between suitable uptake value threshold and tumor parameters.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2010 |
Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Survival Rate | 2010 |
Comparison of 18F-FDG and 11C-choline PET/CT for detecting recurrences in patients with nonsquamous cell head and neck malignancies.
Topics: Biological Transport; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour.
Topics: Biopsy; Carcinoma, Squamous Cell; Diagnostic Imaging; Endoscopy; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
18F-FET PET/CT in advanced head and neck squamous cell carcinoma: an intra-individual comparison with 18F-FDG PET/CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Planning study for available dose of hypoxic tumor volume using fluorine-18-labeled fluoromisonidazole positron emission tomography for treatment of the head and neck cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Can 18-FDG-PET during radiotherapy replace post-therapy scanning for detection/demonstration of tumor response in head-and-neck cancer?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Remission Induction; Survival Rate; Time Factors; Unnecessary Procedures | 2011 |
FDG-PET assessment of the effect of head and neck radiotherapy on parotid gland glucose metabolism.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organ Size; Parotid Gland; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Retrospective Studies | 2012 |
FDG uptake in primary squamous cell carcinoma of the head and neck. The relationship between overexpression of glucose transporters and hexokinases, tumour proliferation and apoptosis.
Topics: Adolescent; Adult; Apoptosis; Carcinoma, Squamous Cell; Child; Female; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Head and Neck Neoplasms; Hexokinase; Humans; Male; Middle Aged; Neoplasm Invasiveness; Radionuclide Imaging; Up-Regulation; Young Adult | 2011 |
Adaptive 18fluoro-2-deoxyglucose positron emission tomography/computed tomography-based target volume delineation in radiotherapy planning of head and neck cancer.
Topics: Aged; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2011 |
The potential role of non-FDG-PET in the management of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Squamous Cell; Chemoradiotherapy; Choline; Cisplatin; Contrast Media; Diagnostic Imaging; Extracellular Space; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Gadolinium DTPA; Glucose; Glycolysis; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Statistics, Nonparametric; Tongue Neoplasms; Tonsillar Neoplasms | 2012 |
Imaging tumor perfusion and oxidative metabolism in patients with head-and-neck cancer using 1- [11C]-acetate PET during radiotherapy: preliminary results.
Topics: Acetic Acid; Adolescent; Aged; Carbon Radioisotopes; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Head and Neck Neoplasms; Humans; Male; Middle Aged; Oxygen; Positron-Emission Tomography; Radiation Tolerance; Radiopharmaceuticals; Radiotherapy Dosage; Regional Blood Flow; Remission Induction | 2012 |
[Paraganglioma as a cause of inflammation of unknown origin: usefulness of positon emission tomography].
Topics: Blood Sedimentation; C-Reactive Protein; Cranial Nerve Neoplasms; Diagnosis, Differential; Female; Fibrinogen; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Inflammation; Magnetic Resonance Imaging; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Syndrome; Vagus Nerve Diseases; Young Adult | 2011 |
Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Reference Standards; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm, Residual; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Failure; Young Adult | 2011 |
Feasibility of simultaneous PET/MR imaging in the head and upper neck area.
Topics: Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Molecular imaging in radiotherapy planning for head and neck tumors.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2011 |
FDG PET imaging of head and neck cancers.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Salvage Therapy; Tomography, X-Ray Computed | 2011 |
Combined [18F]fluorodeoxyglucose positron emission tomography and computed tomography for detecting contralateral neck metastases in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed | 2011 |
FDG PET/CT incidental diagnosis of a synchronous bladder cancer as a fourth malignancy in a patient with head and neck cancer.
Topics: Aged; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2011 |
Neuroendocrine carcinoma of the larynx presenting as a primary unknown carcinoma.
Topics: Aged, 80 and over; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Neoplasms, Unknown Primary; Positron-Emission Tomography | 2012 |
False-positive FDG PET/CT uptake in Warthin tumor in head and neck oncological patients confirmed by a fine needle aspiration.
Topics: Adenolymphoma; Biopsy, Fine-Needle; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Metabolic tumour volume. Prognostic value in locally advanced squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2011 |
Initial staging of the neck in head and neck squamous cell carcinoma: a comparison of CT, PET/CT, and ultrasound-guided fine-needle aspiration cytology.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Cohort Studies; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Prognostic value of fluorine-18 fluorodeoxyglucose positron-emission tomography imaging in patients with head and neck squamous cell carcinoma.
Topics: Aged; Analysis of Variance; Biopsy, Needle; Carcinoma, Squamous Cell; Cohort Studies; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Survival Analysis; Tomography, X-Ray Computed | 2012 |
Suture granuloma showing false-positive finding on PET/CT after head and neck cancer surgery.
Topics: Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Otorhinolaryngologic Surgical Procedures; Positron-Emission Tomography; Postoperative Complications; Sutures; Tomography, X-Ray Computed | 2012 |
The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2011 |
Efficacy of fluoro-2-deoxy-D-glucose positron emission tomography to evaluate responses to concurrent chemoradiotherapy for head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Correlation of 18F-FDG uptake with apparent diffusion coefficient ratio measured on standard and high b value diffusion MRI in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Cell Differentiation; Diffusion; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies | 2011 |
Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment.
Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cinnamates; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Head and Neck Neoplasms; Immunoenzyme Techniques; Lactates; Linear Models; Luminescent Measurements; Mice; Mice, Nude; Monocarboxylic Acid Transporters; Nitroimidazoles; Oxidation-Reduction; Symporters; Tumor Microenvironment; Uterine Cervical Neoplasms | 2011 |
Early prediction of local control in head and neck cancer after chemoradiotherapy by FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Time Factors; Treatment Outcome | 2011 |
Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Aged; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Medical Oncology; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Submandibular salivary gland transfer: a pitfall in head and neck imaging with F-18 FDG PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiation Protection; Submandibular Gland; Tomography, X-Ray Computed | 2011 |
Incidental detection of unsuspected pulmonary embolism on oncologic FDG PET/CT imaging.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Embolism; Tomography, X-Ray Computed | 2011 |
Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paraganglioma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Somatostatin; Succinate Dehydrogenase; Tomography, Emission-Computed | 2011 |
Spatiotemporal analysis of tumor uptake patterns in dynamic (18)FDG-PET and dynamic contrast enhanced CT.
Topics: Adolescent; Adult; Animals; Contrast Media; Dogs; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Software; Tomography, X-Ray Computed; Young Adult | 2011 |
Matched cohort analysis of the effect of pretreatment positron emission tomography on clinical outcomes of patients with head and neck cancer treated with definitive chemoradiotherapy.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Treatment Outcome | 2012 |
¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Image-Guided; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2011 |
F-18 FDG PET/CT imaging of a hidradenocarcinoma of head and neck.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Sweat Gland Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Radiation-associated head and neck sarcomas: spectrum of imaging findings.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasms, Radiation-Induced; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2012 |
Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2011 |
A preliminary report on the impact of ¹⁸F-FDG PET/CT in the management of paediatric head and neck cancer.
Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Pediatrics; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Diagnostic sensitivity of ¹⁸fluorodeoxyglucose positron emission tomography for detecting synchronous multiple primary cancers in head and neck cancer patients.
Topics: Early Diagnosis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2012 |
[Usefulness of 18F-FDG PET/CT examination in the diagnosis of head and neck cancer--preliminary results].
Topics: Adult; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Poland; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
Navigation-assisted localisation and resection of subclinical metastatic malignant melanoma of unknown primary based on 18-fluorodeoxyglcose positron emission tomography computed tomography fusion imaging.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymph Node Excision; Lymphatic Metastasis; Melanoma; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Scalp; Skin Neoplasms; Surgery, Computer-Assisted; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Improved treatment outcomes with (18) F-FDG PET/CT for patients with advanced head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Case-Control Studies; Chemoradiotherapy; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Lower neck neurilemmoma can masquerade as lymph node metastasis on FDG PET/CT in patient with nasopharyngeal carcinoma.
Topics: Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neurilemmoma; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2011 |
The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Disease-Free Survival; DNA, Viral; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Human papillomavirus 16; Humans; In Situ Hybridization; Incidence; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Papillomavirus Infections; Pennsylvania; Population Surveillance; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Tomography, X-Ray Computed | 2011 |
Validation for performing ¹¹C-methionine and ¹⁸F-FDG-PET studies on the same day.
Topics: Aged; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver; Male; Metabolic Clearance Rate; Methionine; Middle Aged; Muscles; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tissue Distribution; Whole Body Imaging | 2012 |
The nodal standard uptake value (SUV) as a prognostic factor in head and neck squamous cell cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2011 |
FDG PET/CT interobserver agreement in head and neck cancer: FDG and CT measurements of the primary tumor site.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2012 |
The value of PET/CT to assess clinically negative necks.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Neck; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2012 |
Predictive value of positron emission tomography-computed tomography image fusion in the diagnosis of head and neck cancer: does it really improve staging and management?
Topics: Biopsy; Carcinoma; Clinical Competence; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
Fluorodeoxyglucose-induced allergic reaction: a case report.
Topics: Anti-Allergic Agents; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Diphenhydramine; Drug Hypersensitivity; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Pyriform Sinus; Radiopharmaceuticals; Secondary Prevention; Squamous Cell Carcinoma of Head and Neck; Terfenadine; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Prognostic value of metabolic tumor volume and velocity in predicting head-and-neck cancer outcomes.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Karnofsky Performance Status; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Treatment evaluation of metastatic lymph nodes after concurrent chemoradiotherapy in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2012 |
Prognostic value of 18F-FDG PET/CT in patients with squamous cell carcinoma of the tonsil: comparisons of volume-based metabolic parameters.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Palatine Tonsil; Positron-Emission Tomography; Prognosis; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2013 |
Different distribution of (62) Cu ATSM and (18)F-FDG in head and neck cancers.
Topics: Adenocarcinoma; Aged; Analysis of Variance; Biopsy; Carcinoma, Squamous Cell; Coordination Complexes; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Thiosemicarbazones; Tomography, X-Ray Computed | 2012 |
Detailed characterization of the early response of head-neck cancer xenografts to irradiation using (18)F-FDG-PET imaging.
Topics: Animals; Area Under Curve; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Mice; Mice, Nude; Multimodal Imaging; Necrosis; Neoplasm Transplantation; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; ROC Curve; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tomography, X-Ray Computed; Transplantation, Heterologous; Tumor Burden | 2012 |
Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiography; Survival Rate | 2013 |
Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary?
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Failure; Tumor Burden | 2012 |
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diffusion; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2012 |
Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Urologic Neoplasms | 2012 |
Nephrotic syndrome leading to the diagnosis of classical Hodgkin's lymphoma in a 13-year-old girl.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Mediastinal Neoplasms; Multimodal Imaging; Neoplasm Staging; Nephrotic Syndrome; Positron-Emission Tomography; Prednisone; Tomography, X-Ray Computed; Vincristine | 2012 |
Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Endoscopy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Function Tests; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Defining PET standardized uptake value threshold for tumor delineation with metastatic lymph nodes in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Linear Models; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2012 |
Detection of neck recurrence in patients with differentiated thyroid cancer: comparison of ultrasound, contrast-enhanced CT and (18)F-FDG PET/CT using surgical pathology as a reference standard: (ultrasound vs. CT vs. (18)F-FDG PET/CT in recurre
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2012 |
It is never too late: ultra-late recurrence of melanoma with distant metastases.
Topics: Aged; Diagnosis, Differential; Fatal Outcome; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Metabolic imaging biomarkers of postradiotherapy xerostomia.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Organs at Risk; Oropharyngeal Neoplasms; Parotid Gland; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Xerostomia | 2012 |
PET/CT significance for planning radiotherapy of head and neck cancer.
Topics: Adult; Aged; Carcinoma, Adenoid Cystic; Carcinoma, Mucoepidermoid; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Young Adult | 2012 |
Virtual 3-D ¹⁸F-FDG PET/CT panendoscopy for assessment of the upper airways of head and neck cancer patients: a feasibility study.
Topics: Aged; Aged, 80 and over; Endoscopy; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Pharyngeal Neoplasms; Positron-Emission Tomography; Respiratory System; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; User-Computer Interface | 2012 |
18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2012 |
Positron emission tomography in the detection of occult primary head and neck carcinoma: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2012 |
The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.
Topics: Carcinoma, Squamous Cell; Child; Cohort Studies; Female; Fluorodeoxyglucose F18; Forecasting; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neck Dissection; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2013 |
Combined PET/CT-perfusion in patients with head and neck cancers.
Topics: Adult; Aged; Biopsy; Contrast Media; Diatrizoate Meglumine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iohexol; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, X-Ray Computed | 2013 |
Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer.
Topics: Adenocarcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Head-to-head comparison between SRS, (18)F-FDG and (18)F-FDOPA PET/CT in a patient with recurrent SDHC-related jugular paraganglioma.
Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Membrane Proteins; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Paraganglioma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Usefulness of 3'-deoxy-3'-18F-fluorothymidine PET for predicting early response to chemoradiotherapy in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Chemoradiotherapy; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Time Factors; Treatment Outcome | 2012 |
Ectopic cervical thymoma: a case report with 18F-fluorodeoxyglucose positron emission tomography findings.
Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Positron-Emission Tomography; Thymoma; Thymus Neoplasms | 2012 |
Use of routine ultrasound-guided fine-needle aspiration cytology to assess the neck in patients with head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Neoplasm Staging | 2012 |
Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2013 |
18F-fluorodeoxythymidine micro-positron-emission tomography versus 18F-fluorodeoxyglucose micro-positron-emission tomography for in vivo minimal residual disease imaging.
Topics: Animals; Carcinoma, Squamous Cell; Dideoxynucleosides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Luminescent Measurements; Mice; Mice, Nude; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays | 2013 |
PET/MRI in head and neck cancer: initial experience.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Whole Body Imaging | 2013 |
A gel tumour phantom for assessment of the accuracy of manual and automatic delineation of gross tumour volume from FDG-PET/CT.
Topics: Algorithms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Gels; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Models, Anatomic; Models, Biological; Multimodal Imaging; Neoplasms; Pattern Recognition, Automated; Phantoms, Imaging; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed | 2013 |
PET/CT of cancer patients: part 2, deformable registration imaging before and after chemotherapy for radiation treatment planning in head and neck cancer.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2012 |
Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours.
Topics: Carcinoma, Squamous Cell; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Glycolysis; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Medical Oncology; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Treatment Outcome; Tumor Burden | 2013 |
Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: preoperative planning for necessity and extent of neck dissection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck Dissection; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Salivary Gland Neoplasms; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2013 |
Technical note: 9-month repositioning accuracy for functional response assessment in head and neck chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Device Removal; Diffusion Magnetic Resonance Imaging; Equipment Design; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immobilization; Masks; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Time Factors | 2012 |
Optimal timing of post-treatment [18F]fluorodeoxyglucose-PET/CT for patients with head and neck malignancy.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2013 |
The role of positron emission tomography with 18F-fluorodeoxyglucose in nodal staging of clinical and radiological N₀ head and neck cancers.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Towards intra-operative PET for head and neck cancer: lymph node localization using high-energy probes.
Topics: Algorithms; Diagnostic Imaging; Fluorodeoxyglucose F18; Gamma Rays; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Intraoperative Period; Lymph Nodes; Models, Statistical; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2012 |
Efficacy of FDG-PET for defining gross tumor volume of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Computer Simulation; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Male; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Hypoxia-targeted radiotherapy dose painting for head and neck cancer using (18)F-FMISO PET: a biological modeling study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cell Hypoxia; Cohort Studies; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Models, Biological; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated | 2013 |
Using FDG-PET to measure early treatment response in head and neck squamous cell carcinoma: quantifying intrinsic variability in order to understand treatment-induced change.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Remission Induction; Reproducibility of Results; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
The potential of FDG-PET in the detection of occult lymph node metastasis: importance of patient selection and reference standard.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Multimodal Imaging; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Tomography, X-Ray Computed | 2013 |
FDG-PET and diffusion-weighted MRI in head-and-neck cancer patients: implications for dose painting.
Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided | 2013 |
Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection.
Topics: Adult; Aged; Disease Progression; Extremities; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Injections, Intravenous; Lymph Nodes; Male; Melanoma; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2002 |
Thyroid nodule mimicking cervical adenopathy on FDG positron emission tomographic imaging.
Topics: Adult; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Radiography; Radiopharmaceuticals; Thyroid Nodule; Tomography, Emission-Computed | 2002 |
Fluorodeoxyglucose imaging using a coincidence gamma camera to detect head and neck squamous cell carcinoma and response to chemotherapy.
Topics: Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study.
Topics: Actuarial Analysis; Bayes Theorem; Carcinoma, Squamous Cell; Cohort Studies; Denmark; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Assessment of clinical utility of 18F-FDG PET in patients with head and neck cancer: a probability analysis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Models, Biological; Models, Statistical; Neoplasm Recurrence, Local; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Switzerland; Tomography, Emission-Computed | 2003 |
Incidental findings of FDG uptake in dental caries.
Topics: Dental Caries; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals | 2003 |
Metastatic malignant proliferating trichilemmal tumor detected by positron emission tomography.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Radiopharmaceuticals; Scalp; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
Differential FDG accumulation associated with GLUT-1 expression in a patient with lymphoma.
Topics: Excitatory Amino Acid Transporter 2; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals | 2003 |
Compare FDG-PET and Tc-99m tetrofosmin SPECT to detect metastatic thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Papillary, Follicular; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Diagnostic accuracy of 2-[fluorine-18]fluro-2-deoxy-D-glucose positron emission tomography imaging in nonsquamous tumors of the head and neck.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Carcinoma, Papillary; Child; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Salivary Gland Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
Staging of head and neck tumors: [18F]fluorodeoxyglucose positron emission tomography compared with physical examination and conventional imaging modalities.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Evaluation of head and neck squamous cell carcinoma after treatment.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2003 |
Staging of head and neck squamous cell cancer with extended-field FDG-PET.
Topics: Carcinoma, Squamous Cell; Digestive System Neoplasms; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Neoplasms, Multiple Primary; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
The impact of FDG PET on the management of occult primary head and neck tumours.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Unknown Primary; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neck Dissection; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Male; Middle Aged; Muscle, Skeletal; Patient Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Do hardware artefacts influence the performance of head and neck PET scans in patients with oral cavity squamous cell cancer?
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Carcinoma, Squamous Cell; Dental Alloys; Dental Prosthesis; Female; Fluorodeoxyglucose F18; Germanium; Head and Neck Neoplasms; Humans; Image Enhancement; Image Processing, Computer-Assisted; Male; Middle Aged; Orthopedic Fixation Devices; Phantoms, Imaging; Radioisotopes; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Positron emission tomography (PET) in the staging of head neck cancer: comparison between PET and CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
18F-FDG PET for detecting recurrent head and neck cancer, local lymph node involvement and distant metastases. Comparison of qualitative visual and semiquantitative analysis.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Software; Tissue Distribution; Treatment Outcome | 2004 |
Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer.
Topics: Adult; Aged; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nitroimidazoles; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2004 |
The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2004 |
Mirror, mirror on the wall--which is the greatest predictive assay of them all?
Topics: ErbB Receptors; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2004 |
FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Oropharyngeal Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
[Clinical evaluation of 18-fluorine fluorodeoxyglucose positron emission tomography-CT imaging in head and neck tumors].
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2004 |
[18F-FDG PET in the diagnosis of head and neck tumor].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2004 |
American Burkitt's lymphoma of the head and neck: evaluation with serial FDG-PET.
Topics: Adult; Antineoplastic Agents; Burkitt Lymphoma; Facial Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2004 |
Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Neck; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sensitivity and Specificity; Treatment Outcome | 2004 |
Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck.
Topics: Aged; Carcinoma, Squamous Cell; Cohort Studies; Combined Modality Therapy; Confidence Intervals; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed | 2004 |
Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Peripheral nerve schwannoma: two cases exhibiting increased FDG uptake in early and delayed PET imaging.
Topics: Adult; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Muscle Neoplasms; Neurilemmoma; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms | 2005 |
A case of cervical paraganglioma: usefulness of FDG PET imaging and a possibility of rare origination.
Topics: Adult; Angiography; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoglossal Nerve Diseases; Magnetic Resonance Imaging; Male; Paraganglioma; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome; Vagus Nerve Diseases | 2004 |
DNA ploidy, S-phase fraction and associations with 2-18F-fluoro-deoxy-2-D-glucose positron emission tomography findings before and during therapy of head and neck squamous cell carcinoma.
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; DNA, Neoplasm; Feasibility Studies; Flow Cytometry; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Cytometry; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Ploidies; Prospective Studies; Radiopharmaceuticals; S Phase; Tomography, Emission-Computed | 2004 |
Physiological uptake of [18F]fluorodeoxyglucose in the neck and upper chest region: are there predictive characteristics?
Topics: Adolescent; Adult; Age Distribution; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neck; Netherlands; Organ Specificity; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thorax; Thyroid Neoplasms; Tissue Distribution | 2004 |
Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Retrospective Studies; Salvage Therapy | 2004 |
Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: a brief technical report.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2004 |
Positron emission tomography in cancer of the head and neck.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage | 2005 |
FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Can post-RT FDG PET accurately predict the pathologic status in neck dissection after radiation for locally advanced head and neck cancer? In regard to Rogers et al. (Int J Radiat Oncol Biol Phys 2004;58:694-697).
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2005 |
Benign lesions in cancer patients: Case 1. Sarcoidosis after chemoradiation for head and neck cancer.
Topics: Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Sarcoidosis | 2005 |
Positron emission tomography (PET) in the management of oro-pharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Impact of combined (18)F-FDG PET/CT in head and neck tumours.
Topics: Adult; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Observer Variation; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed | 2005 |
F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, X-Ray Computed | 2005 |
Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET.
Topics: Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome | 2005 |
Merkel cell carcinoma: two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance.
Topics: Aged; Aged, 80 and over; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2005 |
Positron-emission tomography for surveillance of head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2005 |
Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Computer Simulation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2005 |
[The usefulness of FDG-PET in patients with cervical lymphadenopathy].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Diseases; Male; Middle Aged; Positron-Emission Tomography; Young Adult | 2004 |
Head and neck malignancy: is PET/CT more accurate than PET or CT alone?
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Blood Glucose; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sensitivity and Specificity | 2005 |
Use, accuracy, and implications for patient management of [18F]-2-fluorodeoxyglucose-positron emission/computerized tomography for head and neck tumors.
Topics: Brain; Cohort Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
The role of gamma-PET in the evaluation of patients with recurrent squamous cell cancer of the head and neck.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2005 |
FDG-PET in head and neck, and thyroid cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Thyroid Neoplasms | 2005 |
The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tongue Neoplasms | 2005 |
Comparison of CT- and FDG-PET-defined GT: in regard to Paulino et al. (Int J Radiat Oncol Biol Phys 2005;61:1385-1392).
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2005 |
Positron emission tomography/computed tomography imaging of head and neck tumors: an atlas.
Topics: Anatomy, Artistic; Databases, Factual; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Medical Illustration; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Tomography, X-Ray Computed | 2005 |
[Head and neck neoplasms--combination PET/CT is better than a single approach].
Topics: Controlled Clinical Trials as Topic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Topographic metabolic map of head and neck squamous cell carcinoma using 18F-FDG PET and CT image fusion.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Nasal Cavity; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
The clinical role of CT/PET in oncology: an update.
Topics: Colonic Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiation Oncology; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2005 |
Controversies: is there a role for positron-emission tomographic CT in the initial staging of head and neck squamous cell carcinoma?
Topics: Biopsy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
FDG-PET in radiotherapy treatment planning of advanced head and neck cancer--a prospective clinical analysis.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Palliative Care; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals | 2006 |
[The integrated PET/CT: technological advance in diagnostics of head and neck recurrencies and CUP?].
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Palpation; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2006 |
Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Topics: Aged; Antibodies, Monoclonal; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Isotope Labeling; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron-Emission Tomography; Radioisotopes; Sensitivity and Specificity; Zirconium | 2006 |
[Contribution of 18-F-FDG PET for detection of head and neck carcinomas with an unknown primary tumor].
Topics: Adult; Aged; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2006 |
Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Diagnostic work-up and outcome of cervical metastases from an unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Combined Modality Therapy; Disease-Free Survival; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck Dissection; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Correction of an image size difference between positron emission tomography (PET) and computed tomography (CT) improves image fusion of dedicated PET and CT.
Topics: Algorithms; Artifacts; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Information Storage and Retrieval; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity | 2006 |
[Diagnostic value of 18F-fDG Pet/CT in the detection of the cervical lymph nodes metastasis].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2006 |
Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers.
Topics: Adult; Aged; Carcinoma, Squamous Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Effects of hyperoxygenation on FDG-uptake in head-and-neck cancer.
Topics: Aged; Aged, 80 and over; Carbon; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Niacinamide; Oxygen; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2006 |
FDG--a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer.
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Misonidazole; Neoplasm Metastasis; Oxygen; Polarography; Positron-Emission Tomography; Reference Standards | 2006 |
Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients.
Topics: Aged; Cell Hypoxia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2006 |
High energy probe for detecting lymph node metastases with 18F-FDG in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2006 |
Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Cell Hypoxia; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Middle Aged; Misonidazole; Multivariate Analysis; Positron-Emission Tomography; Survival Analysis | 2006 |
Sentinel lymph node biopsy: A new perspective in head and neck mucosal melanoma?
Topics: Adult; Antineoplastic Agents; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Sentinel Lymph Node Biopsy | 2006 |
Combined 18F-FDG-PET/CT imaging of the head and neck. An approach to metal artifact correction.
Topics: Artifacts; Dental Implants; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mandible; Maxilla; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2006 |
[Role of [18F]-FDG PET-CT in the management of the head and neck cancers].
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2006 |
[Contribution of 18FDG PET/CT post treatment surveillance of head and neck squamous cell carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Clinical Protocols; Data Interpretation, Statistical; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2006 |
Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Middle Aged; Neck; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
Topics: Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2007 |
PET in face and neck tumours.
Topics: Facial Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Setup and characterization of a human head and neck squamous cell carcinoma xenograft model in nude rats.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Rats; Rats, Nude; Transplantation, Heterologous | 2006 |
1-[11C]-acetate PET imaging in head and neck cancer--a comparison with 18F-FDG-PET: implications for staging and radiotherapy planning.
Topics: Acetates; Adolescent; Adult; Aged; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2007 |
FDG uptake after intraarterial chemotherapy in head and neck cancer.
Topics: Aged; Antineoplastic Agents; Biological Transport; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors | 2006 |
FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Case-Control Studies; Cell Line, Tumor; Clinical Protocols; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Evaluation of suspected local recurrence in head and neck cancer: a comparison between PET and PET/CT for biopsy proven lesions.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Research Design; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
[Comparison between 18F-FDG PET and conventional imaging techniques (CT SCAN and MRI) in the diagnosis of head and neck tumor suspicion of recurrence].
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
F-18 FDG PET/CT imaging of a subcutaneous scalp metastasis from primary carcinoma of the thyroid.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Scalp; Skin Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
Clinical utility of 18F-FDG PET for patients with salivary gland malignancies.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Salivary Gland Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumors.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
The impact of positron emission tomography/computed tomography in edge delineation of gross tumor volume for head and neck cancers.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma concurrently diagnosed with a diffuse large B-cell lymphoma localized in the neck.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Nodule; Whole Body Imaging | 2007 |
The Feasibility of 18F-FDG PET scans 1 month after completing radiotherapy of squamous cell carcinoma of the head and neck.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2007 |
18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Technetium Tc 99m Medronate; Whole Body Imaging; Whole-Body Counting | 2008 |
Clinical impact of positron emission tomography (PET) with (18F)fluorodeoxyglucose (FDG) in head and neck tumours.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2007 |
Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Imaging, Three-Dimensional; Male; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
What does PET imaging add to conventional staging of head and neck cancer patients?
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Validated image fusion of dedicated PET and CT for external beam radiation and therapy in the head and neck area.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2008 |
In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Cervical Vertebrae; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
[Value of 18F-FDG metabolic imaging in diagnosis and treatment of head and neck tumors and its mechanism study].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tomography, Emission-Computed | 2007 |
A gradient-based method for segmenting FDG-PET images: methodology and validation.
Topics: Algorithms; Cluster Analysis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Inflammation; Pattern Recognition, Automated; Phantoms, Imaging; Polymethyl Methacrylate; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique | 2007 |
Hypoxia dose painting by numbers: a planning study.
Topics: Cell Hypoxia; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Misonidazole; Radiation-Sensitizing Agents; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated | 2007 |
Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers.
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Papillary; Carcinoma, Papillary, Follicular; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Male; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Statistics, Nonparametric; Thyroid Neoplasms; Thyroid Nodule; Thyroidectomy; Tomography, X-Ray Computed | 2007 |
Head and neck cancer: dedicated FDG PET/CT protocol for detection--phantom and initial clinical studies.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neck Dissection; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2007 |
Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment.
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
F-18 FDG PET/CT incidental finding of large ischiogluteal bursitis.
Topics: Aged, 80 and over; Bursitis; Buttocks; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Ischium; Male; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle o
Topics: Carcinoma, Squamous Cell; Cell Hypoxia; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Misonidazole; Oxygen Consumption; Polarography; Positron-Emission Tomography; Prognosis; Ultrasonography, Doppler, Color | 2007 |
The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Patient Care Planning; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Cost-Benefit Analysis; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Colorectal tubulovillous adenomas identified on fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scans.
Topics: Adenoma, Villous; Adenomatous Polyps; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging | 2007 |
Evaluation of normal FDG uptake in palatine tonsil and its potential value for detecting occult head and neck cancers: a PET CT study.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Palatine Tonsil; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2007 |
[Clinical study of 28 cases of cervical lymph node metastasis from an unknown primary carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Survival Rate | 2007 |
[Analysis of the performance of 18F-fluoro-2-deoxyglucose positron emission tomography in primary tumor detection in metastatic neck cancers].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2007 |
[18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tumor Burden | 2007 |
Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
Topics: Biopsy; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
F-18 FDG PET/CT following dental extraction in a patient with head and neck cancer.
Topics: Carcinoma, Squamous Cell; Cervical Vertebrae; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Peritonitis; Radionuclide Imaging; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Tooth Extraction | 2007 |
Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
TNM staging with FDG-PET/CT in patients with primary head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole-Body Counting | 2007 |
The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist's perspective.
Topics: Carcinoma, Squamous Cell; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Medical Staff, Hospital; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.
Topics: Cell Hypoxia; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Prospective Studies; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2008 |
Oncocytoma of the parotid gland: a potential false-positive finding on 18F-FDG PET.
Topics: Adenocarcinoma; Adenoma, Oxyphilic; Aged; Diagnostic Errors; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neoplasms, Multiple Primary; Parotid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Biopsy; Carcinoma, Squamous Cell; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Time Factors; Tomography, X-Ray Computed | 2008 |
Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Decision Making; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Varying degrees of FDG uptake in multiple benign neurofibromas on PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Mediastinal Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Tracheal Neoplasms | 2007 |
[Detection of FDG-PET and FDG-PET/CT in head and neck squamous cell carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Enhanced response of human head and neck cancer xenograft tumors to cisplatin combined with 2-deoxy-D-glucose correlates with increased 18F-FDG uptake as determined by PET imaging.
Topics: Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxyglucose; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glutathione; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Oxidative Stress; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Transplantation, Heterologous | 2007 |
Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
PET/CT imaging in head and neck tumors.
Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
FDG PET/CT detection of a gossypiboma in the neck.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neck; Positron-Emission Tomography; Surgical Sponges; Tomography, X-Ray Computed | 2007 |
Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.
Topics: Aged; Cell Hypoxia; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2008 |
Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Animals; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals | 2008 |
Posttreatment FDG-PET uptake in the supraglottic and glottic larynx correlates with decreased quality of life after chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Diet; Eating; Female; Fluorodeoxyglucose F18; Glottis; Glucose; Head and Neck Neoplasms; Health Status; Humans; Larynx; Male; Middle Aged; Positron-Emission Tomography; Quality of Life; Radiation Injuries; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome | 2008 |
Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiography, Thoracic; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2008 |
[Role of PET-CT with 18-FDG in the management of UADT squamous-cell carcinomas: a retrospective study of 43 cases].
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Perineural spread of melanoma demonstrated by F-18 FDG PET With MRI and pathologic correlation.
Topics: Aged; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lip Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Neoplasms, Nerve Tissue; Radiopharmaceuticals; Tomography, Emission-Computed | 2008 |
Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Time Factors; Tomography, X-Ray Computed | 2008 |
Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer.
Topics: Adult; Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Radiographic properties of injected calcium hydroxylapatite: potential false positive findings on positron emission tomography.
Topics: Aged; Biocompatible Materials; Carcinoma, Squamous Cell; Durapatite; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngectomy; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2008 |
Disseminated nontuberculous mycobacterial infection mimic metastases on PET/CT scan.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Mycobacterium Infections; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis | 2008 |
Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck.
Topics: Belgium; Bone Marrow; Carcinoma, Squamous Cell; Comorbidity; Disease-Free Survival; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival; Survival Rate | 2008 |
Uptake of (18)F-FLT and (18)F-FDG in primary head and neck cancer correlates with survival.
Topics: Adult; Aged; Aged, 80 and over; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radioisotopes; Survival Analysis | 2008 |
Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Radiography, Thoracic; Radiopharmaceuticals; Risk Factors; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Endotracheal metastasis from squamous cell cancer of the head and neck: PET/CT imaging.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tracheal Neoplasms | 2008 |
FDG-PET staging of head and neck cancer--can improved imaging lead to improved treatment?
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neck; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Clinical Protocols; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Brown adipose tissue demonstrating intense FDG uptake in a patient with mediastinal pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adipose Tissue, Brown; Adrenal Gland Neoplasms; Adult; Bone Neoplasms; Catecholamines; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypertension; Lymphatic Metastasis; Mediastinal Neoplasms; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose.
Topics: Deoxyglucose; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neoplasm Recurrence, Local; Tomography, Emission-Computed | 1995 |
A comparative diagnostic study of head and neck nodal metastases using positron emission tomography.
Topics: Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Neck; Neoplasm Staging; Pharyngeal Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
FDG-PET for predicting the prognosis of malignant lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Prognosis; Proportional Hazards Models; Survival Rate; Tomography, Emission-Computed | 1994 |
Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Radionuclide Imaging | 1995 |
In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck.
Topics: Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Methionine; Radionuclide Imaging; Tumor Cells, Cultured | 1995 |
Comparison of thallium-201 and F-18 FDG SPECT uptake in squamous cell carcinoma of the head and neck.
Topics: Biopsy; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Thallium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1994 |
Chemotherapeutic management of head and neck malignancies with positron emission tomography.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Glucose; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Oropharyngeal Neoplasms; Tomography, Emission-Computed | 1995 |
Functional imaging of head and neck tumors using positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cerebellum; Cicatrix; Deoxyglucose; Female; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Necrosis; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Pituitary Neoplasms; Tomography, Emission-Computed; Tonsillar Neoplasms | 1994 |
The promise FDG in diagnosis and surveillance of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Population Surveillance; Tomography, Emission-Computed | 1994 |
Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.
Topics: Carcinoma; Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Oropharyngeal Neoplasms; Paranasal Sinus Neoplasms; Prognosis; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers.
Topics: Adult; Aged; Deoxyglucose; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Tomography, Emission-Computed | 1994 |
The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Head and Neck Neoplasms; Humans; Tomography, Emission-Computed | 1993 |
Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET.
Topics: Adenoids; Adult; Aged; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gingiva; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mouth; Oropharynx; Palatine Tonsil; Salivary Glands; Tomography, Emission-Computed | 1993 |
Positron emission tomographic imaging of the head and neck.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head; Head and Neck Neoplasms; Humans; Neck; Tomography, Emission-Computed | 1993 |
Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy Dosage; Tomography, Emission-Computed | 1993 |
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Deoxyglucose; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Methionine; Middle Aged; Tomography, Emission-Computed | 1993 |
Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation.
Topics: Contrast Media; Deoxyglucose; Fluorodeoxyglucose F18; Head; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Mouth Neoplasms; Neck; Nose; Orbit; Parotid Neoplasms; Pharynx; Tomography, Emission-Computed; Tongue Neoplasms | 1993 |
Influence of the blood glucose concentration on FDG uptake in cancer--a PET study.
Topics: Aged; Blood Glucose; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Insulin; Male; Middle Aged; Tomography, Emission-Computed | 1993 |
Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxyglucose; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT.
Topics: Biopsy; Carcinoma, Squamous Cell; Contrast Media; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasms, Unknown Primary; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1996 |
Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses.
Topics: Aged; Aged, 80 and over; Contrast Media; Deoxyglucose; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Prospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
The use of PET-18FDG imaging in the clinical evaluation of head and neck lymphoma.
Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hyperplasia; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
[Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor].
Topics: Biopsy; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Prospective Studies; Tomography, Emission-Computed | 1996 |
1996 SNM annual meeting: medical problem solving.
Topics: Artifacts; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Dementia; Deoxyglucose; Eye Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genetic Therapy; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasms; Radioisotopes; Radiotherapy; Rhenium; Societies, Medical; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Influence of hypoxia on tracer accumulation in squamous-cell carcinoma: in vitro evaluation for PET imaging.
Topics: Carcinoma, Squamous Cell; Cell Hypoxia; Cell Survival; Deoxyglucose; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Leucine; Methionine; Oxygen; Tomography, Emission-Computed; Tritium; Tumor Cells, Cultured | 1996 |
Positron emission tomographic imaging of head and neck lesions.
Topics: Absorption; Adenoma; Aspergillosis; Carcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Deoxyglucose; Feasibility Studies; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Granuloma; Head and Neck Neoplasms; Histiocytoma, Benign Fibrous; Humans; Magnetic Resonance Imaging; Maxillary Sinus; Maxillary Sinus Neoplasms; Maxillary Sinusitis; Nasopharyngeal Neoplasms; Papilloma; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tongue Neoplasms; Treatment Outcome | 1997 |
A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Development of oncology protocol using fluorine-18-FDG: one center's experience.
Topics: Blood Glucose; Colonic Neoplasms; Deoxyglucose; Esophageal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphoma; Neoplasm Staging; Neoplasms; Patient Education as Topic; Practice Guidelines as Topic; Problem Solving; Quality Control; Quality of Health Care; Radiation Oncology; Radiology Information Systems; Radiopharmaceuticals; Rectal Neoplasms; Stomach Neoplasms; Tomography, Emission-Computed | 1997 |
FDG PET in head and neck cancer.
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Neoplasms, Unknown Primary; Radiopharmaceuticals; Salivary Gland Neoplasms; Tomography, Emission-Computed | 1997 |
Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography.
Topics: Animals; Antineoplastic Agents; Biopsy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Radiopharmaceuticals; Risk Factors; Survival Analysis; Survival Rate; Time Factors; Tomography, Emission-Computed | 1997 |
Positron emission tomography in the evaluation of the N0 neck.
Topics: Carcinoma, Squamous Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidence; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Early prediction of treatment outcome in head and neck cancer with 2-18FDG PET.
Topics: Adult; Aged; Animals; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 1997 |
Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.
Topics: Abdomen; Abdominal Neoplasms; Adenocarcinoma; Axilla; Bone Marrow; Bone Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Neck; Observer Variation; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Non-invasive estimation of the net influx constant using the standardized uptake value for quantification of FDG uptake of tumours.
Topics: Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
[Value of 18F fluorodeoxyglucose positron emission tomography in radiotherapy planning of head-neck tumors].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Radiotherapy Planning, Computer-Assisted; Tomography, Emission-Computed | 1998 |
Nuclear medicine: the road to smart medicine and surgery.
Topics: Brain Diseases; Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Heart Diseases; Humans; Lung Neoplasms; Nuclear Medicine; Radionuclide Imaging; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Diseases | 1998 |
Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Diagnostic Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Evaluation Studies as Topic; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Mouth Neoplasms; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 1998 |
The use of positron emission tomography scanning in occult and recurrent head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Coregistration of FDG PET and MRI of the head and neck using normal distribution of FDG.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Reference Values; Tissue Distribution; Tomography, Emission-Computed | 1998 |
Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Uses and limitations of FDG positron emission tomography in patients with head and neck cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 1999 |
Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Biopsy; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 1999 |
Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study.
Topics: Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Pilot Projects; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
[Positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) in the diagnosis and preoperative staging of head and neck tumors: a prospective study].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Prospective Studies; Tomography, Emission-Computed | 1998 |
Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Middle Aged; Neoplasms; Phantoms, Imaging; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Radiotherapy, High-Energy; Tomography, Emission-Computed | 1999 |
Head and neck cancer: detection of recurrence with three-dimensional principal components analysis at dynamic FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Reproducibility of Results; Tomography, Emission-Computed | 1999 |
[F-18 FDG PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
FDG PET imaging of malignant paraganglioma of the neck.
Topics: Aged; Cerebral Angiography; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Paraganglioma; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
FDG positron emission tomography in head and neck cancer: pitfall or pathology?
Topics: Adult; Aged; Artifacts; Blood Glucose; Diagnosis, Differential; Fasting; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iatrogenic Disease; Image Processing, Computer-Assisted; Middle Aged; Muscle Contraction; Muscle, Skeletal; Neoplasm Recurrence, Local; Neoplasm Staging; Papilloma; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Wound Healing | 1999 |
Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in a routine clinical setting.
Topics: Academic Medical Centers; Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Neck; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
The diagnostic value of positron emission tomography (PET) with radiolabelled fluorodeoxyglucose (18F-FDG) in head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Nose Neoplasms; Pilot Projects; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tonsillar Neoplasms | 1999 |
Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 1999 |
Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.
Topics: Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Second Primary; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection.
Topics: Adult; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Respiratory Tract Infections; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Reduced F-18 fluorodeoxyglucose uptake within marrow after external beam radiation.
Topics: Adult; Bone Marrow; Carcinoma, Squamous Cell; Cervical Vertebrae; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neoplasm, Residual; Radiopharmaceuticals; Radiotherapy, High-Energy; Tomography, Emission-Computed | 2000 |
Deoxyglucose uptake by a head and neck squamous carcinoma: influence of changes in proliferative fraction.
Topics: Biomarkers; Carcinoma, Squamous Cell; Cell Count; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lactic Acid; Radiobiology; Radiopharmaceuticals; S Phase; Tumor Cells, Cultured | 2000 |
Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomas.
Topics: Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Risk Assessment; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer.
Topics: Adult; Aged; Denmark; Diagnosis, Differential; Female; Finland; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
[Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Palpation; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
FDG positron emission tomography in head and neck cancer.
Topics: Blue Cross Blue Shield Insurance Plans; Clinical Trials as Topic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Outcome Assessment, Health Care; Radiography; Radiopharmaceuticals; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration | 2000 |
Direct comparison of F-18-FDG PET and ultrasound in the follow-up of patients with squamous cell cancer of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography | 2000 |
Reduced F-18 FDG uptake with marrow may predict photopenia of corresponding vertebrae on bone scintigraphy.
Topics: Bone Marrow; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Radiopharmaceuticals; Radiotherapy, High-Energy; Tomography, Emission-Computed | 2001 |
Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Thallium Radioisotopes; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Otorhinolaryngologic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Coincidence detection FDG PET in the management of oncological patients: attenuation correction versus non-attenuation correction.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
[Positron emission tomography in head and neck oncology: five cases].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Pharyngeal Neoplasms; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[[F-18]FDG imaging of head and neck tumors: comparison of hybrid PET, dedicated PET and CT].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cost-Benefit Analysis; Decision Trees; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Life Expectancy; Lymphatic Metastasis; Middle Aged; Models, Econometric; Morbidity; Neck Dissection; Neoplasm Staging; Quality-Adjusted Life Years; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2001 |
Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals | 2001 |
Positron emission tomography in the evaluation of stage III and IV head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Pilot Projects; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2002 |
FDG-PET. A possible prognostic factor in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed; Treatment Outcome | 2002 |
FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Survival Rate; Tomography, Emission-Computed; Treatment Outcome | 2002 |
[Positron emission tomography in head and neck oncology].
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Risk Factors; Time Factors; Tomography, Emission-Computed; Tongue Neoplasms; Tonsillar Neoplasms | 2001 |
Lymph node staging in extracranial head and neck cancer with FDG PET--appropriate uptake period and size-dependence of the results.
Topics: Adult; Aged; Biological Transport; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Injections, Intravenous; Lymph Nodes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Observer Variation; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed; Ultrasonography | 2002 |
Head and neck imaging with PET and PET/CT: artefacts from dental metallic implants.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Dental Restoration, Permanent; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer.
Topics: Adult; Aged; Bronchoscopy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry.
Topics: Carcinoma, Squamous Cell; Deoxyglucose; DNA, Neoplasm; Flow Cytometry; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Tomography, Emission-Computed | 1991 |
Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose.
Topics: Deoxy Sugars; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Radionuclide Imaging; Radiotherapy, High-Energy | 1988 |
Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors.
Topics: Aneuploidy; Cell Division; Deoxy Sugars; Deoxyglucose; DNA, Neoplasm; Flow Cytometry; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Radionuclide Imaging | 1988 |